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                                                   ABSTRACT 
Zhu, Wenhan Ph.D., Purdue University, December 2014. Interactions between 
Host Cell Death Pathways and Legionella pneumophila. Major Professor: Zhao-
Qing Luo. 
 
 Legionella pneumophila is an intracellular pathogen that causes a severe, 
atypical pneumonia termed Legionnaires’ disease. Upon entering the host cell, L. 
pneumophila resides in a membrane-bound vacuole, in which the bacterium 
evades lysosomal fusion and replicates. The establishment of the vacuole 
requires the Dot/Icm (Defect in organelle trafficking/intracellular multiplication) 
transport system, which translocates a large number of substrates into host cells 
to re-orchestrate various cellular processes, such as intracellular trafficking, 
protein synthesis and host cell death pathways. Therefore, a key step in 
understanding the biology of Legionella is to dissect the mechanisms of action of 
the Dot/Icm substrates. A large number of Dot/Icm substrates with diverse 
biochemical functions have been identified by various strategies, based on one 
or more characteristics associated with the candidate proteins. Given the high 
level of diversity exhibited by the identified substrates, it is possible that some 
substrates have been missed in these screenings. The “missing” substrates will 
certainly hinder further studies of L. pneumophila pathogenesis. To solve this 
problem, we took a systematic approach to test Dot/Icm-dependent translocation 
of L. pneumophila hypothetical proteins larger than 100 residues. By fusing the 
gene of interest with β-lactamase, we determined the transfer of the fusions into 
mammalian cells using the β-lactamase reporter substrate CCF4-AM. 164 
Dot/Icm substrates were identified in this screening, which led to the expansion 





facilitated future studies on the biology of L. pneumophila and its interaction with 
hosts.  
 As an important determinant of the outcome of infection, cell death 
pathways are the target of L. pneumophila. Surprisingly, permissive 
macrophages challenged by L. pneumophila are resistant to exogenous cell 
death stimuli despite harboring high levels of active caspase-3. How this 
bacterium achieves such a balance in these cells remains elusive. Several 
reports have described L. pneumophila effectors that contribute to pro-survival 
signaling cascades, however, the Dot/Icm substrates that are responsible for 
caspase-3 activation has not been documented, nor was the mechanisms 
underlying such activation. Taking advantage of the expanded list of L. 
pneumophila Dot/Icm effectors, we initiated a screening to survey all known 
effectors for the ability to activate caspase-3. Our screening led to the discovery 
that at least five Dot/Icm substrates, Lpg0716, Lpg0898, Lpg1831, Lpg1625 and 
Lpg2716, activate caspase-3 when ectopically expressed in mammalian cells. 
We further demonstrated that one of these effectors, VipD (lpg2831), is a 
phospholipase A2 that hydrolyzes the phosphatidylethanolamine (PE) and 
phosphatidylcholine (PC) on the mitochondrial membrane in a manner that 
appears to require host cofactor(s). The lipase activity is essential to its ability to 
activate caspase-3 via the production of free fatty acids and 2-lysophospholipids, 
which destabilize the mitochondrial membranes. Mitochondria membrane 
destabilization may contribute to cytochrome c release and subsequent activation 
of caspase-3. Moreover, whereas caspase-3 activation does not seem to play 
significant roles in limiting L. pneumophila replication in permissive macrophages, 
it is essential to restricting bacterial growth in dendritic cells. We further 
demonstrated that genetic ablation of all five caspase-3 activating effectors 
dampens apoptosis activation in dendritic cells. Our result demonstrate that the 
activation of host apoptosis pathway is a collective effects of multiple effectors 






Host cell death is an integrated component of the immune defense against 
infections. Although amazing strides have been made in how the innate immune 
system responds to Legionella at the interface of host cell death, most if not all of 
these knowledge was acquired using laboratory strains derived from a few 
clinical isolates. To investigate how primary macrophages respond to Legionella 
environmental isolates, which are responsible for most of the Legionnaires’ 
disease outbreaks so far, we analyzed the intracellular growth of a few such 
isolates in A/J mouse macrophages, which is permissive to most, if not all, 
laboratory strains. None of the Legionella environmental isolates were able to 
replicate in these macrophages. Further investigation into one of the isolates, 
LPE509, revealed that such growth restriction is not due to the lack of important 
pathogenic determinants, as this strain is competent of replication in two 
protozoan hosts and the human macrophage U937 cell. Moreover, the inability of 
LPE509 to replicate intracellularly is accompanied by host cell death of unique 
features, as it is independent of most cell death signaling components known to 
control Legionella infection. In an attempt to screen for the factor(s) of LPE509 
responsible for host cell death and growth restriction, we found that a 
spontaneous streptomycin resistant mutant had gained the ability to overcome 
the growth restriction in primary mouse macrophages. Analysis of the mutant 
strain showed a lysine to arginine substitution on position 88 of the 30S ribosome 
small subunit S12 (RpsL, lpg0324) severely attenuates the host cell death 
induction and enables the bacterium to replicate in macrophages. However, 
another spontaneous streptomycin-resistant mutation (Lys 43 to Asn) of rpsL did 
not allow efficient replication of LPE509 in A/J macrophages, suggesting that 
streptomycin per se is not the cause of replication restriction of LPE509. Further 
sequence analysis revealed that commonly used laboratory strains such as Lp02 
and JR32 also harbor the K88R allele of rpsL. Replacing rpsLK88R allele with its 
wild type counterpart completely abolishes the ability of these strains to replicate 
in A/J mouse macrophage, suggesting that rpsL governs the intracellular fate of L. 





diverse bacterial species prompted us to test whether the RpsL protein per se is 
responsible for the induction of host cell death. Indeed, delivery of RpsL into 
mouse macrophages elicits a noncanonical form of cell death involved in the 
permeabilization of lysosomal membranes. Upon the loss of lysosome 
membrane integrity, various hydrolases are released into the cytosol, where they 
process diverse substrates and cause cell death. Amongst these hydrolases, 
cathepsin B plays an important role in RpsL induced cell death, as genetic 
ablation of this gene dampens host cell death induced by recombinant RpsLWT or 
Legionella expressing wild type RpsL. Taken together, our results suggested that 
RpsL is a microbial associated molecular pattern (MAMP) that triggers a unique 
cell death pathway in mouse macrophages, which limits the spread of invading 





CHAPTER I: GENERAL INTRODUCTION 
 
Legionella and Type IV Secretion System 
          In 1976, during the American Legion Convention, 221 American veterans 
were affected by a mysterious infectious disease, which claimed 34 lives. Three 
years later, the causative agent for this highly concerning outbreak was identified 
and designated as Legionella pneumophila, which is a gram-negative bacterium 
that belongs to the γ-proteobacteria [1]. Further studies revealed that L. 
pneumophila is a facultative intracellular pathogen that infects a wide range of 
hosts, from fresh water amoebae to mammalian alveolar macrophages [2]. 
Inhalation of L. pneumophila contaminated aerosols by immune-compromised 
individuals can result in an atypical acute pneumonia known as Legionnaires’ 
disease [3]. Early studies of L. pneumophila pathogenesis using techniques such 
as electron microscopy revealed many interesting features associated with 
infection of this bacterium. For example, upon phagocytosis by macrophages, the 
phagosome containing L. pneumophila does not undergo the canonical pathway 
of lysosomal fusion for degradation; rather it forms an organelle, the Legionella 
containing vacuole (LCV), which recruits selected host proteins and lipids to 
construct a niche permissive for bacterial replication (Fig. 1-1) [4-6].  
            To better understand the pathogenesis of the L. pneumophila, genetic 
screenings were initiated to identify genes that are essential for this bacterium to 
replicate intracellularly. By passing L. pneumophila in rich medium, which 
potentially relives the bacterium from selection pressure to infect eukaryotic hosts, 
Horwitz obtained a mutant named 25D, which had lost the ability to replicate in 





 group later attempted to complement the growth defect of the 25D mutants with 
genomic fragments of the wild type bacterium to identify the genetic elements 
that are important for the bacterial intracellular replication [7]. These efforts led to 
the identification of the icm (defect in intracellular multiplication) genes [7]. On the 
other hand, based on the observation that thymidine-auxotrophs of L. 
pneumophila showed decreased survival in human monocytes in the absence of 
exogenous thymidine, the Isberg group reasoned that mutants that are also 
defective in intracellular replication should survive better, because such strains 
would need less thymidine for replication [8]. Utilizing the “thymidineless death” 
strategy to enrich L. pneumophila mutants that are unable to replicate 
intracellularly, the Isberg group generated a Tn-5 based transposon library of 
Lp02 [9], a thymidine auxothroph of L. pneumophila, and screened for mutants 
that survive thymidine starvation. Analysis of the genomic fragments that could 
complement the intracellular replication defects of these mutants revealed that 
the dot (defect in organelle trafficking) genes are important for the intracellular 
replication and subversion of host organelle trafficking [10]. Taking advantage of 
the phenotypic link between resistance to low amount of sodium and the inability 
to replicate in macrophages, the same group obtained a total of 26 L. 
pneumophila mutants that are incapable of multiplying intracellularly [11]. It is 
worth noticing that most of the dot and icm genes are identical, and the sum of 
these genes was proposed to assemble into an apparatus essential for L. 
pneumophila infection. Although genetic inactivation of many of these genes 
leads to impaired organelle recruitment and defects in intracellular multiplication, 










Fig. 1-1 Life cycle of L. pneumophila  Upon phagocytosis, L. pneumophila 
injects a large number of Dot/Icm substrates to manipulate numerous host 
processes, such as evasion of lysosomal fusion and recruitment of ER-derived 
vesicles, to establish a replicative vacuole. The bacterium replicates in the 














             Further analysis revealed that the Dot/Icm proteins are required for 
transferring DNA such as the IncQ plasmid RSF1010. Such capability, together 
with the association of virulence, and the limited homologies of some Dot/icm 
proteins with the structural components  of the Agrobacterium tumefaciens T-
DNA transfer system, prompted researchers to postulate that the Dot/Icm system 
proteins assemble into a complex with conjugation activity, which belongs to the 
Type IV Secretion System (T4SS) [12]. Shortly after Vogel et al proposed the 
possible origin of the Dot/Icm system, the sequence of the Shigella Collb-P9 IncI 
conjugative plasmid became available [13, 14]. The close resemblance at both 
gene sequences and organization level between the Dot/Icm genes and the 
tra/trb genes on the Collb-P9 plasmid prompted Segal and Shuman to propose 
that the Dot/Icm system should be defined as a Type IVb secretion system, while 
the machines that are similar to the A. tumefaciens VirB system being Type IVa  
[13, 15].  
 
 The molecular functions of the Dot/Icm components were mostly revealed 
through 1) analyzing the phenotypes or 2) the change of Dot/Icm macro-
molecular structure associated with the genetic ablation of one or more of these 
components, or 3) the physical interactions between different components or 
substrates of the system. For example, deleting IcmF and IcmH decreases the 
protein level of DotH and DotG, suggesting that IcmF/H may function to regulate 
the homeostatic levels of DotH and DotG [16]. Further biochemical and genetic 
analysis suggested that DotG forms the central tunnel of the apparatus, with 
DotC and DotD being the outer membrane components [17]. Advances in 
electron microscopes have made visualization of multi-protein, macro-molecule 
machinery such the bacterial translocation system possible [18]. A recent 
transmission electron microscopy analysis of Legionella Dot/Icm system 
demonstrated the ring-shaped structure of the core complex. This report also 
showed the importance of DotC, D, H, G and DotF in Dot/Icm system, as the 





and forms a premature and distinct structure in the absence of DotG or DotF [19]. 
Analysis of other Dot/Icm components such as IcmS and IcmW revealed that 
these two proteins interact with multiple substrates, and that the deletion of either 
one of these two proteins abolishes the translocation of some, but not all 
substrates [20]. Therefore, these two proteins are considered as the soluble 
chaperones of the Dot/Icm substrates [21]. Moreover, yet another Dot/Icm 
component, IcmT, has been linked with bacterial pore-formation mediated exist 
from infected cells, as ablating this gene causes the bacterium to be “trapped” 
inside of the infected cell [22].  
 
          The most important function of a specialized bacterial secretion system is 
to deliver into the host cells the effector proteins that can subvert host processes 
for the benefit of the bacterium. It is therefore not surprising that the nature of the 
substrates of the Dot/Icm secretion system had attracted extensive attention 
since the discovery of the system [15]. Although the Dot/Icm of L. pneumophila 
could deliver DNA into the host as seen in Agrobacterium tumefaciens, it is also 
possible that this system delivers protein substrates, as in the case of Bordetella 
pertussis [23, 24]. The requirement for this transport system within minutes of 
bacterial uptakes hints towards the latter possibility [25]. By examining the 
partially sequenced L. pneumophila genome, Sexton and Vogel noticed a 
bacterial ORF with extensive homology to Sec7 domain found in some eukaryotic 
proteins involved in vesicle trafficking, which functions as an GEF (guanine 
exchange factor) for the small GTPase Arf1[26]. The presence of the Sec7 
domains hinted that this protein may potentially be a substrate of the Dot/Icm 
system, as other bacterial proteins with eukaryotic homology, such as Sptp and 
YopH from S. typhimurium and Y. pestis respectively, had been demonstrated to 
be secreted by bacterial translocation systems [27]. Experimental verification of 
the translocation of this protein, named RalF, lent support to the proteinaceous 
nature of the Dot/Icm substrates [28]. Since the revelation of RalF as the first 





mining of new substrates of the system as well as their molecular functions, 
which had and will continue to shed light on the understanding of the biology of L. 
pneumophila. 
Translocation Assay System and Dot/Icm Substrate Identification 
Intensive efforts devoted into the mining of Dot/Icm substrates and the 
dissection of their biochemical functions have made exciting progress in the past 
decade. Effector proteins with novel enzymatic function and intriguing virulence 
strategies have greatly enhanced our knowledge not only on the biology of L. 
pneumophila but also of bacterial pathogenesis in general. However, our 
understanding of L. pneumophila virulence factors is far from complete. This is 
partly due to the incomplete knowledge of protein substrates translocated by 
Dot/Icm system. Several methods have been developed to measure Dot/Icm 
mediated translocation of protein substrates:1) detection of the presence of the 
protein candidates using immunostaining of infected cells or/and isolated LCV 
[28]; 2) interbacterial transfer of a fusion protein containing the candidate gene 
and the Cre recombinase, which removes the marker gene from the genome of 
the recipient cell (an antibiotic resistant marker, for example). The transfer is then 
measured by the deletion of this marker in the recipient cells [29]; 3) restoration 
of a transfer-deficient mutant of SidC by fusing this mutant to the gene of interest 
(GOI) [30, 31]; 4) bacteria-to-mammalian cell transfer and activation of a fusion 
protein containing GOI and CyaA, the calmodulin-dependent adenylate cyclase 
from Bordetella pertussis [32, 33]; 5) the transfer of a beta-lactamase fusion 
protein into the mammalian cell. As the fusion protein could cleave the pre-
loaded substrate CCF-4AM to make it emit different wavelength of fluorescence 
than its intact form, the protein transfer is then measured by the ratio of 
florescence intensity by the cleaved/intact substrates [34]. Most of the Dot/Icm 
substrates were discovered by studying the candidate genes gathered by the 
following approaches: 1) bioinformatics analysis to retrieve candidate genes with 





proteins [35]; physical interaction with components of the Dot/Icm apparatus [29, 
36]; screening of their ability of disrupting cellular processes in Saccharomyces 
cerevisiae [37-39]; expression regulation profiling which is similar to known 
effectors [40, 41]; or self-learning computing strategies to search for protein 
harboring one or more features mentioned above [42]. The combination of these 
search methods and translocation assays have led to the identification of 204 
protein substrates translocated by Dot/Icm apparatus by 2010. As all previous 
screenings relied on the aforementioned criteria to select candidate genes, it is 
likely that these screens will miss some substrates with undefined features, 
especially considering the sheer number and the diverse function of the Dot/Icm 
substrates. Therefore, I led a project to obtain a more complete list of Dot/Icm 
substrates involved in the modulation of host functions, which would then pave 
the road for subsequent activity-based studies. To this end, I constructed more 
than 600 genes into the pXDC61M vector [43], which is suitable for expression of 
β-lactamase fusions in L. pneumophila, to test for Dot/Icm-dependent protein 
translocation by the FRET-based beta-lactamase assay. Moreover, because of 
the availability of a number of effective genetic and genomic tools, yeast is 
extremely useful in dissecting the molecular functions of pathogenic factors. 
Therefore, I also constructed all of these pGBKT7 plasmids that express each of 
these ORFs to test their capability to disrupt cellular processes of S. cerevisiae.   
Effector Modulation of Host Processes 
As more effectors have been identified and more of their functions 
revealed, it has become clear that elucidating the functions of these substrates 
will not only allow better understanding of  the mechanisms used by L. 
pneumophila to subvert host cellular processes but also could potentially reveal 
novel host signaling mechanisms that are undetectable or difficult to study under 
normal physiological conditions [6]. For examples, the small GTPase Rab1, 
which is a molecular switch involved in regulating vesicle trafficking between ER 





Amongst these effectors, SidM, which harbors both guanine nucleotide exchange 
factor (GEF) and adenylyl transferase activity, activates Rab1 and locks it in the 
activated state by transferring an adenylyl group (AMP moiety) from ATP onto 
the Tyr 77 residue at the switch II region of Rab1, ensuring that it is insensitive to 
unwanted inactivation by bacterial and host GAP [44-46]. Subsequently, another 
L. pneumophila effector SidD removes the adenylyl group in a manner similar to 
those of protein phosphatases [45]. Once the adenylyl group is removed, Rab1 
then becomes sensitive to inactivation by yet another L. pneumophila effector--
LepB for its effective removal from LCV membrane [47]. Amazingly, another 
effector pair, which also functions in a Yin & Yang manner, provides the 
bacterium additional layer of subversion of Rab1 function by 
transferring/removing a phosphocholine group to Rab1 [48, 49]. These studies 
provided us a fascinating example of how studies of bacterial effector functions 
could open the door to the previous unappreciated posttranslational modifications.   
 
Further analysis of the biochemical functions of Legionella effectors 
revealed that this bacterium also subverts a variety of other host cell processes 
beyond membrane trafficking [6]. For instance, when ectopically expressed, 
Dot/Icm substrates LegK1 and LnaB modulate the activation of NF-κB pathway 
[31, 50]; Also, L. pneumophila codes for multiple factors to further support 
sustained activation of NF-κB pathways by inhibiting host protein synthesis, thus 
preventing efficient biosynthesis of IκB, the inhibitor of NF-κB [51]. Further, this 
bacterium injects a V-ATPase specific inhibitor SidK into the host, which, when 
loaded into macrophages, inhibits vacuole acidification [38]. Last but not the least, 
L. pneumophila codes for a factor named SdhA, which maintains the membrane 
integrity of the LCV, allowing the bacterium to evade multiple host innate 







One other significant aspect of the cell biology during Legionella infection 
is phosphatidylinositol (PI) metabolism. It is well established that PIs play 
essential roles in a broad spectrum of cellular processes, such as remolding 
cytoskeleton, defining organelle identity and relaying cellular signaling events 
[53, 54]. Distribution of particular species of PIs in subdomains of cellular 
membranes licenses different biological events by recruiting effector proteins 
through binding of their cytoplasmic head groups to the cytosolic proteins or the 
cytosolic domains of membrane proteins [54]. As for bacterial infection process, 
PIs have been shown to be of particular importance, as PI species such PI3P is 
important for fusing the nascent phagosomes to lysosome, where non-
pathogenic bacteria are normally degraded. Therefore, it is not surprising that 
many pathogens code for virulence factors to subvert PI metabolism for their 
benefit. For instance, Shigella flexneri encodes a PI-4-phosphatase IpgD to 
reduce the level of phosphatidylinositol 4,5-bisphosphate (PIP(2)) at the plasma 
membrane, thereby inhibiting host T cell migration [55]. On the other hand, 
Salmonella typhimurium delivers the PI phosphatase SopB into the host to 
hydrolyze PI(3,4,5)P3, which contributes to the localized membrane ruffling to 
facilitate bacterial entry into nonphagocytic cells [56, 57]. Manipulation of host PI 
metabolism is also key to the establishing the replicative vacuole of Legionella—
the Legionella containing vacuole (LCV) [58, 59]. One of the PI species, PI(4)P, 
has been suggested to be enriched on LCV [60]. Several Legionella effectors 
which requires PI4P to anchor onto the membrane of LCV, such as SidM/DrrA, 
SidC, and SdcA have been identified, and SidF, the effector protein(s) that 
contributes to PI(4)P enrichment on LCV also been recently described [60]. 
Taken together, studies of the biochemical functions of Legionella effectors had 
added an amazing page to our understanding of host-microbe-interactions, and 
will continue to shed light on the intriguing war between these two forces.  
 
Despite the copious advances made on the biochemical functions of L. 





functional redundancy among the Dot/Icm substrates. L. pneumophila 
translocates more than 300 Dot/Icm substrates into the host cells, but deleting 
one or more of these substrates rarely results in detectable intracellular growth 
defect [6, 61, 62]. Further, ablating the effector proteins that have similar 
biochemical consequences or share the same host target does not result in 
defects in intracellular colonization either [62, 63]. More strickingly, SdhA, SidJ 
and MavN are the only three effectors whose deletion causes severe deficiency 
in L. pneumophila intracellular replication [64, 65]. The striking functional 
redundancy in L. pneumophila is further demonstrated by a recent study which 
revealed that seven distinct genomic clusters containing 27.1% of the Legionella 
genome are dispensable for bacterial growth in vitro. More remarkably, L. 
pneumophila mutant lacking six of such clusters, which contain more than 30% of 
the known Dot/Icm substrates, showed no significant growth defects in murine 
macrophages. However, L. pneumophila mutants lacking five such clusters 
showed differential defects in colonizing distinct amoebae species. This evidence, 
together with the low GC content and marked variability of these cluster, 
prompted the authors to propose that these clusters were acquired by acquired 
by the bacterium horizontally to maintain optimal growth in a vast variety of 
amoebae hosts [66]. Although this report shed light on the possible origin of the 
functional redundancy of L. pneumophila, the reason why this bacterium acquires 
and maintains such a large repertoire of Dot/Icm substrates remains to be one of 
the most intriguing challenges in the field. 
 
The functional redundancy has and will continue to puzzle the field of L. 
pneumophila. This problem is, however, not unsolvable, especially considering 
the emergence of novel strategies such iMAD (Insertional mutagenesis and 
depletion) [67]. The iMAD approach, on the other hand, is based on the 
hypothesis that Legionella effector proteins target multiple host pathways, 
therefore inactivating one host pathway or effector proteins targeting the same 





infection, inactivating one host pathway by siRNA and blunting Legionella 
effector proteins targeting another pathway via transposon mutagenesis may 
allow for identification of mutants with appreciable growth defect in vivo [66]. 
Using iMAD, the Isberg group identified 55 Dot/Icm effectors important for 
manipulating distinct host pathways [66]. This approach not only allows for 
surmounting the functional redundancy of Legionella effectors, but also provides 
information on the common host targets shared by distinct Dot/Icm substrates, as 
well as the functional prediction of uncharacterized effector proteins that are in 
the same functional group with the effectors with known functions [66]. iMAD, 
together with other emerging approaches, demonstrated that although the 
functional redundancy among Legionella effectors is a limiting factor for 
Legionella study, it could be a window of opportunities to further our 
understanding in the biology of this fascinating bacterium.  
Host Cell Death Pathways and L. pneumophila Infection 
The host cell death pathways are integrated components of the innate 
immune system that defends against infection and they have become among the 
most important foci of the field, because they are one of the main determinants of 
the outcome of host and pathogen interaction. Upon entering the host cell, the 
pathogen will need to take advantage of the available nutrition from the host for 
its multiplication [68]. As the nutrition inside of the cell is depleted, the pathogen 
will need to leave the host and gain access to a new one to start a new cycle of 
infection [69]. Premature host cell death could be detrimental to the pathogen as 
it could remove the infected niche, kill the pathogen or exposes the pathogen to 
addition layer of immune surveillance [69]. Therefore, it is not surprising that host 
cell death is one of the effector mechanisms of the immune response. On the 
other hand, host cell death could also be beneficial to the pathogen as it could 






Different types of host cells death could result in distinct influence on the 
outcome of infection [71]. For example, apoptosis is licensed by the activation of 
the executioner caspases (cysteine-aspartic proteases)-caspase-3, 6, or 7, which 
cleave various cellular substrates, such as PARP (poly-(ADP-ribose) polymerase) 
and ICAD (inhibitor of caspase activated DNase) [71]. These events are then 
followed by characteristic chromatin condensation and fragmentation, cell 
shrinkage, and the formation of apoptotic bodies [71]. At the end of this process, 
the lipid phosphatidylserine, which is normally on the cytoplasmic surface of cells, 
redistributes to the extracellular surface of the apoptotic bodies, marking these 
structures available for phagocytosis by cells such as macrophages and 
neutrophils [71]. Because the cellular content is not released into the extracellular 
milieu, apoptosis is considered as a non-inflammatory and more “silent” form of 
cell death [72].  
 
On the contrary, pyrotopsis is a rapid, lytic cell death that releases 
inflammatory contents into the extracellular spaces [73]. This form of 
programmed cell death is initiated by the engagement of one or more of the 
pattern recognition receptors (PRRs) to the pathogen associated molecular 
pattern (PAMP) [74]. The engagement of the PRRs with their cognate ligands 
recruits caspase-1/11 to form the high molecular weight protein complexes 
termed inflammasomes, which are platforms for activating caspase-1 by inducing 
its dimerization and autoproteolysis [75]. The activated caspase-1/11 not only 
promotes the pore formation on the plasma membrane of the dying cell, but also 
induces the maturation and active secretion of inflammatory cytokines such as 
IL-18 and IL-1β into the extracellular milieu to attract additional layers of immune 
defense. Therefore, pyroptosis is generally considered as an inflammatory form 
of cell death [74].  
 
In addition to the two distinctive pathways, necroptosis also plays 





of cell death, necroptosis has now been established to be tightly controlled by 
defined molecules [76]. The major governors of necroptosis are the kinase RIP1 
(receptor interacting protein) and RIP3 [76]. Stimuli such as the engagement of 
TNF-α to TNFR, for examples, triggers the formation of the RIP1/RIP3/MLKL 
(mixed lineage kinase domain like) necroptosome, which promotes the rapid, lytic 
cell death followed the loss of the plasma membrane integrity [76]. The loss of 
plasma membrane integrity is accompanied by the dynamic release of CDAMP 
(cell death associated molecular pattern), which strongly attracts immune cells 
[77].   
 
In addition to these conventional pathways, accumulating evidence 
suggests the existence of yet another form of cell death--lysosomal cell death, 
which plays a pivotal role in numerous pathological conditions, such as stroke, 
acute pancreatitis, and parasitic and viral infections [78]. Similar to the roles of 
mitochondria in apoptosis and necroptosis, lysosomes, is the central signaling 
organelle for the lysosomal cell death pathway [79]. Upon perceiving stresses, 
the lysosome membranes destabilize, leading to the release of acidic content as 
well as various hydrolases including the members of the cathepsin protein family 
into the cytosol [80]. Some cathepsins are stable at physiological pH, thereby can 
process various cellular substrates upon translocation and initiate lysosomal cell 
death [81, 82]. Apparently, not all the cathepsins play equal roles in such cell 
death, but rather, certain cathepsins are selectively released into the cytosol, or 
some of them play a more dominant role than others [82]. For example, 
cathepsin B plays a dominant role in tumor necropsies induced by Granulysin, 
while cathepsin D is more important in triggering apoptosis when T lymphocytes 
enter the early commitment phase [83, 84].  
 
The release of cathepsins into cytosol could also activate downstream 
pathways shared by conventional apoptosis, pyroptosis, and necroptosis. For 





mature form (tBID), which inserts into the outer membrane of mitochondria to 
trigger mitochondria outer membrane permeabilization (MOMP) in a Bax 
dependent manner [85, 86]. The permeabilized mitochondria then release 
cytochrome c into the cytosol, where it initiates the assembly of the multi-protein 
complex termed apoptosome to activate the initiator caspase, caspase-9. 
Activated caspase-9 then activates the executioner caspase, caspase-3 [86]. 
Depending on the specific signaling context, cathepsins redistribution into the 
cytosol could also lead to either pyroptosis via the activation of the NLRP3 
inflammasome by ROS burst, or the caspase-independent necrotic cell death 
when caspases are inhibited [78]. Therefore, lysosome membrane 
permeabilization could commit the cell to the “point of no return”, as inhibiting a 
single cell death regulator cannot effectively block such cell death. The 
importance of such a form of cell death during microbial infections has been 
documented, such as those by Mycobacterium tuberculosis and HIV. The 
outcome of this type of cell death, however, could vary, as it could play important 
roles in limiting viral infection or allowing the bacteria to egress from the dying 
host [87, 88].  
Subversion of Host Cell Death Pathways by L. pneumophila 
Since host cell death is of such importance to microbial infection, it is 
thereby not surprising that these pathways are the “hotspots” for pathogen 
manipulations [72]. For instance, Coxiella burnetii, a pathogen that is closely 
related to L. pneumophila, translocates multiple virulence factors through its 
Dot/Icm apparatus to inhibit host apoptosis. One such factor is AnkG, which 
antagonizes the host apoptosis pathway possibly by binding to the host 
mitochondria protein p32 [89]. Anaplasma phagocytophilum, another intracellular 
vacuolar pathogen, injects a Dot/Icm substrate, Ats-1, into the host cell, which 
translocates to host mitochondria and interferes host apoptosis induction [90]. 
Further, Mycobacterium tuberculosis codes for a Type I NADH-dehydrogenase 





Pyroptosis pathway is also targeted by various pathogens. Yersinia pestis 
for example, codes for a T3SS effector YopM, which structurally mimics the 
substrates of caspase-1, inhibits caspase-1 activity through direct binding [92]. 
This bacterium also injects another T3SS effector protein, YopK, into host cells to 
mask the T3SS translocon from the recognition by the inflammasome [93]. 
Moreover, ExoU, a phospholipase A2 translocated by the T3SS of P. aeruginosa, 
also dampens the inflammasome activity, although the mechanisms of action is 
still unknown [94]. Further, pneumolysin, the pore-forming toxin coded by S. 
pneumonia has also been implicated in blunting the caspaspe-1 activation [95]. 
This is surprising, however, because the pore-formation activity of other bacterial 
toxins triggers the activation of NLRP3 inflammasome [95].  
 
To avoid premature termination of bacterial replication, apoptosis inhibition 
is important for the establishment of the replicative vacuole of L. pneumophila.  
Consistent with this notion, permissive cells infected by L. pneumophila exhibit 
remarkable resistance to exogenous cell death stimuli, and such resistance 
requires a functional Dot/Icm system [96, 97]. This anti-apoptotic phenotype 
appears to be the result of the collective functions of several effector proteins, 
such as SdhA, LegK1, Lnab, and SidF [50, 98, 99]. Intriguingly, despite their 
capability to resist cell death stimuli, the cells harboring actively replicating L. 
pneumophila also contain high levels of active caspase-3 [100, 101], indicating 
the presence of a balance between the pro-death and pro-survival signaling. 
Clearly, in permissive mammalian cells, the activation of caspase-3 does not lead 
to restriction of L. pneumophila replication. Interestingly, the effect of such 
activation becomes apparent in the interactions between L. pneumophila and 
dendritic cells (DC). Infection of DCs by L. pneumophila causes extensive 
apoptotic cell death in a process that is dependent upon caspase-3 or Bax/Bak, 
two critical regulatory proteins in the mitochondrial cell death pathway [102]. 
Despite a plethora of literature documenting the anti-apoptotic pathways induced 





activating caspase-3, or the mechanisms behind it [103, 104]. Therefore, 
investigation is warranted to identify these factors and their molecular 
mechanism of caspase-3 activation. To achieve this goal, I performed a 
screening to identify Dot/Icm substrates capable of activating this enzyme upon 
transient expression in mammalian cells. These efforts led to the identification of 
five proteins with such activity. Among these five proteins, I chose to focus on 
VipD, because VipD bears significant homogy to the putative conserved patatin-
like phospholipase A2, and that our laboratory has the necessary reagents and 
expertise to study such proteins. 
 
Patatins are a family of proteins that catalyze the hydrolysis of 
phospholipids at the sn-2 position, liberating a fatty acid and a 2-lysophospholipid 
molecule. Patatin-like-proteins (PLPs) are found in both eukaryotes and bacteria 
and share the conserved GxSxG and DGx (x: any amino acid) catalytic dyad 
motifs that are essential for their phospholipase activity [105]. PLPs play critical 
roles in diverse aspects of lipid metabolism and signal transduction, such as 
membrane trafficking, inflammatory response and apoptosis. Many pathogens 
code for PLPs to facilitate their infection and dissemination [106]. For example, 
ExoU, a phospholipase A2 from Pseudomonas aeruginosa plays an important 
role in diverse aspects of its interactions with hosts such as the inhibition of 
caspase-1 mediated inflammatory responses [94]. L. pneumophila is predicted to 
code for at least 11 PLPs, but the activity of most of these proteins has not yet 
been characterized [107]. The Dot/Icm substrate VipD is one such predicted PLP 
that was first identified in a screening for L. pneumophila Dot/Icm effectors by 
their ability to interfere with membrane trafficking in the budding yeast [108]. This 
protein harbors a phospholipase A2 motif, which has been shown to be essential 





Immune Recognition and L. pneumophila Infection 
A fundamental aspect of immune system lies in its capability to 
differentiate “self” from “non-self”. The innate immune system branch achieves 
such recognition by employing an arsenal of germ-line coded PRRs (Pattern-
Recognition-Receptor) distributed on different cellular locales to perceive the 
presence of the MAMPs (Microbe-Associated-Molecular-Pattern) from microbes, 
in order to initiate and calibrate appropriate immune responses [109].  
 
The PRRs can be categorized based on the subcellular location where the 
receptor initiates signaling. Toll-like-receptors (TLRs) and C-type lectins are 
among the most well characterized membrane associated receptors that mainly 
function to recognize extracellular ligands (some TLRs are located in endosomes 
that recognize intracellular ligands) [110]. These receptors recognize a wide 
ranges of ligands. For example, the mouse genome codes for 12 TLRs, and the 
ligands to these receptors includes bacterial lipopolysaccharides (LPS), 
peptidoglycans, triacyl lipopeptides, and flagellin, as well as the zymosan of fungi 
[111]. On the other hand, C-type lectins are a family of carbohydrate-binding 
proteins, and the most prominent member of this family is the Dectin-1, which 
recognizes exogenous β-glucans [112]. Upon engaging their agonists, these 
receptors activates downstream transcription factors, such as NF-κB and 
interferon-regulatory-factors (IRFs), to promote the production of inflammatory 
cytokines and type-I interferon, respectively [111]. TLR4, for example, turns on 
the expression of inflammatory cytokines after encountering its cognate 
substrate--LPS by activating the NF-κB and Ap-1 pathway in a TIRAP (Toll-
Interleukin 1 Receptor (TIR) Domain Containing Adaptor Protein) and Myd88 
(Myeloid Differentiation Primary Response 88) dependent manner [113]. A 
second pathway is triggered as the LPS-bound TLR-4 is internalized into the 
endosomal network and regulates Type I Interferon expression vis two adaptor 
TRIF (TIR-domain-containing Adapter-inducing Interferon-β) and TRAM(TRIF-





The cytosol of mammalian cell is considered as the “sacred temple” that is 
highly sensitive to foreign biomolecules. It is therefore not surprising that 
mammal code for a huge number of cytoplasmic PRRs, including the NOD-like 
receptors (NLRs), pyrin and HIN domain containing family (PYHIN), RIG-I-like 
receptors (RLRs) and a large number of cytosolic nucleic acid sensors, to guard 
the cytosol from invading microbes [111]. The downstream signaling cascades of 
cytoplasmic PRRs are more diverse than those of TLRs. NOD1 and NOD2, 
members of the NLR family, for instance, activate NF-κB and IFN-β production 
upon the engagement of their cognate ligands [115]. Other NLRs, however, drive 
the assembly of a large protein complex termed the inflammasome, which 
causes pyroptotic cell death, and the secretion of mature inflammatory cytokines, 
such as IL-1β and IL-1α and IL-18 [116]. The diverse ligand recognition capacity 
of NLRs makes them one of the most important guardians of the cytoplasm. For 
example, NLRP1b responds to the protease activity of the lethal toxin of B. 
anthracis and infection by Toxoplasma gondii [117], whereas the AIM2 
inflammasome responds to cytosolic DNA molecules, which contributes to the 
recognition of vacuolar bacteria that aberrantly enter the cytosol, such as the 
sdhA mutant of L. pneumophila [118, 119]. With the help of the NAIP (baculoviral 
IAP repeat-containing protein 1, neuronal apoptosis inhibitory protein) proteins 
for expanded specificity, the NLRC4 inflammasome responds to many bacterial 
MAMPs, such as the rod and needle proteins of bacterial Type III secretion 
system as well as flagellin [120]. The inflammasome that has the widest range of 
MAMP sensing is the NLRP3 inflammsome, which can be activated by bacterial, 
fungal, viral pathogens, as well as pore formation toxin, protein amyloid, 
extracellular ATP, and inorganic substances such as silica and alum [116].  
 
Other cytoplasmic PRRs such as RLRs, including retinoic acid-inducible 
gene I (RIG-I), LGP2 and melanoma differentiation-associated protein 5 (MDA5), 
detect nucleic acid and their derivatives, which are one of most important 





to promote the prion conversion of MAVS (Mitochondrial antiviral-signaling 
protein), which signals to upregulate the production of IFN-β [121]. Of particular 
interest is the long-anticipated revelation of the major cytoplasmic dsDNA sensor, 
cGAS (Cyclic GMP-AMP synthase). This sensor is special in that it is an enzyme 
itself, which catalyzes the formation of cyclic GMP-AMP upon recognizing dsDNA. 
The cyclic GMP-AMP is then sensed by STING (STimulator of INterferon Genes), 
which signals the production of type I IFN [122, 123]. In the case of L. 
pneumophila, induction of type I interferon by macrophages only occurs when the 
cells are challenged with bacterial strains harboring a functional Dot/Icm 
machinery. Considering that the infection by this bacterium is associated with 
potential leak of DNA into the cytosol via the Dot/Icm transporter, and that the 
type I IFN response is STING-dependent, it has been proposed that the ligand(s) 
responsible for the activation is bacterial DNA [119, 124, 125]. 
 
MAMPs are not the only microbe-associated features that the immune 
systems are sensing [126]. The observation that different plants respond 
distinctively to the same pathogen has prompted the plant pathologists to 
postulate the “gene-for-gene” hypothesis, which suggests that resistant plants 
codes for the “resistant gene (R gene)” that is required for the recognition of the 
virulence factor “avirulence gene (Avr gene)” [126]. Since the presence of the Avr 
gene is sufficient to trigger immune responses from the resistant plants, it was 
proposed that the R gene product directly recognizes the gene product of the Avr, 
which is similar to the PRR-PAMP paradigm in metazoans [126]. However, as 
the interactions between Avr and R genes have rarely been demonstrated, and 
that the Avr genes usually code for bacterial virulence factors with distinct 
biochemical activities, Dangl and other researchers hypothesized that the R 
genes are not recognizing the Avr genes per se, but their biochemical 
consequences in the plant cells [127]. This hypothesis was further supported by 
the observation that Avr genes lacking their enzymatic activities are not 





consequences of bacterial effectors is defined as effector-triggered immunity (ETI) 
[128]. Evidence supporting this theory is plentiful in plants: R gene RPS2 senses 
the proteolytic cleavage of RIN4 by the Pseudomonas syringae effector AvrRpt2, 
and another R gene RMP1 recognizes the kinase activity of P. syringae T3SS 
substrates AvrB and AvrRPM1 [127]. Despite being well established in plants, 
whether the metazoan immune system functions in a similar way was not clear 
until recently. It was reported that Escherichia coli CNF (cytotoxic necrotizing 
factor-1) modifying host proteins RAC2 actives NF-κB pathway, and that pore 
formation activities by various bacterial toxins trigger inflammasome activation in 
a NLRP3 dependent manner [129, 130]. A recent report describing that the GAP 
(GTPase Activating Protein) activity of the Yersinia pestis T3SS effector YopE 
triggers killing of Yersinia in macrophages lent further support to the presence of 
ETI in mammals [131]. One of the first R gene equivalences in mammals was 
also recently identified:  Pyrin, the defining member of the Pyrin-domain-
containing protein (PYD) family, detects various bacterial modifications, such as 
ampylation, ADP-ribosylation, deamindation, glucosylation, on small GTPase 
RhoA at its switch I region and activates caspase-1 [132]. Taken together, ETI 
constitutes a newly emerging and import branch of innate immune surveillance in 
both plants and metazoans.  
 
ETI also contributes to immune recognition of L. pneumophila. It has been 
shown that infection of macrophages by wild type L. pneumophila but not a 
mutant deficient in Dot/Icm induces both the MAP kinase pathway 
(transcriptionally) and the NF-κB pathway [65, 133, 134]. Interestingly, protein 
synthesis inhibition conferred by five Dot/Icm substrates is part of the signals 
sensed by both the NF-κB and the MAP kinase pathways [135, 136]. Prolonged 
activation of the NF-κB pathway is achieved by the delayed re-synthesis of IκB, 
the labile inhibitory protein of NF-κB [136]. The MAP kinase response, on the 
other hand, is “frustrated”, because the genes involved in this pathway are 





signaling pathways that allow selective translation of at least two inflammatory 
cytokines, IL-1α and IL-1β, in a MyD88 dependent manner, providing further 
evidence of ETI in metazoan [99].  
 
Studying how L. pneumophila manipulates host pathways during infection 
is undoubtedly important to the understanding of Legionella and host interactions; 
also essential is the host immune responses elicited during infection, which 
seems to have equally great impact on the outcome of infection. Toll-like 
receptors play salient roles in innate immune defenses against L. pneumophila. 
TLR4 for examples, contributes significantly to the immune responses to L. 
pneumophila, as mouse macrophages lacking a functional TLR4 allele showed 
increased permissiveness to this bacterium [137]. Further, analysis of a regional 
outbreak of Legionnaires’ diseases showed that TLR4 polymorphisms is 
associated with the resistance to the disease [138]. Another TLR, TLR5, which 
recognizes bacterial flagellin and promotes TNF-?, IL-6, and other chemokines 
[139]. Consistent with the important role of TLR5 in innate recognition of L. 
pneumophila, individuals that bear non-functional TLR5 allele are more 
susceptible to the infection by this bacterium [140].  
 
Studies using mice lacking MyD88-/-, the common signaling adaptor for 
TLR pathways, lent further support to the importance of TLR receptors in host 
defenses against L. pneumophila. MyD88 deficient mice are impaired in 
production of TNF-α, IL-6 and IFN-γ, cytokines that are important in eliminating 
infected cells and controlling systematic bacteria dissemination. As a result, mice 
lacking MyD88 fail to clear L. pneumophila lung infection and eventually succumb 
to acute pulmonary infection, with bacteria spreading to lymph nodes and the 
spleen [141].  
 
 NOD receptors also contribute to L. pneumophila recognition, at least at 





heat-killed Legionella, NOD1 seems to play a dominant role in sensing Legionella, 
as mice lacking NOD1 are impaired in neutrophils infiltration and the ability to 
clear L. pneumophila in the lungs, while the mice lacking NOD2 respond normally 
to this bacterium [142]. Despite the apparent importance of NOD1 in Legionella 
recognition, the identity of the ligand and the molecular mechanisms of NOD1 
sensing remain elusive.  
 
Despite the fact that L. pneumophila dedicates almost 10% of the its total 
genomic capacity to code for virulence factors, most of the inbred mice strains 
are refractory to its infection, making the search for an appropriate animal/cellular 
model to study its pathogenesis frustrating [143]. This phenomenon, however, 
also hints that L. pneumophila could be a useful tool to dissect immune pathways 
that are difficult to study because they are not induced by other more adapted 
pathogens. For example, BMDMs (Bone Marrow Derived Macrophage) derived 
from C57BL/6 mouse challenged by L. pneumophila results in bacterial clearance 
accompanied by extensive, lytic host death termed pyroptosis, suggesting the 
involvement of active host immune responses [144]. However, macrophages 
from one particular strain, the A/J mouse, allow intracellular replication of L. 
pneumophila [143]. Taking advantage of the sharply different immune responses 
of the two mouse strains to L. pneumophila, Dietrich et al. mapped the genetic 
elements responsible for the permissiveness of A/J mice to the Lgn1 locus, which 
was later pinpointed to the gene Naip5 [145, 146]. The very same phenotype 
also was utilized to identify the bacterial factor that engages Naip5—flagellin, the 
conserved component of the bacterial flagellum [147, 148]. Further investigation 
of this pathways revealed that, upon engaging flagellin, Naip5 recruits and 
activates NLRC4, which recruits caspase-1 into inflammasome [149]. Formation 
of the NLRC4 inflammasome leads to the oligomerization and proteolytic 
activation of caspase-1, which promotes the processing and secretion of 
inflammatory cytokines (IL-18 and IL-1β) accompanied by rapid, lytic pyrototic 





replicative niche and further recruitment of other immune cells [151]. These 
exciting successes in revealing previously underappreciated immune pathways 
by studying L. pneumophila infection clearly demonstrate the great potential of 
investigating host responses using less adapted pathogens. A schematic 
presentation of the immune surveillance engaged by L. pneumophila is illustrated 





















Fig 1-2. Innate immune recognition of L. pneumophila A schematic 
presentation of the immune surveillance engaged by L. pneumophila. Note that 
the inhibition of protein synthesis conferred by the L. pneumophila is sensed by 
the host via a MyD88 dependent mechanism. Host perception of these activities 
promotes selective translation of pro-inflammatory genes such as IL-1α. RIG-I, 
retinoic acid-inducible gene 1; IRF-3, Interferon regulatory factor 3; STING, 
stimulator of interferon genes; MAVS, Mitochondrial antiviral-signaling protein; 
RNAPIII, RNA polymerase III; cGAS, cyclic GMP-AMP synthase; NOD1/2, 
Nucleotide-binding oligomerization domain-containing protein 1/2; TLR2, Toll like 
receptor 2; TLR5, Toll like receptor 5; MyD88, Myeloid differentiation primary 
response gene 88; NF-κB, nuclear factor kappa-light-chain-enhancer of activated 
B cells; Naip5, NLR family, apoptosis inhibitory protein 5; NLRC4, NLR family 
CARD domain-containing protein 4; AIM2, Absent in melanoma 2; Casp-1, 










Legionella and Underappreciated Host Immune Signaling  
Despite these exciting progresses, most of our understanding of L. 
pneumophila pathogenesis was based on the use of laboratory strains such as 
Lp02 and JR32 [152]. These laboratory strains were constructed from the original 
clinical isolate Philadelphia-1, necessitated by the need of effective genetic 
manipulations [152]. Further, because environmental bacteria are considered the 
primary source of outbreaks of Legionnaires’ disease, many studies have 
directed to analyze L. pneumophila isolated from natural or man-made water 
systems [153, 154]. Although some of these studies have examined intracellular 
bacterial growth of these environmental isolates in cultured human macrophages, 
few of them have determined the response of different hosts such as primary 
murine macrophages to challenge of these bacteria [154-156]. Last but not the 
least, because the primary evolutionary pressure for virulence of L. pneumophila 
comes from amoebae hosts, L. pneumophila does not seem to have evolved 
significant immune-evasive mechanisms. As a result, challenge of immune cells 
such as primary macrophages with this bacterium could lead to strong immune 
responses often not seen with more adapted pathogens. We recently found that 
LPE509, a strain recently isolated from a man-made facility was unable to 
replicate in A/J mouse macrophages, which is permissive to most, if not all 
laboratory strains [157]. As host cell death plays indispensable roles in limiting 
bacterial replication in the case of a resistant host challenged by L. pneumophila 
expressing flagellin, we set out to test whether host cell death plays a role in the 
growth restriction of LPE509. Our results revealed that infection by this strain in 
BMDM induces rapid and extensive cell death in a manner independent of the 
known mechanisms of cell death associated with by L. pneumophila [157]. These 
results suggested the strain LPE509 is capable of triggering a unique cell death 
pathway, probably by activating an immune surveillance system. In order to 
identify the factor encoded by LPE509 responsible for this cell death phenotype, I 
screened for LPE509 mutants that are capable of growing in A/J macrophages 





LPE509 to replicate in similar efficiency as laboratory strains. I demonstrate that 
RpsL, after accessing the host cytosol presumbly by the Dot/Icm secretion 
system of L. pneumophila, engages host immune systems and triggers the 





CHAPTER II: COMPREHENSIVE IDENTIFICATION AND FUNCTIONAL 
CHARACTERIZATION OF SUBSTRATES OF THE DOT/ICM TYPE IV 
SECRETION SYSTEM OF LEGIONELLA PNEUMOPHILA 
 
Abstract 
 The vacuolar pathogen Legionella pneumophila utilities a Type IV 
Secretion System (Dot/Icm) to translocate a large cohort of substrates into the 
host cells to coordinate various cellular pathways, such as intracellular trafficking, 
protein synthesis and host cell death pathways. A large number of Dot/Icm 
(Defect in Organelle Trafficking/ IntraCellular Multiplication) substrates have been 
identified by various strategies, based on one or more characteristics associated 
with the tested proteins. Given the high level of diversity exhibited by the 
identified proteins, it is possible that some substrates have been missed in these 
screenings. To better understand the interaction between host and L. 
pneumophila, we took a systematic approach to test Dot/Icm dependent 
translocation of L. pneumophila hypothetical orfs larger than 300 base pairs. The 
transfer of the fusions into mammalian cells was determined using the β-
lactamase reporter substrate CCF4-AM. 164 Dot/Icm substrates were identified 
in this screen and expanded the list of known Dot/Icm substrates by 70 effectors. 
Our effort has identified a large number of Dot/Icm substrates and facilitated 
future studies on the biology of L. pneumophila. 
Introduction 
 As a “master manipulator”, L. pneumophila subverts various host 





Dot/Icm of the bacterium, which injects a large number of virulence factors into 
the host [61]. Despite much exciting process made in understanding the biology 
of L. pneumophila, our knowledge of this bacterium is far from complete. Part of 
the reason is due to the lack of a comprehensive list of effector proteins 
translocated by the Dot/Icm of L. pneumophila [6]. Much effort have been 
dedicated in developing methods for measuring the translocation of Dot/Icm 
substrates into the host cells: such as immune-staining for the presence of 
effector protein(s) on LCV, cellular fractionation, CYA-based Elisa assay, and 
intra-bacterial protein transfer [158]. A recently developed beta-lactamase-based 
assay has been shown to be useful in detecting protein transfer by specialized 
bacterial secretion system [34]. This assay takes advantage of the fluorescence 
resonance energy transfer (FRET) between the coumarin and fluorescein 
fluorophores of the substrate CCF4-AM, which is disrupted when the beta-
lactamase fusion protein is delivered by the bacteria into the host cytosol. These 
features make beta-lactamase assay amenable to high throughput screening 
while retaining high sensitivity.  
Most screens for Dot/Icm substrates have chosen candidate genes with: 
features that are present mostly in eukaryotic organisms [35]; physical 
interactions with components of the Dot/Icm apparatus [29, 36]; or capabilities to 
disrupt cellular processes in S. cerevisiae [37-39]; or expression regulation 
profiles similar to known effectors [40, 41]. Self-learning computing strategies to 
search for protein harboring one or more features mentioned above have also 
been shown to be useful in such screens [42]. Although these methods and 
translocation assays have led to the identification of 204 protein substrates 
translocated by Dot/Icm apparatus by 2013, it is likely that these screens have 
missed some substrates with undefined features, as these screens are of a 
biased nature [6]. To this end, we initiated a genome wide screen, which 
surveyed hypothetical genes larger than 300 bp for novel effectors of L. 





Functional redundancy amongst Dot/Icm substrates makes L. 
pneumophila recalcitrant to many studies aiming at elucidating the roles of these 
proteins in infection [159]. For example, L. pneumophila codes for at least six 
virulence factors to interfere Rab1 function, and deleting some of these factors 
may not result in detectable phenotype [160]. Therefore, a comprehensive list of 
L. pneumophila effectors would certainly facilitate the functional studies of these 
protein, especially in the context of infection.  
Results 
Construction of a library expressing Legionella-protein-β-lactamase 
fusions 
In order to obtain a more complete list of protein substrates transferred 
by the L. pneumophila Dot/Icm system, I initiated a comprehensive screen to 
test Dot/Icm-dependent translocation of hypothetical proteins in strain 
Philadelphia-1. β-lactamase was chosen as the reporter because this system 
is applicable for large-scale screens while holding comparable, if not higher 
sensitivity than other systems such as the adenylate cyclase (Cya) assay [34]. 
In this method, each candidate gene is amplified and fused to TEM1 (β-
lactamase), and the bacterial strain expressing the fusion protein is used to 
infect differentiated human U937 cells. Infected U937 are then loaded with 
CCF4-AM which, when excited at 409 nm, emits green fluorescence (520 nm) 
due to fluorescence resonance energy transfer (FRET) between the coumarin 
and fluorescein fluorophores. Delivery of the β-lactamase fusion protein into 
host cells leads to cleavage of the β-lactam ring of CCF4-AM, releasing the 
two fluorophores and changing the fluorescence emission from green to blue 
(447 nm) when excited at the same wavelength. Translocation detected by 
this reporter can be easily quantitated by the percentage of infected cells 






To construct the fusion library, I first retrieved all the open reading frames 
larger than 300 base pairs annotated as hypothetical genes from the L. 
pneumophila Philadelphia 1 genome (Table 1). We chose 300 bp as the cut off 
parameters because most of the bacterial effector proteins discovered so far 
have specific enzymatic activity, and the probability that a gene smaller than 100 
amino acids codes for an enzyme is relatively low. After eliminating genes that 
have been reported as substrates of the Dot/Icm system at the time the project 
was initiated, a total of 833 candidate genes were obtained (Table 1). To make 
the process more amenable for large scale cloning, I first modified pXDC61 
plasmid in such a way that BamHI and SalI site could be used as “universal sites” 
to make in frame fusion of the genes of interest to TEM1 in this vector. I then 
examined whether there are BamHI/SalI sites on these genes. These two sites 
were used to design primers for the genes that cannot be digested by 
BamHI/SalI. For those which have one or more BamHI/SalI sites, BglII and XhoI 
were used as compatible site. For very limited number of genes that have 2 or 
more of these sites, alternative sites such as HindIII and NotI were used for 
cloning. To clone the genes, I designed primer pairs to amplify each open 
reading frame by PCR, used BamHI/SalI or BglII/XhoI to digest the inserts, and 
ligated them individually into pXDC61M to generate translational fusions with the 
upstream β-lactamase gene (Fig. 2-1, A). A total of 798 plasmids expressing the 
β-lactamase fusion were constructed. To examine the quality of the library, we 
randomly chose 30 L. pneumophila strains harboring the plasmid to detect the 
expression of the fusion proteins with an antibody specific for TEM1. Although 
the level of expression varies, a protein corresponding to the expected sizes of 
the chimeras was detected in most of the samples (Fig. 2-1, B), indicating that 






                 
 
Figure 2-1. Construction of a library expressing fusions of β-lactamase and 
L. pneumophila hypothetical proteins. A.  A schematic structure of the fusion 
proteins and the screening strategy. In most cases, the gene was fused with the 
b-lactamase by inserting into the vector as a BamHI/SalI fragment. After 
infection, samples were loaded with the CCF4-AM dye and were inspected 
under a fluorescence microscope. B. Evaluation of the library for expression of 
the fusion proteins. Plasmids directing expression of β-lactamase fusions were 
introduced into a wild type L. pneumophila strain. Total cell lysates of bacteria 
grown in the presence of IPTG were used to examine the steady state of the 
fusion proteins by immunoblot via a anti-beta-lactamase antibody. In each image, 
the detection of a protein nonspecifically recognized by the antibody (arrow) was 


















Identification of proteins transferred by the Dot/Icm system 
 
After verifying the expression of the fusion proteins in L. pneumophila, we 
infected U937 macrophages with L. pneumophila strains expressing β-lactamase 
fusions grown to post exponential phase. Experiment was done in 96-well format 
to facilitate high-throughput screening. A group of 24 bacterial strains expressing 
β-lactamase were used to infected host cells for each screen. One day before the 
experiment, differentiated human U937 cells were plated into each well of the 96-
well plate at the density of 1x105 cells per well. L. pneumophila strains expressing 
individual β-lactamase fusions were cultured in AYE in the presence of IPTG to 
induce expression of fusion protein. On the day of the experiment, L. 
pneumophila strains grown to post exponential phase were used to infect 
differentiated U937 cells at the MOI of 20. One hour after infection, cells were 
loaded with CCF4-AM dye and incubated for an additional 2 hours at room 
temperature. Translocation of the β-lactamase chimera was assessed by the 
presence of cells emitting blue fluorescence signals. Each infection experiment is 
triplicated. In each experiment, we used the TEM-RalF and TEM1-FabI chimera 
as the positive and negative controls, respectively [34]. Samples were visually 
inspected under a fluorescence microscope and strains that gave more than 5% 
of blue cells were retained for further study. Under this experimental condition, 
more than 95% of the cells infected by wild type L. pneumophila strain expressing 
the TEM-RalF fusion emits blue fluorescence, whereas similar infections with the 
strain expressing TEM- FabI  resulted in no blue cells, which are consistent with 
the results from an earlier study [34]. Infections were repeated at least twice for 
strains that gave positive translocation results. Constructs harboring genes 
exhibiting detectable transfer were introduced into the dot/icm-deficient strain 
Lp03 and the resultant strains were similarly tested for delivery the β-lactamase 
fusions into host cells. None of these fusions caused detectable translocation in 






In this study, 798 of the 832 analyzed orfs were successfully fused to the 
carboxyl end of β-lactamase (Table 1). In the 798 proteins tested in this study, a 
total of 164 proteins that consistently promoted translocation of TEM 
translational fusions in a Dot/Icm-dependent manner were obtained (Tables 2 
and 3). Among these, 94 proteins had been reported as Dot/Icm substrates by 
the time of this study (Table 3), further validating the reliability of our screen 
strategy. Thus, our efforts have added 70 proteins to the inventory of the 
substrate pool of the L. pneumophila Dot/Icm transporter (Table 2). The transfer 
efficiencies of these proteins vary greatly, ranging from 5% to 95% (Fig. 2-2). 
Among these, 5 proteins exhibited transfer efficiencies comparable to that of 
RalF, causing more that 90% of infected cells to emit blue fluorescence signals 
(Fig. 2-2). These 5 proteins do not share any detectable common features. 
Instead, the primary sequence of the C-terminal portion of Lpg2844 is quite 
different from all known substrates (see below). Twenty-five proteins converted 
50%–80% of the green cells into blue cells, while 13 proteins exhibited 
translocation efficiencies between 20% to 45%, and 27 proteins showed low 






            
Figure 2-2. Dot/Icm-dependent translocation of substrates. Effectors 
identified in this study were divided into four groups according to their transfer 
efficiencies: 5 genes from each group were shown as representatives. U937 
cells seeded in 96-well plates were infected with wild type or dot/ icm-deficient L. 
pneumophila strains expressing a gene fusion and images were acquired 2 hrs 
after CCF4-AM loading with a DP72 color camera (Olympus). Group I, genes 
with translocation efficiency greater than 90%; Group II, genes with 
translocation efficiency between 50% and 80%; Group III, genes with 
translocation efficiency between 20% and 45% and Group IV, genes with 







Although all candidates were annotated as hypothetical proteins in the 
genome database of the Philadelphia 1 strain, careful bioinformatic analysis 
revealed that a small fraction of them harbor motifs of known or putative 
functions (Table 2). Further, most of these proteins have a homolog in the 
genome of the Paris, Lens or the Corby strain; the number of proteins without a 
detectable homolog are 7, 12 and 13 for these three strains, respectively (Table 
2). Two proteins, Lpg1083 and Lpg1684 are specific for the Philadelphia-1 strain 
(Table 2). In some cases, two or more genes were clustered in a specific region 
in the chromosome (Table 2), a common phenomenon in gene organization of L. 
pneumophila type IV substrates [29] that often accounts for the remarkable 
plasticity of genomes of this organism [161, 162]. 
 
Many factors could influence the translocation efficiency of an effector 
protein as demonstrated in the β-lactamase assay, and one of the important 
parameter is the stability of the fusion protein. To examine whether the 
difference in transfer efficiency among proteins was due to the stability of the 
fusion proteins, we examined the levels of the fusion proteins in several strains 
from each group. In general, there was no clear correlation between the steady 
state levels of the hybrids and translocation efficiencies. For example, the steady 
state levels of the TEM-Lpg0021 and TEM-Lpg0181 were among the highest in 
these strains, but their transfer efficiencies were not the highest (Fig. 2-3). On 
the other hand, the poorly expressed TEM-Lpg2555 and TEM-Lpg2874 were 
translocated at high efficiency (Fig. 2-3). To further determine to what extent the 
lack of detectable translocation was a result of a failure to express the protein 
fusions, we examined the β-lactamase fusions in 27 transfer deficient strains. 
Although the protein levels vary, all of these strains produced readily detectable 
fusion proteins (Fig. 2-3). Therefore, the level of fusion protein expressed in L. 






                     
 
Figure 2-3. Translocation efficiency does not correlate with levels of b-
lactamase fusion expressed in L. pneumophila. A. The translocation 
efficiency of 9 substrates in the β-lactamase assay. After CCF4-AM loading, 
macrophages infected with bacterial strains expression fusions between β-
lactamase and individual genes were inspected under a fluorescence 
microscope, translocation efficiencies were obtained by enumerating cells 
emitting blue and green fluorescence signals, respectively. Experiments were 
performed in triplicates and at least 300 cells were counted each sample. Similar 
results were obtained in at least two independent experiments. B. The levels of 
the fusion proteins in L. pneumophila strains used for infections shown in A. 
Bacterial cells equivalent to one OD600 unit were lysed in 200 ml of SDS loading 
buffer, 15 ml of boiled supernatant were resolved by SDS-PAGE. After 
transferring to nitrocellulose membranes, the fusion protein was detected with a 
β-lactamase specific antibody by immunoblot. The isocitrate dehydrogenase   
(ICDH) was probed as a loading control. Samples: 1. Lpg1776; 2, Lpg0021; 3, 











Recognition of diverse translocation signals by the Dot/ Icm transporter 
 
In our efforts to identify common features in the last 100 amino acids of 
the substrates that may be important for Dot/Icm-dependent protein 
translocation, we found that a few proteins that have amino acid composition 
greatly different from the known features. One such example is Lpg2844, a 361 
aa protein in which more than 1/3 of the residues are serine. Interestingly, the 
last 100-aa region of this protein contains few of the features known to be 
important for Dot/Icm-dependent translocation. A hydrophobic residue 
(methionine) at the -3rd position [163] is the only recognizable characteristic 
associated with translocation found in this region of this protein (Fig. 2-4, A). 
Full-length Lpg2844 promoted the translocation of β-lactamase with 85% 
efficiency (Table 2 and Fig. 2-4, B&D). Importantly, a chimera containing β-
lactamase fused to the last 100 amino acids of Lpg2844 promoted translocation 
at efficiencies only marginally lower than  those of full-length proteins, indicating 
that like other Dot/Icm substrates, signals important for translocation localized to 
the C-terminal portion of this protein  (Fig. 2-4, B–D). As expected, a fusion that 
contained Lpg2844 lacking the last 100 amino acids failed to promote 
translocation at a detectable level (Fig. 2-4, B&D). These data indicate that the 
Dot/Icm transporter  is capable of recognizing diverse features in the C-terminal 
portions of its substrates and that in some cases such differences do not affect 






              
Figure 2-4. Diverse features presented in the C-terminal end of Dot/Icm 
substrates.  A. Alignment of the last 50 amino acids of three well established 
effectors and the new substrate Lpg2844 to highlight the features important for 
translocation found in Dot/Icm substrates, including: i) The hydrophobic residue 
at the -3rd position (red) [163] and ii) the E-block [164] (the three blue residues 
in SidF). Note the different amino acids composition in Lpg2844. B–D. A region 
containing the last 100 amino acids of Lpg2844 is important and sufficient for 
promoting translocation. Bacterial strains expressing fusions of b-lactamase to 
full-length Lpg2844 (I), its last 100 aa (II) or a fragment lacking the last 100 aa 
(III) were used to infect macrophages and infected cells were loaded with the 
CCF4-AM dye. Translocation efficiency shown in B. was obtained as described 
in Fig. 1-3, data shown are the average of three independent experiments done 
in triplicates; stable expression of the fusions by L. pneumophila, equal amount 
of protein samples resolved by SDS-PAGE was probed for the fusions with a β-
lactamase specific antibody. The ca. 60-kDa non-specific band detected by the 
antibody was used as a loading control (arrow in panel C). Representative 
images of infected cells loaded with CCF4-AM (D). Similar results were 






Almost four decades after its initial discovery, L. pneumophila continues to 
be the “hot spot” of microbe-host interaction studies. This is not due to that this 
bacterium is any more lethal than many other pathogens such as Yersinia pestis, 
but lies in the fact that it is both an excellent “cell biologist”, as this bacterium 
encodes multiple virulence factors to efficiently manipulate host intracellular 
cellular processes, and a “terrible immunologist” because it triggers many 
underappreciated immune responses that are not stimulated or even silenced by 
more adaptive pathogens [99, 165].  
 
 Arguably the most important virulence determinant of L. pneumophila is 
the Dot/Icm secretion system. L. pneumophila utilizes this system to deliver a 
large cohort of substrates in order to create a replication niche inside of many 
different hosts [158]. Functional studies of the protein delivered into the host by 
specialized translocation system has proved to be extremely useful in dissecting 
the biology of both the pathogen and host [6]. Studying the molecular functions of 
the Dot/Icm substrates had led to the revelation of novel posttranslational 
modifications such as the ampylation and the phosphocholination, as well as 
intriguing strategies such the “meta-effector” utilized by the bacterium to 
coordinate host cellular processes [49, 62, 158]. However, our understanding of  
this field is far from complete because many Dot/Icm substrates could be “missed” 
in the previous screening due to the potentially biased nature of these screening. 
To gain more insights into the functions of these substrates and the revolutionary 
pressure that drives the diversity of them, we initiated the genome-wide 
screening for a more complete list of the substrates of the Dot/Icm system.  
 
 The genome-wide screening for new effector was effective, as it did not 
rely on potentially biased parameters to choose candidates and it utilized a high-
throughput yet sensitive beta-lactamase assay as the readout. This screen led to 





substrate inventory [158]. The overlap between the proteins identified in this 
study and other studies validates the effectiveness of our methods. The 
identification of these new effectors also raises exciting possibilities to uncover 
novel effector functions, as the predicted activities of these effectors cover 
acyltransferases, peptidases, Rho-GEF (Guanine nucleotide exchange factors), 
hydrolases, and methyltransferases [158]. Despite the comprehensiveness of the 
screening, it is not without limitations. First, we only selected the candidate genes 
bigger than 300bp, since most of the effectors harbor enzymatic activities, and 
the probability of smaller genes coding for enzymes is lower. However, at least 
one L. pneumophila effector, Lpg0045, is smaller than this threshold [166]. 
Second of all, we excluded the genes that have been annotated by proteins with 
known functions. One exception will be the flagellin, which is thought to be 
translocated into the host by the Dot/Icm system [147]. Third, although we 
showed that the protein level does not necessarily correlate with the level of 
translocation, it is possible that some of our constructs were not expressed well 
enough to allow detectable translocation. In agreement with this concern, eight 
proteins that were shown capable of promoting translocation of SidCΔ100 did not 
show positive signals in our assay, even though the beta-lactamase fusion of 
seven of these proteins were stably expressed in L. pneumophila. Further, since 
the translocation signal has not been unequivocally determined, it is possible that 
some translocation signals are located at other parts of the protein other than the 
C-terminus. If this were the case, our N-terminus beta-lactamase fusion might not 
work. Clearly, there are different limitations that could be applied to different 
systems that measure substrate translocation, our the beta-lactamase reporter 
system is of no exception. Nevertheless, the fact that we have re-identified 94 
Dot/Icm substrates that have been reported prior to our study validated the 
reliability of our reporter system [158, 167]. The newly identified effectors in this 
report not only facilitated the research of L. pneumophila, but also showed the 





system substrates in other microbes, such as Coxiella burnetii, Salmonella 
Typhymurium and Helicobacter pylori [167].  
 
 The number of the Dot/Icm substrates coded by Legionella pneumophila 
far exceeds that of any bacterium studied so far. Such a large repertoire may 
explain the lack of intracellular growth defects when one or more effectors are 
deleted from the genome of the bacterium. The obvious question that follows is, 
what is the evolutionary pressure that drives the bacterium to acquire and 
maintain so many effectors in its genome? A recent study aimed at this question 
revealed that seven distinct genomic clusters containing 27.1% of the Legionella 
genome are dispensable for in bacterial growth in vitro and in murine 
macrophages. However, L. pneumophila mutants lacking five such clusters 
showed differential defects in colonizing distinct amoebae species. This evidence, 
together with the low GC content and marked variability of these clusters, 
prompted the authors to propose that these clusters were acquired by the 
bacterium horizontally to maintain optimal growth in a wide variety of amoebae 
hosts [66]. Although this bacterium could encode such a large number of Dot/Icm 
substrates to conquer a wide variety of amoebae hosts in the natural 
environment, other bacteria, such as Pseudomonas aeruginosa, whose virulence 
also depends on a functional secretion system (Type III Secretion System), 
harbors significantly fewer effectors, yet colonize hosts that range from plants to 
mammals [168]. Therefore, an alternative explanation could be that the Dot/Icm 
apparatus is more promiscuous than other secretion systems and “accidentally” 
translocates bacterial proteins into the host [148]. This is in agreement with the 
observation that this bacterium delivers bacterial flagellin into the host with no 
obvious benefits [148]. Even if the large number of L. pneumophila Dot/Icm 
effectors are the result of the promiscuousness of the translocation system, it 
does not reduce the significance of our study in any way. On the contrary, this 
could lead to the identification of more conserved bacterial molecules that are 





understudied immune pathways that are not elicited by more adaptive pathogens. 
Regardless the driving force for acquiring such a large repertoire of effectors, the 
study aimed at elucidating the biochemical and cell biological functions of these 
substrates will definitely contribute to the better understanding of the biology of 









 Permissive macrophages challenged by L. pneumophila are resistant to 
exogenous cell death stimuli despite harboring high levels of active caspase-3. 
Although several reports have described the L. pneumophila effectors that 
contribute to pro-survival signaling cascade, the Dot/Icm substrates that fuel 
caspase-3 activation have not been documented, nor have the mechanisms 
underlying such activation. Taking advantage of the expended list of L. 
pneumophila Dot/Icm effectors, we initiated a screening to survey all known 
effectors for their ability to activate caspase-3. Our screening led to the discovery 
that at least five Dot/Icm substrates, Lpg0716, Lpg0898, Lpg1831, Lpg1625 and 
Lpg2716, could activate caspase-3 when expressed in mammalian cells. We 
further demonstrated that one of these effectors, VipD (lpg2831), is a 
phospholipase A2 that hydrolyzes phosphatidylethanolamine (PE) and 
phosphocholine (PC) on the mitochondrial membrane in a manner that appears 
to require host cofactor(s). The lipase activity is essential to its ability to activate 
caspase-3 and leads to the production of free fatty acids and 2-
lysophospholipids, which destabilize the mitochondrial membrane. Mitochondria 
membrane destabilization may contribute to cytochrome c release and 
subsequent activation of caspase-3. Moreover, whereas caspase-3 activation 
does not seem to play significant roles in limiting L. pneumophila replication in 
permissive macrophages, it is essential to restricting bacterial growth in dendritic 
cells. We further demonstrated that genetic ablation of all five caspase-3 





demonstrated that the activation of host apoptosis pathway is a collective effect 
of multiple effectors with diverse biochemical activities. 
Introduction 
Host cell death pathways are essential determinants of the outcome of 
infection [169]. It is not surprising that numerous pathogens utilize various 
strategies to manipulate these processes to their benefit. For instance, Coxiella 
burnetii, a pathogen that is closely related to L. pneumophila, translocates 
multiple virulence factors through the Dot/Icm to inhibit host apoptosis [170]. 
Yersinia pestis, on the other hand, codes for a T3SS effector YopM, which 
structurally mimics the substrates of caspase-1, to inhibit caspase-1 activity 
through direct binding [92]. Similar to many other vacuolar pathogens, L. 
pneumophila actively thwarts host cell death to avoid premature termination of 
bacterial replication. It is therefore almost “cliché” that permissive macrophages 
infected by L. pneumophila showed strong resistance to exogenous cell death 
stimuli [100]. However, it is intriguing that these macrophages also harbor active 
caspase-3, the executioner of cellular apoptosis [100]. The importance of this 
phenomeon was demonstrated in dendritic cells, which die of apoptosis soon 
after L. pneumophila infection [104]. Suppressing cellular apoptosis allows L. 
pneumophila to replicate in dendritic cells, which otherwise are not permissive to 
this bacterium [104]. Although the L. pneumophila effectors contributing to the 
suppression of host cell death have been well documented, almost nothing is 
known about the Dot/Icm substrates that activate caspase-3. Therefore, we 
attempted to take advantage of the newly available list of L. pneumophila 









Identification of Dot/Icm substrates capable of activating caspase-3  
 
 Many host cell signaling cascades including the host cell death 
pathways, are modulated by numerous effector proteins of L. pneumophila. 
Despite the fact that permissive cells that harbor actively replicating L. 
pneumophila are resistant to exogenous cell death stimuli, these cells also 
contain active caspase-3, the executioner caspase [100]. The caspase-3 
activation in L. pneumophila infection could be the result of the innate immune 
responses to the biochemical activities of the Dot/Icm substrates, or the 
consequences of one or more Dot/Icm substrates directly activating this enzyme. 
The recent availability of a more complete list of Dot/Icm substrates made the 
latter possibility more practical to test [171]. To identify the Dot/Icm substrates 
capable of activating caspase-3, I utilized two independent approaches: The first 
is a commercially available Caspase-Glo 3/7 Assay System (Promega), a 
luminescence assay that measures the activity of caspase-3. In the presence of 
active caspase-3, the proluminescent luciferase substrate containing the DEVD 
caspase-3 cleavage site will be released for luciferase to produce light. To 
identify caspase-3 activating effectors using this system, I transfected 293T cells 
with the GFP-candidate-gene fusion constructs in a 96-well format (to facilitate 
the high throughput screening) using Lipofectamine 2000, 24 hours later, cells 
were lysed to measure the caspase-3 activity. One protein, Lpg0898, capable of 
activating caspase-3 was identified using the Caspase-Glo 3/7 Assay System, 
providing evidence that L. pneumophila does code for factors that activate 
caspase-3. However, deleting Lpg0898 did not ablate caspase-3 activation L. 
pneumophila during infection, suggesting that L. pneumophila codes for more 
effectors capable of activating caspase-3. To achieve a more comprehensive 
screening, I used an immunoblot-based method to probe for the presence of 
activated caspase-3 (p-17 and p-19) in 293T cells ectopically expressing the 





marginally higher reading than control in the Caspase-Glo 3/7 Assay, and also 
ones that have been shown to be toxic to mammalian cells, also found in earlier 
studies. 100μg total lysate of each sample was resolved by SDS-PAGE gels. And 
the immunoblot-based method led to the identification of five Dot/Icm substrates, 
Lpg0716 [158], Lpg0898(Ceg18) [41], Lpg1625 (Lem12) [42], Lpg2176 (LegS2) 
[35], and Lpg2831 (VipD) [30, 108] that are able to induce caspase-3 activation in 
293T cells under  transfection condition (Fig. 3-1). Although some of these 
proteins are toxic to mammalian cells, expression of GFP fusions of these 
proteins was readily detectable (Fig. 3-1, middle panel). Sequence analyses 
revealed that Lpg2716 (LegS2) is a sphingosine-1-phosphate lyase, which has 
been shown to target to the mitochondria during bacterial infection [172]. Further, 
the product of sphingosine-1-phosphate lyase, sphingosine-1-PO4, has been 
shown to cooperate Bak and Bax to induce the onset of apoptosis [173].  
Lpg2831 (VipD) possesses a domain found in the catalytic motif of members of 
the patatin-like phospholipase A2 [30, 108]. On the other hand, Lpg0716, 
Lpg0898 (Ceg18), Lpg1625 (Lem12) and Lpg1803 harbor no motif suggestive of 










Fig. 3-1 Activation of caspase-3 by L. pneumophila Dot/Icm substrates.  
Lysates of HEK293T cells transfected to express GFP or its fusions of indicated 
proteins for 24 hr were probed for active caspase-3 with a specific antibody 
(upper panel). The p-17 and p-19 bands are the processed mature form of 
caspase-3. The expression of the GFP fusions in these samples was probed with 
a GFP specific antibody (middle panel). Arrows indicate the band corresponding 














Some of the Legionella caspase-3 activators localize to the mitochondrion  
 
The mitochondrion is the central regulator for the intrinsic apoptotic 
pathway. The sphingosine-1-phosphate lyase Lpg2176 (LegS2) had been shown 
to localize to this organelle [172]. We thus examined whether other identified 
caspase-3 activators also target to mitochondria. Cells transfected to transiently 
express GFP fusions of each of these proteins were stained with an antibody 
specific for Cyto c oxidase (COX4I1). We found that like GFP-Lpg2176, in cells 
expressing GFP-Lpg1625, the GFP signal exclusively localized to the 
mitochondria and the patterns of the signal were identical to those of COX4I1 
(Fig. 3-2).  Most, but not all of GFP-Lpg0898 localized to the mitochondria (Fig. 
3-2).  However, the expression level of GFP-0716 is low and the GFP signals 
appeared to localize to the cytosol. GFP-2831(VipD) mostly occupied the plasma 
membrane of transfected cells, and did not significantly colocalize with the 
COX4I1 staining signals (Fig. 3-3).   







Fig. 3-2 Some of the caspase-3 activators localized to the mitochondrion.  
Hela cells transfected to express GFP fusion of the indicated proteins were 
stained with antibody specific for the mitochondrial protein COX4I1. Samples 
were analyzed using an Olympus IX-81 fluorescence microscope for images 






       
Fig. 3-3 GFP-VipD localizes in the cytoplasm of mammalian cell.  Hela cells 
transfected to express GFP, GFP-0898, GFP-0898A151S, GFP-VipD or GFP-
VipDS73A for 18 hr were fixed and stained for the mitochondrial protein COX4I1. 
Samples were analyzed using an Olympus IX-81 fluorescence microscope for 
images acquisition. Images were pseudocolored with the IPLab software 








We also found that protein Lpg0898 and Lpg2831 (VipD) caused 
significant rounding of mammalian cells (Fig. 3-2).  To rule out the possibility that 
the cytotoxicity of these proteins interferes with the proper cellular localization, 
we isolated a non-toxic mutant of Lpg0898, Lpg0898A151S; and this mutant still 
partially localized to the mitochondria (Fig. 3-1). For Lpg2831, we determined 
whether the putative phospholipase A2 is responsible for the cell rounding 
phenotype by mutating serine 73 in the predicted catalytic motif to alanine. 
Although this mutation did not reveal the targeting of Lpg2831(VipD) to a specific 
organelle, it abolished its ability to cause the cell rounding phenotype in 
mammalian cells (Fig. 3-4).  These results suggest that mitochondrion is the site 
of action for some of the caspase-3 activators. Our observations also suggest 
that the putative phospholipase A2 activity of VipD is important for its role in 
caspase-3 activation. Because of the potential biochemical activity and the 
availability of many useful reagents for VipD [30], I chose to focus on this protein 





                  
Fig. 3-4 Cell rounding phenotype caused by Lpg0898 and VipD and their 
nontoxic mutants.  293T cells transfected to express GFP-Lpg0898 (A), GFP-
Lpg0898 A151S (B), GFP-VipD (C) or GFP-VipDS73A (D) for 24 hr. Images were 
acquired with an Olympus IX-81 fluorescence microscope equipped with a CCD 
camera.  Note the cell rounding phenotype caused by wild type Lpg0898 and 







VipD induces the release of Cyto c from mitochondria   
 
The fact that VipDS73A is no longer toxic to mammalian cells prompted me 
to hypothesize that the putative phospholipase A2 activity may be important for 
VipD’s capability to activate caspase-3. Lysates of 293T cells transfected to 
express VipD or its mutant were probed for active caspase-3. Whereas 
expression of GFP-VipD consistently led to production of the p-17 and p-19 
fragments of caspase-3, cells expressing GFP or GFP-VipDS73A did not produce 
detectable active caspase-3 (Fig. 3-5, A). Thus, the putative PLA2 activity of 
VipD is essential for its role in the activation of caspase-3.   
 
 In the intrinsic apoptotic pathway, the release of the cytochrome c from 
mitochondria is a prerequisite for caspase-3 activation; I then asked whether 
VipD is able to cause Cyto c release in vivo. Cells transfected with appropriate 
constructs were permeabilized with mitochondrial buffer (20 mM HEPES, pH 7.4, 
250 mM sucrose, 100 mM KCl, 5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, and 100 
μg/μl digitonin) on ice for 5 mins, which selectively disrupts plasma membrane 
while leaving the mitochondrial membrane intact [174]. The resulting cytosolic 
fraction was separated from the mitochondria-rich membrane fraction by low 
speed centrifuge and tested for the presence of Cyto c.  Expression of wild type 
VipD, but not the S73A mutant or GFP alone led to Cyto c release (Fig. 3-5, B).  
 
Although VipD is capable of causing cytochrome c release under 
transfection conditions, it was not clear whether that was a direct or indirect 
consequence of its biochemical activity. To test these two possibilities, I further 
examined the activity of VipD using a cell-free system. To purify mitochondria 
from 293T cells, cells were suspended in hypotonic solution followed by 
mechanical homogenization to remove the plasma membrane, and the heavy 
membrane fraction and nucleus were removed by low speed centrifugation. 





(Sigma) and further purified by sucrose-gradient centrifuge. Recombinant VipD 
was added to purified mitochondria and the release of Cyto c was monitored as 
mentioned above after 2 hr of incubation. As little as 0.65 μg His6-VipD caused 
significant Cyto c release (total volume of 100μl), and 2.5 μg protein was 
sufficient to disperse more than 90% of Cyto c from 100 μg of mitochondria (Fig. 
3-5, C). Interestingly, addition of VipD also led to the release of SOD2, a 
mitochondria matrix resident protein, into the supernatant, suggesting the 
integrity of the mitochondrial inner membrane was also compromised in this 
process (Fig. 3-5, C). Consistent with the in vivo results, as much as 40 μg 
















Fig. 3-5 VipD-induced caspase-3 activation and Cyto c release require the 
phospholipase motif.  A. The phospholipase motif is essential for the activation 
of caspase-3. 100μg lysates of HEK293 cells transfected to express GFP (1st 
lane), GFP-VipD (2nd lane) or GFP-VipDS73A (3rd lane) for 24 hr were probed for 
active caspase-3.  Note the high level expression of GFP-VipDS73A (3rd lane, 
middle panel).  Tubulin was probed as loading controls (lower panel). B. VipD-
induced Cyto c release in vivo. 50μg soluble fraction and mitochondrial fraction of 
HEK293 cells transfected to express GFP-VipD or GFP-VipDS73A for 24 hr were 
probed for Cyto c. The expression of the GFP fusions was also analyzed. Tubulin 
present in the soluble fraction was detected as a loading control. C. VipD-
induced Cyto c release from purified mitochondria.  Indicated amounts of His6-
VipD or His6-VipDS73A were incubated with 50μg mitochondria at 30°C for 2 hr.  
The presence of Cyto c in the soluble fractions was detected by immunoblotting.  







The disruption of the mitochondrial inner membrane potential (Δψm) often 
precedes the release of Cyto c [175]. I thus examined whether VipD disrupted 
the integrity of the mitochondrial inner membrane. Hela cells transfected to 
produce VipD, VipDS73A, or GFP were stained with the mitochondrial 
transmembrane potential sensitive dye, tetramethylrhodamine methyl ester 
perchlorate (TMRM), and the fluorescence intensity of mitochondrion (Fm) and 
cytosol (Fc) reflected by the TMRM staining was quantified. TMRM images were 
thresheld to isolate the mitochondrial florescence (Fm), and the florescence 
intensity of areas of one square micrometer was measured using the software 
ImageJ (NIH). Cytoplasmic florescence (Fc) is determined in hand-drawn regions 
in close proximity to the mitochondria. The value of Δψm was obtained with the 
formula Δψm=[(Fm-(2/3)Fc)/(1/3) Fc]. Expression of VipD but not its S73A mutant 
compromised the integrity of the mitochondrial inner membrane (Fig. 3-6). Taken 
together, these results indicate that induction of caspase-3 activation by VipD is 
mediated by its putative PLA2 activity, which triggers the mitochondrial inner 







Fig. 3-6 VipD compromises the mitochondrial inner membrane integrity.  
Culture medium of HEK293T cells transfected with indicated constructs for 18 hr 
was replaced with medium containing 20 nM TMRM for 20 min.  Dye loaded 
samples were then mounted on a Teflon holder for image acquisition using a 
Nikon Eclipse Ti microscope (60x oil Plan Apo objective). TMRM images were 
thresheld to isolate the mitochondrial florescence (Fm), and the florescence 
intensity of areas of one square micrometer was measured using the software 
ImageJ (NIH).  Cytoplasmic florescence (Fc) is determined in hand-drawn 
regions in close proximity to the mitochondria.  Δψm is then determined as the 
ratio of Fm/Fc using the following formula: [(Fm-(2/3)Fc)/(1/3) Fc].  At least 300 
mitochondria in each sample were analyzed and the statistical analysis was 













VipD-mediated mediated Cyto c release is independent of Bax and Bak 
 
Since Bax and Bak, the two pro-death, pore-forming proteins important for 
MOMP [175] appear essential for cell death induction during L. pneumophila 
infection [102], I sought to determine whether these two proteins are necessary 
for the activity of VipD in caspase-3 activation. To this end, I transiently 
expressed VipD in both WT mouse embryonic fibroblasts (MEFs) and deficient in 
Bax and Bak. Similar levels of activated caspase-3 could be detected in both 
MEFs (Fig. 3-7 upper left panel,). Of note is that the Mirus transfection reagent 
nonspecifically caused caspase-3 activation in this cell line (Fig. 3-7, A, upper 
left panel, 1st lane). Although caspase-3 activation occurred in samples that 
received no DNA or received the catalytically inactive VipDS73A mutant, the 
amount of active caspase-3 in the sample expressing wild type VipD is 
consistently higher (Fig. 3-7, A&B).  Importantly, in the Bax/Bak-/-MEFs, similar 
activation of caspase-3 was detected, but only in samples expressing wild type 
VipD (Fig. 3-7, A, upper right panel). Similarly, purified His6-VipD but not the 
VipDS73A, was able to induce Cyto c release from mitochondria isolated from both 
wild type and bak/bax-/- MEFs (Fig. 3-7, C). Thus, VipD appears to directly act on 
the mitochondrial membranes to compromise its integrity, leading to Cyto c 






Fig. 3-7 VipD-induced Cyto c release is independent of Bax and Bak. A.  
Induction of caspase-3 in MEFs by transient expression.  Wild type and bax/bak-/- 
MEFs were transfected with plasmid DNA that allows the expression of GFP-
VipD, GFP-VipDS73A and indicated controls for 24 h, and the lysates of these 
samples were analyzed for activated caspase-3 by immunoblot (upper panel).  
The levels of the GFP fusions were probed by an antibody specific for GFP 
(lower panel) and tubulin was detected as a loading control (middle panel). Note 
that in wild type MEFs, caspase-3 can be activated by the Mirus transfection 
reagent (Thermo Scientific, Waltham, MA), which is the only one that allows 
efficient transfection of these cells (lane 1).  B. Quantitation of the caspase-3 in 
panel A.  Quantitation was obtained by measuring the band intensity using the 
Odyssey imaging system.  Similar results were obtained in two independent 
experiments.  C.  Induction of Cyto c release by VipD from mitochondria isolated 
from MEFs.  40μg His6-VipD or His6-VipDS73A was added to 50μg mitochondria 
purified from wild type mouse embryonic fibroblast (MEF) or from MEF of 
bak/bax-/- mouse.  After incubation at 30oC for 3 hr, the release of Cyto c was 






Inhibition of VipD-mediated Cyto c release by two PLA2 inhibitors  
 
The observation that the predicted PLA2 active site of VipD was important 
for the induction of Cyto c release strongly suggests that VipD is a phospholipase 
A2.  We thus examined this activity by determining the effects of two specific 
phospholipase A2 inhibitors, Methyl arachidonyl fluorophosphonate (MAFP) [176] 
and (R)-Bromoenol lactone ((R)-BEL) [177], on VipD-mediated Cyto c release. 
As little as 0.2 μM MAFP almost completely abolished Cyto c release caused by 
VipD (Fig. 3-8); (R)-BEL also blocked VipD activity, but with a relatively lower 
potency; 10 μM of this compound was required to exert detectable inhibitory 
effects (Fig. 3-8). Because both MAFP and (R)-BEL are highly selective, active 
site directed, irreversible inhibitors of PLA2 [176, 177], these results further 















Fig. 3-8 Inhibition of VipD-induced Cyto c release by two inhibitors for 
phospholipase A2. The inhibitors MAFP or (R)-BEL was added to suspensions 
of 50μg purified mitochondria at indicated concentrations simultaneously with 42 
μg of His6-VipD. After incubation for 3 hr at 30oC, samples were subjected to 
centrifugation to obtain the soluble fraction and the insoluble membrane pellet 
and each fraction was analyzed for the presence of Cyto c. Samples receiving 
















VipD does not indiscriminately disrupt biological membranes  
 
 Phospholipase A2s have a relatively broad substrate spectrum and are 
capable of disrupting the integrity of membranes from different sources [178, 
179]. To determine whether VipD-mediated Cyto c release is due to 
indiscriminate membrane disruption, we first examined whether VipD 
compromises the integrity of the plasma membrane. Hela cells were transfected 
with GFP-VipD for 24 hours and the integrity of the plasma membrane (PM) was 
assessed with low concentration (4 μM) of ethidium bromide (EtBr), a dye 
impermeable to intact PM. Treatment with 0.2% TritonX-100 effectively facilitated 
the uptake of EB. However, although exhibiting the cell rounding phenotype, cells 
expressing GFP-VipD were not detectably permeable to this dye (Fig. 3-9, A). 
We also tested the effects of exogenous VipD on PM integrity. Inclusion of His6-
VipD in cell culture medium at 10 μM, which is 2-fold higher than the 
concentration necessary for effective Cyto c release, did not detectably disrupt 
the PM (Fig. 3-9, B). Taken together, these results indicate that VipD specifically 










Fig. 3-9 VipD does not cause damage in plasma membrane.  A. Hela cells 
transfected to express GFP or GFP-VipD for 24 hr were washed and stained with 
4 μM EtBr.  Retaining of the dye by the cells was analyzed by microscopic 
analysis using an Olympus IX-81 fluorescence microscope equipped with a CCD 
camera. Untransfected cells treated by Triton-100 were included as a control 
(lower panel).  Note that the nuclei of cells treated by Triton-100 were stained by 
the dye. B. His6-VipD or BSA was added to culture medium at a final 
concentration of 8 μg/ml. After 3 hr of incubation, the integrity of the plasma 
membrane was assessed by the retaining of EtBr using an Olympus IX-81 














VipD hydrolyzes two phospholipids on mitochondrial membranes   
The specific disruption of mitochondrial membranes by VipD suggests that 
its substrates are associated with this organelle. To identify these substrates, we 
extracted total lipids from the mitochondria treated with His6-VipD or His6-
VipDS73A by the Folch method [180] and subjected these samples to mass 
spectrometry analysis. Briefly, chloroform, methanol, and water with a volume 
ration of 8:4:3 were mixed in a separation funnel, allowed to stand to obtain a 
biphasic system. The upper phase was used as the pure-solvent-upper-phase. 
The mitochondria samples were placed into a glass homogenizer with 5 drops of 
ice-cold chloroform-methanol extraction solvent (2:1) and manually homogenized 
with a pestle. The volume of extraction solvent was slowly increased to 0.5-mL in 
order to achieve complete homogenization.  Homogenates were filtered through 
a lipid-free paper and mixed with 0.2 volumes of H2O, and the mix is allowed to 
separate into 2 phases. After removing the upper phase, the lower phase was 
rinsed 3 times with the pure-solvent-upper-phase. The lower organic phase 
containing the total lipids was collected, dried under a stream of nitrogen, and 
subjected to mass spectrometry analysis. 2-lysophosphatidylcholine and 2-
lysophosphatidylethanolamine, the products of phospholipase A2, increased 18 
and 16-fold, respectively in samples receiving VipD but not in those receiving 
VipDS73A, indicating that phosphatidylcholine (PC) and phosphatidylethanolamine 







Fig. 3-10 Identification of the natural substrates of VipD. Total lipids from 
mitochondria treated with His6-VipD or His6-VipDS73A were extracted using the 
Folch method. The composition of the lipids was profiled by mass spectrometry 
on an LTQ Orbitrap instrument. Shown are representative base peak 
chromatograms of mitochondrial lipid extracts obtained in positive (A) and 
negative (B) ion modes using reversed-phase chromatography. Lysophospholipid 















Despite extensive efforts, we were unable to detect the phospholipase 
activity of His6-VipD in biochemical assays using synthetic substrates, which was 
reported in a recent study on the structure of this protein [181]  (Fig. 3-11, A).  To 
test the possibility that VipD needs co-factor(s) from the host, we treated isolated 
mitochondria with proteinase K prior to examining VipD-mediated Cyto c release.  
Exposure of mitochondria to 1 μg/ml of this proteinase abolished VipD-mediated 
Cyto c release (Fig. 3-11, B).  The loss of this activity is not caused by the 
potential residual proteinase activity as VipD recovered from this reaction was 
able to compromise membranes in fresh mitochondrial samples (Fig. 3-11, B). 














Fig. 3-11 A. VipD did not detectably hydrolyze phospholipids in reactions with 
defined components. His6-VipD or commercial phospholipase A2 was added to 
liposome established with phosphoethanolamine and the reactions were allowed 
to proceed for 3 hr at 30oC. Total lipids extracted from the reactions were 
separated on thin-layer chromatograph (TLC) Silica gel 60 F254 (EMD) and lipids 
were detected using iodine vapor. B.  Mitochondria were treated with proteinase 
K or buffer before incubated with VipD or its mutant. The release of cytochrome c 













Lysophospholipids and fatty acids can mimic the effect of VipD in inducing 
cytochrome c release  
It is well-documented that phospholipids adopt a cone shape conformation 
when it is inserted in to the lipid bilayer [182]. The 2-lysophospholipid and fatty 
acid molecules produced by phospholipase A2 from phospholipids adopt an 
inverted cone shape and cone shape, respectively, making them unsuitable in 
forming lipid bilayer [183].  Membrane damage and the subsequent Cyto c 
release caused by phospholipase A2 can be the result of either direct lipid 
degradation [184] or the formation of curvature or lesions on the mitochondrial 
membranes by the lipids and fatty acids [185]. To determine whether the 
products of VipD contribute to such damage, we prepared a mixture of 
lysophospho-ethanolamine and linolenic acid at a 1:1 ratio and examined the 
effects of the mixed compounds on purified mitochondria. This mixture is capable 
of recapitulating the effects of VipD on mitochondria, and at least 9 μM of the 
mixed compounds were required to induce Cyto c release to the level induced by 
40 μg of His6-VipD (Fig. 3-12). Thus, VipD-mediated production of 
lysophospholipids and fatty acids contributes to the disruption of mitochondrial 











Fig. 3-12 A mixture of lyso-PE and linolenic acid induces Cyto c release 
from mitochondria.  5μl of linonelic acid and 7.5 mg of 
lysophosphoethanolamine were dispersed in 5-ml of L buffer. The mixture was 
brought to dryness under gentle nitrogen stream and was reconstituted with 5-ml 
L buffer; the indicated amounts of lipid mixture was then added to 50μg purified 
mitochondria, and incubated at 30°C for 2 hr. The samples were then separated 
by centrifugation, soluble or pellet fraction was resolved on SDS-PAGE and 
















The caspase-3 activating effectors are required for maximal induction of 
cell death in dendritic cells 
To determine whether these effectors proteins contribute to caspase-3 
activation during L. pneumophila infection, we constructed a series of mutants 
lacking one or more of these genes. To assess their roles in caspase-3 activation 
during L. pneumophila infection, non-polar deletions of each of these genes and 
the combination of all of them were constructed. The deletion strain, along with 
WT L. pneumophila and a Dot/Icm mutant cultured to post-exponential phase 
were used to infect U937 at an MOI of 1 [102].  Infected cells were lysed six 
hours after infection to assay for caspase-3 activity. Similarly prepared bacterial 
cells were used to infect mouse bone marrow-derived macrophages to evaluate 
intracellular replication. Deletion of single caspase-3 activator or all five of these 
genes (Lpg0898, Lpg1625, Lpg0716, Lpg2716, and Lpg2831) did not cause a 
detectable defect in caspase-3 activation (Fig. 3-13, A). This was not due to the 
fact that U937 being a more permissive host, as the primary mouse 
macrophages challenged by these strains also showed no defect in caspase-3 
activation (Fig. 3-13, B). Consistent with this observation, the ∆5 mutant did not 






Fig. 3-13 Deletion of caspase-3 activators has little impact on the activation 
of this caspase by L. pneumophila.  A & B. Differentiated U937 cells were 
infected by indicated L. pneumophila strains for 6 hr, lysates of infected samples 
resolved by SDS-PAGE were probed for active caspase-3.  B. L. pneumophila 
deletion strain lacking one or more of the caspase-3 activating effectors still 
potently induced caspase-3 activation. A/J mouse macrophages were infected by 
indicated L. pneumophila strains for 6 hr, lysates of infected samples resolved by 
SDS-PAGE were probed for active caspase-3. Similar results were obtained in 
multiple independent experiments. Strains: ∆2 (Lp02∆0898, ∆1625); ∆3 
(Lp02∆0898, ∆1625, ∆0716); ∆4 (Lp02∆0898, ∆1625, ∆0716, ∆2831); ∆5 
(Lp02∆0898, ∆1625, ∆0716, ∆2831, ∆2176). The wild type strain Lp02 and Lp03, 











Because dendritic cells (DCs) are more sensitive to cell death induced by 
L. pneumophila [102], and that cell death seems to be important in restricting 
bacterial intracellular replication, we then sought to determine whether any of 
these effectors contribute to the cell death induced in DCs.  Although the ∆5 
mutant did not productively replicate in DCs, comparing to the wild type strain, it 
was not efficiently killed by these cells (Fig. 3-14, A). The mutant survived in 
rates very similar to a mutant deficient in the Dot/Icm transporter. Evaluation of 
the apoptotic status of infected DCs revealed that less than 5% of the cells 
harboring the ∆5 mutant stained positively by the TUNEL reagent, whereas more 
than 25% of the cells infected by the wild type strains are apoptotic (Fig. 3-14, B-
C). Thus, deletion of the five genes only partially abolished the ability of L. 
pneumophila to induce cell death in DCs. Together with the fact that this mutant 
still grew robustly in macrophages, cells that are less sensitive to cell death 
induction by the bacteria, these data suggest the existence of yet unidentified 
caspase-3 activating effectors. Alternatively, activation of caspase-3 by L. 
pneumophila could be a result of the collective effects of many effectors, which 







Fig. 3-14 The five caspase-3 activating proteins are important for maximal 
cell death induction in dendritic cells.  A. Dendritic cells prepared from bone 
marrows of A/J mice used infected with indicated bacterial strains and the total 
bacterial counts were determined at indicated time points.  Note the drastic drop 
in the number of survived wild type bacteria over the 48-hr infection duration.  B-
C. DCs similarly infected as panel A were subjected to immunostaining to label 
the cells, the bacteria and the apoptotic status of the infected cells with specific 
antibodies. Infected cells stained positively by the TUNEL reagent were 
enumerated under an Olympus IX-81 fluorescence microscope.  At least 200 
infected cells were scored from each sample done in triplicate.  Representative 
images of the cells were acquired from these samples.  Similar results were 












 Host cell death plays an indispensable roles in shaping the outcome of 
infection, in which L. pneumophila achieves an intriguing balance between pro-
death pathways and pro-survival signaling cascade. Permissive macrophages 
infected by L. pneumophila are resistant to cell death stimuli, yet harbor high 
levels of activated caspase-3, the executioner caspase in apoptotic process [186]. 
Although caspase-3 activation does not seem to play a significant role in 
restricting L. pneumophila in macrophages, it does seem to be important for 
limiting replication of this bacterium in dendritic cells [104]. Since this 
phenomenon requires a functional Dot/Icm secretion system, it could be possible 
that a subset of Dot/Icm substrates, or the host responses against these 
substrates, trigger the activation of the caspase-3. To test this hypothesis, I 
initiated a screening to identify Dot/Icm substrates capable of activating caspase-
3. Using the combination of western blotting and a luminescence-based activity 
assay, five Dot/Icm substrates were identified to be capable of activating 
caspase-3 when ectopically expressed. Of these five effectors, I chose to focus 
on VipD for detailed analysis because of the presence of a conserved 
phospholipase A2 domain [30, 187] and the availability of the useful reagents in 
the lab. We showed that when ectopically expressed, VipD causes mitochondria 
outer membrane permeabilization and cytochrome c release into the cytosol. 
Further, recombinant VipD is capable of liberating cytochrome c from purified 
mitochondria in a Bax/Bak independent manner, suggesting mitochondria 
membrane permeabilization is a direct consequence of the activity of VipD. 
Because mutating the putative catalytic residue Ser73 or application of 
phospholipase inhibitor abolished the capability of VipD to activate caspase-3 
and liberate cytochrome c, we reason that VipD is a putative phospholipase A2. 
The capability of VipD to hydrolyze phosphatidylcholine (PC) and 
phosphatidylethanolamine (PE) on the mitochondria membrane lends further 
support to this hypothesis. However, despite repeated attempts, we could not 





phospholipids. It seems that VipD is active only in the presence of a 
proteinaceous molecule on mitochondria, indicating that a eukaryotic co-factor is 
necessary for the phospholipase activity of VipD.  
 
 Interestingly, another report investigating the biochemistry function of VipD 
showed that VipD is a phospholipase A1 instead of phospholipase A2 [187]. 
Although the products of these two closely resemble enzymes are both 
lysophospholipids, the mechanisms of action of these two enzymes are different, 
as phospholipase A1 targets the SN-1 acyl bond on the phospholipids while 
phospholipase A2 cleaves the SN-2 bond. The two different products of 
phospholipase A1 and phospholipase A2, however, cannot distinguished by 
mass spectrometry analysis such the one we utilized to identify the product of 
VipD. Gasper et al. reached the conclusion that VipD is a phospholipase A1 
using phospholipase A1-specific phospholipase inhibitors and a fluorescence-
substrate-based phospholipase activity assay. In this assay, a fluorescent moiety 
capable of FRET (fluorescence resonance energy transfer) is covalently attached 
to the phospholipid substrates on the SN-1 position. The phospholipase activity is 
measured by the alteration of FRET emission prior and after the enzymatic 
cleavage of the substrates. Due to the specific position of the fluorescent moiety, 
the alteration of FRET is only detected in the presence of an active 
phospholipase A1, but not phospholipase A2. Therefore, this assay could be 
more specific than the mass spectrometry analysis [187]. On the other hand, 
Gasper et al. also demonstrated that the eukaryotic protein Rab5 is necessary for 
the phospholipase activity of VipD, which is consistent with our observation. They 
further showed that VipD is activated on endosome, where Rab5 is located, to 
hydrolyze PI(3)P to protect L. pneumophila from endosomal fusion [187]. These 
observations are inconsistent with our observation that VipD is involved in the 
activation of caspase-3 and contribute to the cell death response elicited in 
dendritic cells. Several lines of evidence suggest that VipD has functions beyond 





cellular distributing pattern other than co-localizing with endosomal 
compartments when expressed in eukaryotic cells. The discrepancy may be the 
results of 1) the utilization of different cell lines, plasmids that drives heterologous 
expression of VipD; 2) the transfection reagents that deliver VipD-constructs into 
the cells; 3) the sampling time post transfection. The diffused distribution pattern 
may contribute to the protein localization in mitochondria where it stimulates 
caspase-3 activation. Second, although it was shown that Rab5 could activate 
VipD, the possibility that VipD is activated by other mammalian proteins present 
on mitochondria cannot be excluded (Fig. 1-17 B). Third, despite these 
inconsistencies, Gasper et al. did observe that VipD expression in mammalian 
cells caused cell rounding and decreased cell viability, which is line with our 
observation that VipD causes cell death. The cell death caused by VipD cannot 
be simply explained by the PI(3)P hydrolyzing activity, especially if VipD 
exclusively localizes on the endosomal membrane. Taken together, it is possible 
that VipD contributes to the interference with the endosomal trafficking and to the 
induction of cell death. Such a phenomenon is not without precedent, as ExoU, 
the phospholipase A2 coded by P. aruoginosa, bears functions from causing cell 
death to dampening inflammasome activation; a Salmonella effector protein, 
SopB, contributes to both bacterial invasion and the maturation of the 
Salmonella-containing-vacuole [56, 94].   
 
 In this study, we identified five Dot/Icm substrates that are capable of 
activating caspase-3. However, the mechanisms underlying the activation by four 
other effectors remains elusive. One possibility is that caspase-3 activation is an 
“unintended” consequence of the biochemical activities of these five Dot/Icm 
substrates. Alternatively, L. pneumophila could encode effectors to directly 
activate caspase-3. Considering that the major evolutionary pressure of L. 
pneumophila comes from protozoan amoebae, which do not seem to contain 
caspase-3, this possibility is unlikely to be the case. Another possibility is that 





refers to the phenomenon in which the biochemical activity of the virulence 
factors, but not the virulence factors per se, is recognized by the host immune 
system. Such paradigm has been well established in plant-pathogen interactions 
[188], as well as in metazoa [136]. For example, at least five L. pneumophila 
effectors are capable of inhibiting host protein synthesis, and the consequence of 
such inhibition includes prolonged activation of the NF-κB pathways, up-
regulation of anti-apoptotic genes, and activation of the MAPK pathway [136]. 
Inhibition of protein translation has been shown to trigger the MyD88 dependent 
“frustrated responses”, which allow the host to overcome translation inhibition 
and selectively translate certain transcripts such as the inflammatory cytokines 
IL-1α [99]. More examples of ETR in metazoans comes from the Pyrin 
inflammasome, which detects various bacterial modifications, such as ampylation, 
ADP-ribosylation, deamindation, glucosylation, on small GTPase RhoA at its 
switch I region and activates caspase-1 [132]. These observations prompted us 
to propose that caspase-3 activation is a result of host sensing of the biochemical 
activity of at least five effectors from L. pneumophila. In line with this hypothesis, 
activation of caspase-3 is essential in host cell death and bacterial replication 
restriction in dendritic cells [104]. Although similar phenomena were not observed 
in macrophages, the different responses may result from the differing level of 
sensitivity to active caspase-3 in the two cell types, or the differences in the 
abundance of the host molecules that detect the effector activity. Despite its 
frequent association with cell death, activation of caspase-3 in infection does not 
always translate into host cell death [189]. S. Typhimurium activates this enzyme 
by a Type III secretion system effector SipA without triggering host apoptotic cell 
death. The activated caspase-3 in turn processes SipA into two functionally 
distinct domains [190]. It will therefore be interesting to determine whether 
caspase-3 activation also contributes to the pathogenesis of L. pneumophila, 
because the caspase-3 recognition motif “DEVD” could indeed be found on some 
proteins encoded by this bacterium. Nonetheless, we demonstrate that five L. 





replication restriction during infection. Further investigation is warranted to study 
the mechanisms of action of these five effectors to activate caspase-3, and 
whether more effectors contribute to such activities during infection. It will be 
interesting to further determine whether these effectors directly trigger caspase-3 
activation, or caspase-3 stimulation is a result of the effector-triggered-responses 
to the biochemical consequences of these effectors. If the latter possibility is true, 
it will certainly be compelling to determine whether the ETR is responding to a 
common activity that is shared among these effectors, as in the case of host 









Although environmental Legionella are responsible for most of the 
Legionnaires’ disease outbreaks so far, most of our knowledge of Legionella 
pathogenesis was acquired using laboratory strains. To investigate how mouse 
macrophages respond to Legionella environmental isolates, we analyzed the 
intracellular growth of these isolates in A/J mouse macrophages, which is 
permissive to most, if not all, laboratory strains. None of the Legionella 
environmental isolates were able to replicate in A/J mouse macrophages. Further 
investigations into one of the isolates, LPE509, showed that such growth 
restriction is not due to the lack of important pathogenic determinants, as this 
strain is competent for replication in two protozoan hosts and the human 
macrophage U937 cell line. Moreover, the inability of intracellular growth of 
LPE509 is accompanied by host cell death of unique nature, as it is independent 
of most signaling components known to control Legionella infection. In an 
attempt to screen for the unique properties of LPE509 responsible for host cell 
death and growth restriction, we found that a spontaneous streptomycin resistant 
mutant had gained the ability to overcome the growth restriction in macrophages. 
Analysis of the mutant strain revealed that a lysine to arginine substitution on 
position 88 of the 30S ribosome small subunit S12 (RpsL) severely attenuates 
the host cell death induction and enables the bacterium to replicate in 
macrophages. We also demonstrate that RpsL is a Microbe-Associated-
Molecular-Pattern (MAMP), which is sensed intracellularly and triggers the 





membrane integrity, various hydrolases are released into the cytosol, where they 
process diverse substrates and cause cell death. Amongst these hydrolases, 
cathepsin B plays an important role in RpsL sensing, as genetically ablating this 
gene dampens host cell death induced by recombinant RpsLWT and Legionella 
expressing wild type RpsL. Our results suggeste that RpsL is a microbial 
associated molecular pattern (MAMP) that triggers a unique cell death pathway 
in mouse macrophages to limit the spread of invading bacterial pathogens. 
Introduction 
 Host cell death is an important determinant of outcome of an infection. At 
the early stage of infection, host responses such as secretion of inflammatory 
cytokines, recruitment of immune cells, and production antimicrobial molecules 
are initiated as attempts to clear the infection [191]. If the infection is not resolved, 
host cell death could be an effective defense mechanism, as the demise of host 
cells could remove the niche of infection and expose the pathogens to additional 
layers of immune surveillance [191]. Exposing the pathogens is important to the 
host defense, as the release of PAMPs that accompanys this process could help 
the training of incoming immune cells, such as macrophages and dendritic cells, 
for a more robust immune response [192, 193]. Further, phagocytosis of dead 
infected cells helps to boost the activation of adaptive immune system through 
antigen presentation [194]. On the other hand, host cell death could also lead to 
elimination of key immune cells, resulting in the impairment of immune responses, 
leading to successful evasion of the host defenses by the pathogen and 
systematic spread of the infection [195].  
 
The primary evolutionary pressure for L. pneumophila is believed to come 
from its environmental amoebae, its natural hosts [159]. As an opportunistic 
pathogen, L. pneumophila does not seem to have evolved to evade the immune 
surveillance of mammalian hosts [159]. It is therefore not surprising that immune 





otherwise silent or not detectable during infection by better adapted pathogens 
[147]. For example, taking advantage of the strong cell death phenotype 
associated with L. pneumophila infected BMDM derived from C57BL/6 but not 
A/J mouse, investigators revealed that the bacterial flagellin is recognized by the 
the NLR receptor--Naip5 [143]. Further investigation of this pathways 
demonsrated that, flagellin, engaged by Naip5, recruits and activates NLRC4, 
which leads to caspase-1 activation and subsequent pyrototic cell death [149]. 
These signaling events eventually result in removal of the replicative niche and 
further recruitment of other immune cells [151].  
 
Almost all of the disease outbreaks in history have been caused by 
environmental or clinical isolates of pathogens [159]. However, despite the 
importance of the environmental isolates, most of our understanding on the 
pathogenesis of L. pneumophila has been based on studies of laboratory strains 
such as Lp02 and JR32 [152], which were acquired through the domestication of 
the original clinical isolate Philadelphia-1 [152]. The important roles of the 
environmental isolates in Legionnaires’ disease have prompted researchers to 
analyze the intracellular bacterial growth of these isolates in cultured human 
macrophages, but few of them have determined the response of different hosts 
such as primary murine macrophages to challenge of these bacteria [154-156]. 
  
The lack of knowledge of how L. pneumophila environmental isolates 
interact with mammalian hosts prompted us to investigate the immune responses 
to these bacteria. We recently found that LPE509, a strain from a man-made 
facility was unable to replicate in A/J mouse macrophages, which is permissive to 
most, if not all laboratory strains [157]. Because host cell death is important to 
restrict bacterial replication in the case of resistant host challenged by flagellin 
expressing L. pneumophila, we set out to test whether host cell death plays a 
role in the growth restriction of LPE509. We found that infection by this strain in 





known mechanisms of cell death induced by L. pneumophila [157]. These results 
suggest that LPE509 is capable of triggering a unique cell death pathway, 
probably by activating an immune surveillance system. To identify the bacterial 
factor responsible for this cell death phenotype, we screened for LPE509 
mutants that of growing in A/J macrophages and revealed that a mutation on the 
bacterial ribosome protein S12, rpsL, enables LPE509 to overcome the 
intracellular growth restriction. Further analysis demonstrates that RpsL, after 
reaching the host cytosol presumbly by the Dot/Icm secretion system of L. 
pneumophila, engages host immune pathways and triggers lysosomal and 
apoptotic cell death. Our results established RpsL as a ligand capable of 
triggering a unique immune recognition by inducing lysosomal cell death. 
Results 
Several environmental L. pneumophila strains are unable to replicate in A/J 
macrophages 
 
Although it has been almost four decades since L. pneumophila was found 
to be a human pathogen, most of the research on this particular pathogen was 
done using the “domesticated” strains for more amenable genetic manipulations. 
Few studies had analyzed how primary macrophages responsd to clinical or 
environmental isolate of L. pneumophila, which are responsible for most of the 
Legionella outbreaks in history [154-156]. To fill in this gap in our knowledge, Dr. 
Lili Tao isolated several serogroup 1 L. pneumophila strains from hospital water 
distribution systems in Shanghai, China and tested the interactions between 
these strains and mouse macrophages [196]. As shown in Fig. 4-1, A/J 
macrophages allowed for efficient intracellular replication by strain JR32, a 
derivative of the original Philadelphia-1 strain to replicate (at a multiplicity of 
infection (MOI) of 0.05) [197]. As expected, the dotA mutant of JR32, which is 
deficient in the ability to translocate substrates of the Dot/Icm type IV system, 





none of the 4 environmental isolates yielded productive bacterial replication 
throughout the entire experimental duration, despite a similar level of bacterial 
uptake (Fig. 4-1).  Moreover, whereas the Dot/Icm mutant of JR32 was not 
effectively cleared by A/J macrophages, all four environmental were readily 
cleared by 72 hours post infection (Fig. 4-1). These results indicate under the 
infection conditions used, none of these four environmental L. pneumophila 
strains can replicate in mouse macrophages that are permissive for standard 







Fig. 4-1 Intracellular replication of several L. pneumophila environmental 
isolates in A/J mouse macrophages. Bone marrow-derived macrophages were 
challenged with indicated bacterial strains grown to post-exponential phase at an 
MOI of 0.05.  Infections were synchronized two hour after adding the bacteria.  At 
indicated time points, total bacterial counts (colony-forming-unit) were 
determined by plating appropriately diluted saponin solubilized infected cells onto 
bacteriological medium.  Infections were performed in triplicate and data shown 
were from one representative of three independent experiments with similar 






Vacuoles containing LPE509 are targeted properly in A/J macrophage 
 
To determine the mechanism underlying the growth defect of LPE509 in 
A/J macrophage, we analyzed the trafficking of its phagosome in this host.  Cells 
infected with LPE509, its dotA mutant and appropriate control strains for 1 hr 
were stained for the lysosomal marker LAMP-1. Similar to wild type JR32, 
positive staining signals for LAMP-1 were absent in about 82% of the vacuoles 
formed by strain LPE509 (Fig. 4-2A).  Deletion of dotA led to acquisition of this 
marker by the bacterial vacuoles (Fig. 4-2A).  We also examined the recruitment 
of Rab1, the small GTPase important for L. pneumophila infection [198] to 
vacuoles of LPE509. About 60% of phagosomes containing LPE509 stained 
positively for Rab1, which was abolished by the deletion of the dotA (Fig. 4-2B).  
Thus, vacuoles containing strain LPE509 are not delivered into the lysosomal 
network and the defect in intracellular growth is not caused by its inability to 






                           
Fig. 4-2 Intracellular trafficking of strain LPE509 in A/J macrophages. Bone 
marrow-derived macrophages seeded on glass coverslips were infected with 
properly grown bacterial strains at an MOI of 2. One hour after infection, samples 
were washed with medium and were fixed at the indicated time points. After 
labeling extracellular and intracellular bacteria differently by immunostaining, the 
host proteins LAMP-1 (A) and Rab1 (B) were stained with specific antibodies. 
Data were collected using an IX-81 Olympus microscope by inspecting bacterial 
vacuoles for the association of the protein staining signals. All infections were 
performed in triplicate and at least 100 bacterial phagosomes were scored for 







A fraction of internalized LPE509 bacteria establish larger vacuoles in A/J 
macrophages 
In permissive host, after a brief lag phase of 4-6 hours, L. pneumophila 
begins to replicate and the size of the vacuole expanses. By 14 hours post 
infection, the replicating vacuole can contain more than 10 bacteria [6]. The 
observation that phagosomes of LPE509 were properly targeted in macrophages 
indicates that some of them may develop into large vacuoles containing multiple 
bacteria when infection proceeds to later phase. We thus determined the 
distribution of vacuoles formed by this strain 14 hr after uptake. In infections 
using strain JR32, more than 63% of the vacuoles were large phagosomes 
containing ≥10 bacteria. The fraction of small (1-3 bacteria/vacuole) and medium 
size (4-9 bacteria/vacuole) phagosomes was about 19% and 17%, respectively 
(Fig. 4-3). In contrast, the majority (~58%) of the LPE509 vacuoles at this time 
point contained 1-3 bacteria; about 22% of them were intermediate vacuoles with 
4-9 bacteria and only about 18% were large vacuoles containing more than 10 
bacteria (Fig. 4-3). Thus, strain LPE509 was able to form replicative vacuoles in 









Fig. 4-3 The formation of replicative vacuoles by strain LPE509 in 
macrophages.  A/J mouse macrophages on glass coverslips were infected with 
appropriately grown bacterial strains at an MOI of 1. Infections were 
synchronized one hour after bacterial challenge and were allowed to proceed for 
an additional 13 hours.  Samples were then fixed and subjected to 
immunostaining to label intracellular and extracellular L. pneumophila with 
different fluorescent colors. When necessary, samples were further staining with 
DAPI to highlight the nuclei of host cells. The bacterial phagosomes were scored 
under a fluorescence microscope according to the number of bacteria they 
harbored.  Phagosomes containing more than 10 bacteria were categorized as 
large; those with 4-9 bacteria were called medium and those with 1-3 bacteria 
were classified as small vacuoles. A. The distributions of vacuole sizes of strain 
JR32 and LPE509 and their derivatives defective in the Dot/Icm transporter. **, 
p<0.001 for values of big or small vacuoles between strain JR32 and LPE509. B. 












LPE509 flagellin is not responsible for its intracellular replication 
restriction in A/J macrophages 
The subtle balance of host cell death controls the outcome of the infection. 
The phenotypes associated with the interactions between strain LPE509 and A/J 
macrophages are reminiscent of those seen in infections of C57BL/6 
macrophages with strain Philadelphia 1, in which sensing of flagellin by NAIP5 
leads to pyroptosis and termination of intracellular bacterial replication [120, 199]. 
To examine whether the defects were caused by the recognition of LPE509 
flagellin by NAIP5 of A/J mice, we constructed LPE509∆flaA, a mutant that no 
longer expressed flagellin (Fig. 4-4A). Challenge of A/J macrophages with this 
mutant at a low MOI (0.05) did not lead to productive intracellular bacterial 
growth (Fig. 4-4B). These results indicate that the lack of intracellular growth of 
LPE509 in A/J macrophages was not due to variations in flagellin that can be 











Fig. 4-4 Intracellular growth of a mutant of strain LPE509 lacking flagellin in 
A/J macrophages. A. Expression of flagellin by the testing bacterial strains.  
Cells of indicated strains grown to post-exponential phase were lysed with 
Laemmli sample buffer and total protein was resolved by SDS-PAGE. Flagellin 
was detected by a specific antibody and the isocitrate dehydrogenase (ICDH) 
was probed as a loading control (lower panel).  B. Testing bacterial strains grown 
in AYE broth to post-exponential phase were used to infect bone marrow-derived 
macrophages from A/J mice at an MOI of 0.05. Infections synchronized 2 hrs 
after adding bacteria were lysed with saponin at indicated time points and total 
bacterial counts were determined by plating appropriate diluted lysates onto 
bacteriological medium. Infections were performed in triplicate and similar results 













LPE509 causes extensive membrane damage in A/J macrophages 
To determine the phenotypic changes associated with infection of A/J 
macrophages by LPE509, we examined the morphology of these cells infected 
with a moderate MOI (2).  Under this condition, strain JR32 did not cause 
discernible change in cell morphology (Fig. 4-5A, top panel).  However, 
challenge with LPE509 led to extensive cell rounding and no such phenotype 
was detected in infections with the strain LPE509∆dotA (Fig. 4-5A, middle and 
lower panels, respectively).  We further examined the integrity of plasma 
membrane of macrophages infected with these strains. Infected macrophages 
were stained simultaneously by propidium iodide (PI), which is 
membrane impermeable and generally excluded from viable cells and by 
Hochest 33342, which allows the staining of nuclei of both live and dead cells. In 
samples receiving LPE509 at an MOI of 1, about 45% of macrophages became 
permeable to PI. In infections using strain JR32, only approximately 6% of the 
cells were stained positively by PI (Fig. 4-5, B-C). The dotA mutants of neither 
strain caused detectable membrane damage under this infection condition (Fig. 








Fig. 4-5 Infection by strain LPE509 damages macrophage morphology and 
membrane integrity.  Bone marrow derived macrophages from A/J mice were 
challenged with indicated bacterial strains grown to post-exponential phase at an 
MOI of 1 for 2 hrs. A-B. Cell morphology and membrane integrity of infected 
samples was examined under a microscope. Similarly infected samples were 
simultaneously stained with propidium iodide (PI) and Hoechst 33342 and were 
analyzed by imaging with a fluorescence microscope. Bar, 10μm. C. Quantitation 
of membrane damaged cells. Membrane damage was determined by positive 
staining by PI under a microscope, at least 500 cells were scored in each sample 
for infections done in triplicate. Data shown are from one representative 





At 14 hr post-infection, a portion of vacuoles containing more than 10 
bacteria were established but the total bacterial counts at 24 hrs actually 
decreased, suggesting that some of the bacteria are not viable (Figs. 4-1, 4-3). 
We thus used TUNEL staining to examine whether these cells were undergoing 
cell death, which is an effective way for macrophages to eliminate internalized 
and replicating bacteria. At 14 hr post-infection, about 40% of cells infected by 
strain LPE509 stained positively for TUNEL and deletion of flaA did not 
significantly reduce the rate of TUNEL positive cells (Fig. 4-6, A-B). For cells 
harboring JR32, less than 20% were TUNEL positive (Fig. 4-6, A-B). Disruption 
of the Dot/Icm transporter abolished the ability of both strains to induce cell death 
(Fig. 4-6, A-B).   
 
We further examined the cytotoxicity of LPE509 to A/J macrophages by 
measuring membrane integrity of infected cells using LDH release as an indicator. 
At an MOI of 1, LDH release induced by strain LPE509 was significantly higher 
than that caused by strain JR32 (Fig. 4-6C). Deletion of flaA abolished the ability 
of strain JR32 to induce cell death. However, although deleting flaA in strain 
LPE509 detectably reduced the cytotoxicity, this mutant still significantly caused 
LDH release when infection was performed with an MOI of 1 (Fig. 4-6C). Again, 
the type IV secretion system in both strains is essential for the cytotoxicity (Fig. 
4-6C). Taken together, these results indicate that strain LPE509 is more cytotoxic 
than strain JR32 to A/J macrophages. Importantly, the cytotoxicity of strain 






Fig. 4-6 Infection by LPE509 caused extensive cell death on A/J 
macrophages. A-B. Bone marrow-derived macrophages from A/J mice were 
infected by indicated L. pneumophila strains at an MOI of 1 for 14 hrs and 
infected cells were immunostained to identify extracellular and intracellular 
bacteria followed by TUNEL staining to obtain representative images of the 
nuclei of infected cells. The label of host nuclei by the TUNEL reagent was 
C. Cells 
infected with the similar bacterial strains at an MOI of 1 were assayed for the 
release of LDH. Each experiment was performed in triplicate and similar results 










The cytotoxicity induced by LPE509 is independent of caspase 1 and 
caspase 11 and can be inhibited by glycine 
Two pathways are known to be important for the activation of pyroptosis in 
response to infection of murine macrophages by L. pneumophila with a functional 
Dot/Icm system. The first is the NLRC4/NAIP5 inflammasome pathway, which 
senses flagellin by the leucine-rich repeat containing protein (NLR) NLR family, 
apoptosis inhibitory protein 5 (NAIP5) [120, 199] and induces the activation of 
caspas-1 and the subsequent pyroptosis. The second is the caspase 11-
dependent pathway, which senses the cytosolic LPS that is probably released 
during vacuolar bacteria entering host cytosol [200, 201], and activates caspase-
1 by proteolytic cleavage, which is followed by the rapid and lytic pyroptotic cell 
detah. To determine whether either of these two pathways is involved in the cell 
death induced by strain LPE509, we examined the intracellular growth and 
cytotoxicity of this strain in macrophages from mice deficient in both caspase 1 
and caspase 11 (Casp1/11-/-). Consistent with earlier results, macrophages from 
C57BL/6 or Casp1/11-/- supported robust intracellular growth the flaA mutant of 
JR32 [147, 148], but no productive intracellular growth of LPE509∆flaA was 
detected (Fig. 4-7, A-B). Further, mutants without a functional Dot/Icm 
transporter were unable to cause cytotoxicity in C57BL/6 macrophages (Fig. 4-7, 
C). Importantly, whereas the flaA mutant of JR32 almost completely failed to 
cause cytotoxicity on C57BL/6 macrophages, the flagellin-deficient mutant of 
LPE509 is still able to induce LDH release from these cells at levels similar to its 
wild type parent strain (Fig. 4-7, C).  
 
When macrophages from Casp1/11-/- mice were tested, we found that 
strain LPE509∆flaA still strongly induced cytotoxicity (Fig. 4-7, D). In contrast, the 
flaA-deficient strain of JR32 failed to induce membrane damage and LDH release 
(Fig. 4-7, D). Taken together, these results indicate that the rapid cell death 
induced by strain LPE509 occurs in a way that requires the Dot/Icm system but 





JR32 still caused considerable LDH release from Casp1/11-/- macrophages (Fig. 
4-7, D). Although JR32 and Lp02 are derivatives of strain Philadelphia 1, the 
latter strain was not able to induce cytotoxicity on macrophages from Casp1/11-/- 
mice [200, 201]. Such differences may result from the genetic variations between 
these strains. For example, the type IVB secretion system Lvh found in JR32 
[202] is absent in the genome of Lp02 [159, 203].   
  
Pathogen-induced pyroptosis can be prevented by exogenous glycine, 
which blocks the formation of non-specific plasma membrane leaks for small ions 
such as sodium [204, 205]. We thus determined the nature of cell death induced 
by infections with our bacterial strains in macrophages from caspase1/11-/- mice.  
Macrophages infected by strains LPE509, JR32 and LPE509∆flaA all exhibited 
extensive cytotoxicity (Fig. 4-7, D). On the other hand, similar to results in 
previously experiments, JR32∆flaA failed to induce LDH release in these cells 
(Fig. 8D). Importantly, glycine treatment significantly blocked cytotoxicity induced 
by these bacterial strains, including LPE509∆flaA (Fig. 4-7, D). Interestingly, 
glycine cannot rescue the defect in intracellular growth of LPE509 in A/J 
macrophages (Fig. 4-8). This result is consistent with the fact that exogenous 
glycine functions to prevent non-specific plasma membrane damage, which is the 
consequence of the cell death initiation [204, 205]. Taken together, these results 
suggest that cytotoxicity induced by strain LPE509∆flaA is caused by a form of 






Fig. 4-7 Intracellular growth and cytotoxicity of strain LPE509 in 
macrophages from mouse deficient in caspase 1 and caspase 11.  A-B. 
Bone marrow-derived macrophages from C57BL/6 (A) mice and capase1/11-
deficient mice (Casp1/11-/-) were infected with indicated bacterial strains at an 
MOI of 0.05 and intracellular replication of the bacteria was determined by 
obtaining total colony-forming-unit (CFU) at a 24-hr interval. C-D. The cytotoxicity 
of the relevant bacterial strains to these cells was examined by measuring the 
release of lactate dehydrogenase (LDH) upon be challenged by these bacterial at 
an MOI of 1 for 4 hrs.  All assays were performed in triplicate and similar results 





Fig. 4-8 Glycine cannot rescue the intracellular growth defect of LPE509 in 
A/J macrophages. A/J macrophages were challenged with indicated bacterial 
strains grown to postexponential phase at an MOI of 0.05.  Glycine was added at 
a final concentration of 20 mM to a subset of samples throughout the entire 
experimental duration. Total bacterial counts were determined at indicated time 
points. Infection was performed in triplicate and similar results were obtained in 






A K88R mutation in rpsL allows L. pneumophila strain LPE509 to replicate 
in mouse primary macrophages  
Our previous studies found that the environmental L. pneumophila strain 
LPE509 cannot replicate in primary mouse macrophages; instead, it induces 
extensive macrophage death by a mechanism that is independent of the several 
factors involved in cell death during infection [157]. We hypothesized that this 
strain codes for unique factor(s) capable of triggering a signaling cascade that 
leads to cell death and that mutants lacking such factor(s) may enable the 
bacterium to replicate in macrophages, presumably by evading a yet unidentified 
immune surveillance mechanism. To identify such factor(s), we attempted to 
generate an insertion mutant library of LPE509 with a transposon introduced by 
bi-parental mating. To acquire an antibiotic resistance marker for eliminating the 
E. coli cells harboring the transposon, we first isolated a spontaneous 
streptomycin resistant (StrepR) mutant of LPE509, which was used for 
subsequent production of mutant pools by transposition. These mutants were 
then used to infect BMDMs, and bacterial yields at 72 hr post-infection were 
determined. Unexpectedly, we found that robust growth occurred in all mutant 
pools derived from one particular StrepR clone of strain LPE509 (Fig. 4-9). 
Further analyses indicated that the parental strain used for mutant production 
has gained the ability to grow in BMDMs (Fig. 4-10A). These results suggest that 
that the growth phenotype may result from the StrepR property of the bacteria. 
Because multiple mutations in the ribosomal protein RpsL (Lpg0324) and 16S 
rRNA can lead to StrepR [206], we next examined a number of such mutants for 
intracellular growth in BMDMs to determine whether all mutations that confer 
StrepR result in the gain of intracellular replication. From 8 such mutants tested, 
we found that 4 mutants have overcome the restriction whereas the other 4 failed 
to replicate in macrophages similar to the wild type (Fig. 4-9 & 4-10A). 
Sequencing analysis of the rpsL gene in these mutants revealed that in the 4 
mutants capable of replicating in BMDMs, an A to G mutation occurred at 





of the protein. In the 4 StrepR mutants unable to grow in BMDMs, an A to T 
mutation at nucleotide 129 that led to a Lys to Asn substitution (K43N) in residue 
43 was detected (Fig. 4-10B). To rule out the possibility that additional mutations 
contribute to this phenotype, we introduced the rpsLK88R allele into strain LPE509 
by gene replacement to produce LPE509rpsLK88R; in BMDMs, this strain grew at 
rates comparable to the laboratory strain Lp02, which increased almost 1000-fold 
after 72 hrs of incubation (Fig. 4-10C). Consistent with earlier observations [157], 
wild type bacteria were steadily cleared by macrophages within the same 
experimental duration (Fig. 4-10C). These results suggest that the K88R 
mutation in RpsL (rpsLK88R) is specific for overcoming the growth restriction of 
strain LPE509 in BMDMs. To further rule out the possibility that StrepR per se is 
responsible for the intracellular growth phenotype, we introduced a plasmid 
expressing a streptomycin 3`-adenyltransferase that confers resistance to this 
antibiotic  into strains LPE509 [207]. This strain has a minimal inhibitory 
concentration (MIC) of 30 μg/ml (Table 4-1), and cannot productively replicate in 
BMDMs (Fig. 4-11). Taken together, these results indicate that a K88R mutation 
in the ribosome protein RpsL is sufficient to allow strain LPE509 to replicate in 
BMDMs and that resistance to Strep does not necessarily confer L. pneumophila 

















Fig. 4-9 Some streptomycin resistant mutants of L. pneumophila could 
replicate in A/J mouse macrophages. Bone marrow-derived macrophages 
from A/J mouse were challenged with indicated bacterial strains grown to post-
exponential phase at an MOI of 0.05.  After synchronization 2 hrs after infection, 
total bacterial counts (colony-forming-unit) were determined by plating 
appropriately diluted saponin solubilized infected cells onto bacteriological 
medium. Infections were performed in triplicate and data shown were from one 














































Fig. 4-10 A streptomycin resistant mutant of L. pneumophila could replicate 
in A/J mouse macrophages. A & B. Bone marrow-derived macrophages from 
A/J mouse were challenged with indicated bacterial strains grown to post-
exponential phase at an MOI of 0.05.  After synchronization 2 hrs after infection, 
total bacterial counts (colony-forming-unit) were determined by plating 
appropriately diluted saponin solubilized infected cells onto bacteriological 
medium. Infections were performed in triplicate and data shown were from one 
representative of multiple experiments with similar results. C. Diagram 
representation of the rpsL gene of the spontaneous strepR L. pneumophila 






                              
 
Fig. 4-11 The inability of rpsLWT L. pneumophila strains to replicate in A/J 
BMDMs is not due to the presence of the residual streptomycin in the cell 
culture medium. The intracellular growth of Lp02, LPE509 and their counterpart 
carrying plasmid pRB970, which constitutively expresses a streptomycin 3’-
adenylyltransferase, was tested in A/J mouse macrophage. The streptomycin 
resistance conferred by this plasmid (MIC=30μg/ml) did not allow Lp02 or 









                    
 
Table. 4-1 MIC of L. pneumophila strains A suspension of each isolate was 
prepared in AYE/AYET medium. A final inoculum of 1x105 CFU/ml of indicated 
strain was added to each well of a 96 well microtiter plate containing serially 
diluted streptomycin in AYE/AYET. Plates were incubated at 37°C in a humidified 
incubator for 3 days. MIC was determined as the lowest concentration of 



















RpsL is responsible for intracellular growth restriction of L. pneumophila in 
primary mouse macrophages  
RpsL is a component of the 30S subunit of the ribosome involved in 
protein translation accuracy and is highly conserved among bacteria [208]. The 
fact that the RpsLK88R mutation is required for L. pneumophila to grow in BMDMs 
suggests that the commonly used laboratory strains (all resistant to streptomycin) 
such as Lp02, JR32 and AA100 could harbor the same mutation [152]. Thus, we 
sequenced the rpsL gene of these strains and found that a K88R mutation 
indeed exists in each of them. This mutation was identified in strains Lp02 and 
JR32 in a recent study [152]. The requirement of the K88R mutation for growth 
also suggests that BMDMs should be restrictive to the original streptomycin 
sensitive isolates. To test this hypothesis, we examined the growth of the original 
isolate of strain Philadelphia 1 (Phil 1). As expected, unlike its derivative Lp02, 
this strain was unable to replicate in BMDMs (Fig. 4-12, A).  Similar results were 
obtained from the wild type strain Paris and strain Thunderbay [209], a more 
recent clinical strain (Fig. 4-13). Similarly, a K88R mutation allowed both strains 
to grow in BMDMs (Fig. 4-13).  Importantly, robust growth occurred when the 
rpsL gene of strain Phil 1 was replaced by homologous recombination with 
rpsLK88R but not with rpsLK43N (Fig. 4-11, A). To further confirm that RpsL is the 
sole factor that accounts for the phenotype, we replaced rpsLK88R in strain Lp02 
with a wild type allele to produce Lp02rpsLWT ; this strain retained the ability to 
replicate in the cultured human macrophage cell line U937 (Fig. 4-14), but has 
lost the ability to grow in BMDMs (Fig. 4-12, B). Again, introduction of the 
streptomycin adenyltransferase gene into this strain conferred antibiotics 
resistance but not intracellular replication (Table 4-1; Fig. 4-11), further 
supporting the notion that wild type RpsL restricts bacterial replication in these 
cells.  Taken together, these results indicate that wild type RpsL is the genetic 
determinant that governs the outcome of macrophage infection by L. 
pneumophila: the WT protein restricts intracellular growth of L. pneumophila in 





Because the genomic information of strain Lp02 has been independently verified 
[210] and this strain is more genetically amenable, we chose to use this strain 



























Fig. 4-12 RpsL determines intracellular replication of L. pneumophila. A & B. 
Bone marrow-derived macrophages from A/J mouse were challenged with 
indicated bacterial strains grown to post-exponential phase at an MOI of 0.05.  
After synchronization 2 hrs after infection, total bacterial counts (colony-forming-
unit) were determined by plating appropriately diluted saponin solubilized 
infected cells onto bacteriological medium. Infections were performed in triplicate 
and data shown were from one representative of multiple experiments with 






            
Fig. 4-13 K88R mutation on rpsL allows L. pneumophila clinical isolates to 
replicate in A/J mouse macrophages. K88R mutation was introduced into wild 
type L. pneumophila Paris and L. pneumophila Thunderbay clinical isolates via 
homologues recombination. Bone marrow-derived macrophages from A/J mouse 
were challenged with indicated bacterial strains at an MOI of 0.05. After 
synchronization, at indicated time points, total bacterial counts (colony-forming-
unit) were determined by plating appropriately diluted saponin solubilized 
infected cells onto bacteriological medium. Infections were performed in triplicate 








                          
Fig. 4-14 Lp02rpsLWT could replicate efficiently in human U937 cells. 4x105 
human U937 cells were challenged with indicated bacterial strains at an MOI of 
0.05. After synchronization, at indicated time points, total bacterial counts 
(colony-forming-unit) were determined by plating appropriately diluted saponin 
solubilized infected cells onto bacteriological medium. Infections were performed 
in triplicate and data shown were from one representative of multiple experiments 
with similar results. This result indicates that the inability of Lp02rpsLWT to 
replicate in primary mouse macrophages is not due to a compromised Type IV 


















Infection by L. pneumophila expressing wild type RpsL leads to 
macrophage cell death   
Our previous study with strain LPE509 indicated that host cell death 
accompanied the restriction of intracellular growth [157], we thus determine 
whether a similar event occurred in infections with strain Lp02rpsLWT. Comparing 
to infections with strain Lp02rpsLK88R, significantly higher levels of lactate 
dehydrogenase (LDH) was detected in culture supernatant of BMDMs challenged 
with strain Lp02rpsLWT (Fig. 4-15, A).  Single cell analysis by TUNEL staining 
revealed that at 12 hrs post-infection, close to 50% of the macrophages infected 
with Lp02rpsLWT stained positive for apoptosis, whereas only about 10% 
Lp02rpsLK88R infected cells appeared apoptotic (Fig. 4-15, B). It is established 
that after a 4-6 hours of lag phase after bacterial uptake, L. pneumophila stars to 
replicate and expands the size of the LCV. 12 hours post infection, the LCV could 
accommodate more than 10 bacteria [157]. Unlike bacteria of strain Lp02rpsLK88R 
that can be distinctly stained by the anti-Legionella antibody, the staining signals 
of bacteria of strain Lp02rpsLWT appeared blurry and diffusing, which may result 
from the debris from dying bacterial cells (Fig. 4-15, C). Kinetics experiments 
revealed that such differences became apparent within 8 hrs post-infection (Fig. 








Fig. 4-15 Infection by L. pneumophila bearing rpsLWT results in macrophage 
cell death A. A/J mouse macrophages on glass coverslips were infected with 
appropriately grown bacterial strains at an MOI of 1. Infection was synchronized 
and LDH release was determined 6 hours post infection. B. Infection was done 
similarly to (A). 12 hours post infection, macrophages were fixed and stained with 
TUNEL. c. Representative images of (B). D. C57BL/6 and caspase-1/7/11-/- 
BMDMs were challenged with indicated strains. 12 hours post infection, 
















Fig. 4-16 Infection by L. pneumophila bearing rpsLWT results in macrophage 
cell death A/J mouse macrophages on glass coverslips were infected with 
appropriately grown bacterial strains at an MOI of 1. Infection was synchronized 










































Inflammatory caspases such as caspase 1, 7 and 11 have been 
demonstrated to play important role in macrophage cell death associated with L. 
pneumophila infection [211], we thus examined whether any of these caspases 
are involved in the cell death induced by L. pneumophila expressing wild type 
RpsL by constructing a mouse line lacking caspase 1, 7 & 11 (Caspase-1/7/11-/-, 
generous gift by Dr. Russell Vance at University of California, Berkeley). 
Challenge of macrophages from these mice with Lp02rpsLWT ΔflaA still led to cell 
death as measured by LDH release and by TUNEL staining.  In contrast, 
infection by the Lp02rpsLK88R ΔflaA strain caused significantly less death in these 
macrophages (Fig. 4-15, D). Consistent with this observation, BMDMs lacking 
caspase-1/7/11 did not support the growth of strain Lp02rpsLWT ΔflaA (Fig. 4-17). 
Thus, macrophage cell death is linked to the intracellular growth restriction of L. 
pneumophila expressing wild type RpsL. Moreover, the cell death occurred in a 

















Fig. 4-17 Caspase-1, 7 and 11 are dispensable for growth restriction of L. 
pneumophila bearing rpsLWT. Bone marrow-derived macrophages from 
C57L/B6 or caspase-1/7/11-/- mice were challenged with indicated bacterial 
strains grown to post-exponential phase at an MOI of 0.05.  After synchronization, 
at indicated time points, total bacterial counts (colony-forming-unit) were 
determined by plating appropriately diluted saponin solubilized infected cells onto 
bacteriological medium. Infections were performed in triplicate and data shown 




















RpsL directly induces cell death in macrophage  
There are several possibilities that could account for the cell death 
phenotypes that are associated with the genotypes of RpsL. First of all, as we 
know, the major role of RpsL is to control translation accuracy [212]. It is 
therefore possible that the K88R mutation, which is known to confer mildly higher 
translational accuracy, may cause fewer mistranslated proteins, which might be 
the cause of host cell death and bacterial replication restriction. However, this 
may not be the case, because L. pneumophila expressing RpsLK43N, a mutation 
known to impose even higher translation accuracy to the ribosome [213], cannot 
grow in BMDMs. Second, as the Type IV Translocation System (Dot/Icm) is 
known to be promiscuous in substrate recognition, RpsL could get access to the 
host cytosol and recognized by the host immune surveillance pathways [214]. 
The fact that non-effector proteins such as bacterial flagellin are translocated into 
the host cytosol by this very Dot/Icm and recognized as MAMPs, together with 
the high level conservation of RpsL among phylogenetically diverse bacteria, 
prompted us explore this possibility. To this end, we purified recombinant Sumo-
RpsLWT and Sumo-RpsLK88R with a procedure involved in the removal of 
endotoxin (LPS) (Methods) and delivered the proteins into macrophages by 
transfection [215]. When directly added to the BMDMs culture, neither protein 
caused detectable cell death (Fig. 4-18, A-B). However, when a transfection 
reagent was used, Sumo-RpsLWT triggered significantly higher amount of LDH 
release than similarly treated samples receiving Sumo-RpsLK88R (Fig. 4-18, A). 
Similar results were obtained when cell death was evaluated by TUNEL staining, 
in which close to 30% of cells receiving wild type RpsL were apoptotic and less 
than 10% cells were TUNEL positive in samples transfected with Sumo-RpsLK88R 
(Fig. 4-18, B-C). Consistent with the genetic results, Sumo-RpsLK43N was able to 
induce macrophage death at rates comparable to the wild type protein (Fig. 4-18, 
D). Importantly, wild type RpsL but not the K88R mutant of RpsL from 
Escherichia coli induced cell death in macrophages (Fig. 4-18, E), which is 





these two bacteria. Further, the cell death induced is specific for RpsL, as Sumo-
RpsM, another ribosomal protein, was unable to induce macrophage death (Fig. 
4-18, E). Finally, because dsRNA delivered into macrophages is known to trigger 
cathepsin-dependent apoptotic cell death [Rintahaka, 2011 #2779], we 
determined the potential effects of contaminated dsRNA by treating the proteins 
with RNAase III. This treatment did not alter the cell death inducing ability of 
RpsLWT, indicating that dsRNA did not contribute to the cell death (Fig. 4-18, F). 
On the other hand, treatment of protease K led to abolishment of the cell death-
inducing ability of the protein samples, further supporting the proteinaceous 
nature of the cell death stimuli (Fig. 4-18, F). Consistent with our previous 
observation that macrophage cell death induced by Legionella strains expressing 
RpsLWT is independent of caspase 1, 7 and 11, purified RpsLWT could efficiently 
induce cell death in Caspase-1/7/11-/- macrophages. This observation also 














Fig. 4-18 RpsL directly induces cell death in macrophage A. 12.5 μg purified 
RpsL protein was then either directly added to culture supernatant or delivered 
intracellularly into A/J BMDM using Lipofectamine 2000. LDH release was 
measured 6 hours post transfection. B. Purified RpsL proteins were added to 
culture supernatant or delivered intracellularly into A/J BMDM similarly to (A). 6 
hours post transfection, macrophages were fixed and stained with TUNEL. c. 
Representative images of (B). D&E. Indicated proteins were delivered 
intracellularlly into A/J BMDM. 6 hours post transfection, macrophages were fixed 
and stained with TUNEL. F. Mock, RNAase III or Protease K treated RpsL 
proteins were transfected into A/J BMDM. Cell death was measured by TUNEL 
staining 6 hours post transfection. G. C57BL/6 and caspase-1/7/11-/- BMDMs 
were transfected with indicated RpsL proteins and cell death was measured by 














The fact that L. pneumophila strains harboring wild type rpsL were able to 
replicate in alternative hosts such as U937 and Hela cells (Fig. 4-14, Fig. 4-19, A 
and [157]) suggests that RpsL cannot induce death in these cells. In agreement 
with this notion, Hela cells transfected with Sumo-RpsL did not detectably stain 
positive for apoptosis (Fig. 4-19, B). The lack of cell death is not due to 
deficiency in protein delivery because a similar procedure successfully 
transfected purified beta-galactosidase into these cells (Fig. 4-19, C). Taken 
together, these results establish that wild type RpsL is able to directly induce cell 
death in macrophages, whilst the K88R mutant triggers similar responses in a 

























Fig. 4-19 Hela cells are not responsive to RpsL A. The intracellular growth of 
indicated strains in Hela cells were determined similarly as aforementioned. B. 
Hela cells were either treated with 1μg/ml STS or transfected with indicated 
proteins using Lipofectamine as aforementioned. Hela cells were then fixed at 6 
hours post transfection and stained with TUNEL. The percentage of TUNEL-
positive cells in each sample were numerated. C. 2x105 Hela cells were 
transfected with 2μg beta-galactosidase. 6 hours later, the presence of 
intracellular beta-galactosidase was visualized using a beta-galactosidase 




















RpsL causes lysosome membrane permeabilization in macrophages 
That macrophages from mice lacking the three inflammatory caspases are 
still sensitive to RpsL suggests that the cell death is not caused by canonical 
pyroptosis. We thus explored the involvement of alternative cell death pathways 
[216].  Lysosome is a acidic organelle which contains a variety of hydrolases, 
and has long been implicated in functions other than the garbage disposal inside 
of the cell [81]. Stress stimuli could trigger selective or complete permeabilization 
of lysosome membrane, leading to the release of hydrolases such cathepsins 
(e.g. capthepsin B, D, or L) from the lysosomal lumen into the cytosol, which 
could induce apoptotic or pyrototic cell death through caspase activation, or 
necroptosis when caspase activation is inhibited [217, 218]. If RpsL activates the 
lysosomal cell death pathway, inhibiting lysosomal acidification should reduce its 
cytotoxicity. Thus, we treated macrophages with the lysosome acidification 
inhibitor bafilomycin A1 (BFA1) (which targets the vacuolar ATPase responsible 
for regulating organelle pH [218]) prior to RpsL transfection. Cell death was 
almost completely abrogated in samples pre-incubated with BFA1 (Fig. 4-20, A). 
To eliminate the potential non-specific effects of this compound, we co-
transfected RpsL with SidK, a L. pneumophila effector known to inhibit v-ATPase. 
Similarly, cell death was blocked in samples receiving both proteins (Fig. 4-20, 
B).  
 
We next examined the integrity of lysosomal membranes in macrophages 
receiving RpsL by using acridine orange (AO), a lysotrophic dye that when 
concentrated in lysosome emits orange florescence upon excitation by blue light, 
but green florescence when redistributed into the cytosol and nucleus upon the 
loss of lysosome membrane integrity [219]. In samples treated with the 
transfection reagent, essentially all macrophages emitted orange fluorescence 
(Fig. 4-20, C-D); in samples receiving RpsL, close to 40% of the cells gave green 
fluorescence signals, indicating the loss of lysosomal membrane integrity (Fig. 4-





lower rates (Fig. 4-20, C-D). Similar results were obtained in infected BMDMs in 
which Lp02rpsLWT caused significantly higher lysosome damage strain 























Fig. 4-20 Lysosome cell death pathway is involved in RpsL recognition. A. 
A/J BMDM were treated with lysosome acidification inhibitor bafilomycin A1 
(20nM) for 1 hour before protein transfection. Cell death was measured by 
TUNEL staining 6 hours post transfection. B. Purified RpsL proteins were 
delivered with buffer or equal amount of SidK proteins into A/J BMDM. Cell death 
was measured by TUNEL staining 6 hours post transfection. C&D. Indicated 
proteins were transfected into A/J BMDM. 8 hours later, cells were stained with 5 
μg/ml AO in 37°C for 15 min before imaging by a fluorescent microscope. Data 
shown are the percentage of cells with damaged lysosome (loss of red 
florescence) from one representative from multiple experiments with similar 
results. E&F. A/J BMDMs were challenged with indicated strains at an MOI of 1. 
Extracellular bacteria were removed with extensive washes 1 hour post infection, 












Release of cathepsins into the cytoplasm could lead to the activation of 
the mitochondria cell death pathway by cleaving the BH3-only protein BID, which 
subsequently inserts into the mitochondria and induces cytochrome c release 
and caspase activation [78]. Cathepsin B has also been shown to activate 
caspase-2, which in turn induces cytochrome c release [220].If lysosome 
permeabilization occurs upon the detection of RpsL, apoptosis likely will be 
activated, which could eliminate infected macrophages. Pretreating macrophages 
with a specific inhibitor of cathepsin B, but not cathepsin D, significantly dampens 
the responses against RpsL, suggesting lysosome permeabilization acts 
upstream of apoptosis and cathepsin B plays a major role in this process (Fig. 4-
21, A). Consistent with this notion, marked increase of cytosolic cathepsin B 
activity was detected in macrophages transfected RpsLWT but not its K88R 
mutant (Fig. 4-21, B). Further, genetically ablating cathepsin B blunts apoptotic 
signaling upon RpsL sensing, as we observed a marked decrease of apoptotic 
cells in cathepsin B-/- BMDMs receiving RpsLWT (Fig. 4-21, C). This is not due to 
a general defect in the apoptotic pathway, as the pathways activated upon 
staurosporine treatment are intact in both C57BL/6 and cathepsin B-/- BMDMs; 
nor to the non-specific effects resulting from cathepsin deletion, because BMDMs 
lacking another cathepsin, cathepsin H, respond normally to RpsL (Fig. 4-21, C). 
Moreover, A/J BMDMs challenged with Lp02rpsLWT showed significantly 
increased level of cleaved BID and activated caspase-3 than those challenged 
with Lp02rpsLK88R. Lp02rpsLWT infected macrophages also harbor significantly 
more cleaved product of one of the best characterized caspase-3 substrates, 
cPARP (cleaved Poly (ADP-ribose) polymerase), further strengthening the notion 
that cathepsin B activates the BID-Caspase-3 pathway once it is released from 
lysosome upon RpsL sensing (Fig. 4-21, D). Correspondingly, we also observed 
marked increase of activated caspase-3 and cPARP in macrophage transfected 
with RpsLWT but not RpsLK88R, further strengthening that RpsL is a MAMP that 






In permissive host cells, L. pneumophila resides in an intracellular 
compartment that escapes the endocytic pathway and recruits organelles such 
as mitochondria and ER-derived small vesicles [221]. After a lag phase of 4-6 
hours, bacteria start to replicate and form spacious vacuoles that contain more 
than 10 bacteria [222]. If infected cells undergo apoptosis, large vacuoles cannot 
form, and bacterial replication will be limited. We thus examined the formation of 
bacterial vacuoles by relevant L. pneumophila strains. A/J BMDM challenged 
with Lp02rpsLWT has significantly fewer large vacuoles than those challenged by 
Lp02rpsLK88R (Fig. 4-21, F). Further, inhibition of cathepsin B by CA-074ME 
partially reverses such defects, further supporting the notion that lysosome 















Fig. 4-21 RpsL causes lysosome membrane permeabilization in 
macrophages A. A/J BMDM were treated with cathepsin B inhibitor CA074-ME 
(25μM) and cathepsin D inhibitor pepstatin A (25μM) 1 hour before protein 
transfection. Cell death was measured by TUNEL staining 6 hours post 
transfection. B. A/J BMDMs pretreated with indicated inhibitors were transfected 
with the indicated proteins. 6 hours post transfected, BMDMs were partially 
permeabilized with 100μg/ml saponin and the cytosolic cathepsin B activity was 
determined with z-FR-AMC. C. C57BL/6, cathepsin B-/- and cathepsin H-/- 
BMDMs were transfected with indicated RpsL proteins or treated with 1μg/ml 
staurosporine (STS). 6 hours later, cell death was measured by TUNEL staining. 
D. A/J BMDMs were challenged with indicated strains at an MOI of 1 for 8 hours. 
BMDMs were lysed and 100μg total proteins were resolved in SDS-PAGE. 
Activated caspase-3 (p19), tBID, and cleaved-PARP (cPARP) were detected with 
specific antibody. Tubulin was probed as a loading control. E. A/J BMDMs were 
transfected with indicated proteins or treated with 1μg/ml staurosporine. 100μg 
total proteins were resolved in SDS-PAGE. Activated caspase-3 (p19) and 
cleaved-PARP (cPARP) were detected with specific antibody. Tubulin was 
probed as a loading control. F. Diagram showing the possible downstreaming 











Fig. 4-22 Mass spectrometry analysis of the presence of thiomethylation on 
RpsL. Purified recomboinant RpsLWT/K88R proteins were subjected to mass 
spectrometry analysis to identify the post-translational modification-
thiomethylation on RpsL. These results indicated that RpsLWT could be readily 





















Fig. 4-23  RpsL is not detectably translocated into host cells by L. 
pneumophila. A. RpsL and RpsLK88R were fused to b-lactamase on a plasmid, 
respectively and the resulting constructs were transformed into L. pneumophila 
strains. The bacterial strains were used to determine Dot/Icm-dependent protein 
translocation with the CCF4 substrate with an established protocol. Strains 
expressing RalF or FabI were used as positive and negative controls, 
respectively. Note the robust translocation by the RalF construct indicated by the 
appearance of blue cells after bacterial infection.  B. Expression of the relevant 
fusions in L. pneumophila. The bacterial cells used for infection in (A) were 
probed for the expression of the fusion with a b-lactamase specific antibody. The 













Discussion   
 Our study demonstrates that environmental isolates of L. pneumophila 
cannot replicate in A/J mouse macrophages, which is permissive to most, if not 
all laboratory strains. The inability of environmental strains to replicate in A/J 
macrophages was accompanied by rapid and extensive host cell death [223]. 
LPE509-elicited cell death is of unique nature, as it is independent of L. 
pneumophila factors that are known to be involved in host cell death induction, 
such as flagellin, and factors shown to protect bacterium from host cell death 
surveillance components through maintaining the integrity of the LCV, such as 
SdhA [201]. The uniqueness of LPE509-elicited cell death also applies to the 
host pathways engaged by this bacterium. Two major cell death pathways have 
been demonstrated to be important in restricting intracellular L. pneumophila. 
The first one is governed by the non-permissive allele of Naip5, which recognizes 
flagellin presumably translocated into the host cytosol by the Dot/Icm of L. 
pneumophila, where it induces the assembly Naip5-NLRC4-Caspase-1 
inflammasome [120, 224]. The formation of inflammasome activates caspase-1, 
leading to a rapid and lytic form of cell death termed pyroptosis, as well as the 
maturation of inflammatory cytokines IL-1α and IL-1β [120]. The other parallel 
pathway involves the collaboration of a cluster of guanylate-binding proteins 
(small interferon-inducible GTPases) and yet another caspase, caspase-11 [225]. 
During infection of vacuolar Gram-negative bacteria, these guanylate-binding 
proteins are recruited to the damaged bacterial phagosomes and are required for 
the lysis of bacterial vacuoles. The lysis of the bacterial vacuoles then leads to 
the release of LPS, which activates caspase-11 [226]. Caspase-11, being the 
only component known so far that are both the receptor and executioner 
molecule in a same immune surveillance pathway, binds to cytosolic LPS and 
oligomerizes into the non-canonical inflammasome, which allows the activation of 
caspase-11 [226, 227]. Activated caspase-11 could induce pyroptosis alone or 
process caspase-1 for its activation, to accelerate the cell death process and to 





inflammatory pathways have been shown to be important for controlling L. 
pneumophila infection, we first tested whether these components are important 
to the cell death induced by LPE509. We found that mouse macrophages lacking 
caspase-1/11 still respond to and restrict the intracellular growth of LPE509, 
suggesting the involvement of other cell death pathways. Further, genetic 
ablation of caspase-3, the executioner caspase of the classic apoptotic pathway, 
or the application of necrostatin-1, a potent inhibitor of the necroptosis pathway 
[229], was unable to dampen the responses or rescue the intracellular growth of 
LPE509. Finally, the cell death triggered by LPE509 displays both apoptotic and 
pyroptotic features, as it is companied by loss of plasma membrane integrity, 
positive TUNEL staining and the formation of membrane blebs (Fig. 4-3). These 
results suggested 1) LPE509 codes for a unique factor that stimulates host 
immune responses, and 2) these responses are governed by alternative cell 
death pathways. Thus, we postulate that murine macrophages code for 
receptor(s) that can detect one or more factors specifically coded for by LPE509 
and that the engagement of the receptor with the ligand leads to the activation of 
enzymes such as caspases capable of causing membrane permeabilization, 
DNA fragmentation and the subsequent cell death. 
 
In our attempt to generate a transposon-mediated mutant library of 
LPE509 for the identification of the unique factor(s) of this bacterium, we 
obtained a spontaneous streptomycin resistant mutant that was capable of 
overcoming the growth restriction imposed by the A/J macrophages. Further 
analysis showed that a K88R mutation on the conserved bacterial ribosomal 
component RpsL in this particular strain. This allele also dictates the ability of 
different environmental and clinical strains of L. pneumophila to replicate in A/J 
mouse macrophages. Several lines of evidence below favor the hypothesis that 
RpsL is a MAMP directly responsible for the macrophage death induced by wild 






First, all examined L. pneumophila strains expressing wild type RpsL 
failed to replicate in A/J macrophages, while a K88R mutation allowed all these 
strains to overcome such restriction. The drastic difference between these strains 
is not simply due to the increased bacterial resistance to streptomycin, as 
rpsLK43N, a mutation that confers similar streptomycin resistance (Table 4-1), 
failed to support the replication of L. pneumophila in mouse macrophages. 
Moreover, the strain Lp02rpsLWT harboring pRG970, a plasmid that confers the 
bacterium streptomycin resistance, also fails to replicate in A/J mouse 
macrophages. These lines of evidence strongly argue against the involvement of 
streptomycin in clearing the bacteria. Second, the severity of host cell death by L. 
pneumophila infection depends on the genotype of rpsL in these strains. Third, 
intracellular delivery of purified WT RpsL protein recapitulates the host responses 
that are elicited during the infection by L. pneumophila carrying WT RpsL, such 
as lysosome membrane permeabilization, DNA fragmentation, and loss of 
plasma membrane integrity. Interestingly, the region surrounding the K88 residue 
(KVDL), is highly conserved even among phylogenetically distant bacteria, such 
E. coli, S. Typhimurium, and B. subtilis, which is consistent with our results that 
RpsL of E. coli also stimulates similar host responses as L. pneumophila RpsL 
does. Many rpsL homologues in eukaryotes harbor a Gly (mitoribosome) or Gln 
(cytoribosome) residue at position 87 instead of Lys, although the K43N mutation 
of rpsL could also confer resistance against streptomycin [230]. If RpsLWT is 
immune-stimulating, these mutations could be an effective mechanism to avoid 
autoimmunity. Together, we reason that RpsL, a conserved bacterial ribosomal 
protein, is a MAMP that is recognized by mouse macrophage by a putative 
cytosolic receptor. 
 
RpsL is not the first ribosome component shown to trigger immune 
response. In plants, EF-Tu, an accessory ribosomal protein is recognized by the 
receptor kinases EFR, a member of the PRRs, to induce antibacterial immunity 





cytokines such as interleukin-1β [232]. Interestingly, methylation of an adenosine 
in the antibiotic-binding site of 23S rRNA camouflages it from TLR13, and 
bacteria carrying this modification are resistant to antibiotics such as 
erythromycin [233]. Similar to this observation, lysine88 of RpsL is directly 
involved in binding to streptomycin, and mutation of this residue to arginine 
confers resistance to the antibiotic [206]; clearly this mutation also made the 
protein less recognizable by macrophages. Consistent with this notion, 
nonpathogenic E. coli strains harboring rpsLK88R survived significantly better than 
their wild type counterparts in macrophages [234], likely due to less immune 
activation by RpsLK88R from mutant bacteria. The K88R mutation in RpsL may 
represent an evolved mechanism that enables the bacteria to gain resistance to 
both antibiotics and the innate immunity. Alternatively, antibiotics and host innate 
immune sensors appear to have converged to recognize the same constrained 
epitope of the pathogen.  
 
Although our results suggest that RpsL is likely to be recognized by host 
immune system, how this molecule is sensed is yet to be determined. There are 
two possible mechanisms of immune recognition of RpsL. First, the distinct 
architecture of RpsL could be the trigger of immune responses, as it shares 
limited homology with its eukaryotic counterpart. A similar scenario could be 
found in recognition of profilin by TLR11/12, which is also distantly related to its 
mammalian counterpart [111]. The K88R mutation escapes recognition probably 
due to the altered structure of the mutation, making it a less suitable ligand for 
the putative receptor. Second, a unique posttranslational modification is 
responsible for the detection. One possible candidate is methylthiolation, which is 
present on the Gln89 residue on RpsL. The only known biomolecule harboring  
this modification in eukaryotic cells is tRNA [235]. Although Gln89 mutation could 
not be tolerated, mutation of the adjacent amino acid Leu to Phe or Tyr causes 
the loss of methylthiolation on Gln89, possibly due to steric hindrance. Therefore, 





Gln89, prevents proper methylthiolation on Gln89. If this were the case, the 
bacterium would gain the ability to escape immune recognition and gain 
resistance to streptomycin without paying the “hefty price tag” of a lethal mutation. 
In agreement with this hypothesis, mass spectrometry analysis showed that 
methylthiolation was only detected on RpsLWT, but not its K88R counterpart (Fig. 
4-22). Further, although the significance of methylthiolation on Gln89 is yet to be 
elucidated, it would be interesting to determine whether the loss of the enzyme 
responsible for this modification, RimO, would impact the ability of RpsL to 
induce host responses.  
 
Our hypothesis that RpsL is a universal MAMP seems to be difficult to 
reconcile with the fact that L. pneumophila is the only bacterium known to display 
such distinct a cell death phenotype. This difference most likely results from the 
promiscuous nature in substrate recognition of the Dot/Icm system of L. 
pneumophila. This transporter recognizes hundreds of substrates with diverse 
primary sequences in the region essential for translocation [158, 236]. It is 
therefore possible that L. pneumophila Dot/Icm system may “accidentally” deliver 
RpsL into the host cytosol to elicit immune responses, although the relative 
contribution of bacterial lysis cannot be ruled out. Such a phenomenon is not 
without precedent, as the Dot/Icm system has been implicated in the delivery of 
bacterial flagellin into the host cell, where it is sensed by the Naip5-NLRC4 
inflammasome and thus dictates the susceptibility of mouse line to L. 
pneumophila infection [147]. Flagellin from other bacteria is similarly potent in the 
activation of the NLRC4 inflammasome but does not exhibit such distinct 
phenotypes in infections [120]. It is notable that Dot/Icm-dependent flagellin 
translocation has not yet been experimentally demonstrated with standard 
reporters. Similarly, we cannot detect Dot/Icm-dependent delivery of RpsL into 
host cells (Fig. 4-24). Thus, although these proteins can be robustly sensed by 
the immune recognition systems, the amount delivered by the transporter is 





 The lysosome is emerging as a signal integration center for a wide variety 
of stress stimuli, such as oxidative and osmatic stress, various lipids, 
engagement of certain cell death receptors, ischemic injury, and lysosomal 
detergent [78]. Upon the perception of various stresses, the membrane of 
lysosome permeabilizes (LMP) and releases various hydrolases from the lumen 
of lysosome into the cytosol. As some of these hydrolases, such as cathepsins B 
and D, which are catalytically active even at neutral pH, could process various 
molecules in cytosol, to activate the intrinsic apoptosis pathways in apoptosis-
competent cells, or caspase-independent cell death when caspases are inhibited 
[78]. Although most of the lysosomal contents are leaked into the cytosol in case 
of extensive LPM, in the scenario of limited LMP, certain cathepsins are 
selectively released into the cytosol. This notion is supported by the observation 
that genetic ablation or specific inhibitor(s) of one or more cathepsins can confer 
significant protection against cell death [78]. For example, cathepsins B is 
selectively released and plays a dominant role in chemotherapy-triggered NLPR3 
inflammasome activation and IL-1β secretion, as well as in TNF-α induced 
cellular apoptosis in fibrosarcoma cells [237, 238]. In scenarios such as the 
caspase-8 mediated inflammation resolution in neutrophils, cytosolic cathepsin D 
plays the dominant role [239]. This is in line with our observation that the host 
perception of RpsL triggers the onset of LMP, which selectively releases 
cathepsin B into the cytosol to activate the intrinsic apoptosis pathways. Our 
observations are akin to those of bacterial flagellin, which also induces LMP upon 
entry into the host cytosol [216]. Additional examples of LMP as an immune 
response to MAMP come from the HIV protein Nef, which causes LMP when 
present in cytosol, and may contribute to the massive CD4+ T cell upon HIV 
infection [87]. It seems that lysosome is becoming one signal integrated center 
for host response to MAMPs. The future challenges will be the identification of 
the receptors for these MAMPs and how the relevant signaling pathways govern 





 The important role of cathepsin B in host responses to RpsL is seemingly 
irreconcilable with the inability of ctsB-/- macrophages to support intracellular 
growth of L. pneumophila expressing the wild type RpsL. The apparent complex 
roles of cathepsin B in lysosomal cell death may provide explanations to this 
conundrum. For instance, cathepsin B could be the signaling component 
upstream of LMP [240], the amplifier of signaling cascade [241], a signal relaying 
molecule [237], or the terminal executioner in the cell death pathway [242]. If 
cathepsin B functions in one of the branches in the signaling cascade that 
governs the responses against RpsL, it is possible that genetic ablation of this 
enzyme could not support the growth of L. pneumophila carrying RpsLWT allele. 
This scenario is akin to the Naip5-NLRC4-caspase-1 axis of inflammasome 
which responds to flagellin, as delecting caspase-1 leads to only limited 
replication of L. pneumophila that expresses flagellin, while ablating Naip5 or 
NLRC4 greatly alleviates the growth restriction [147, 243]. It is also possible that 
the arrest of bacterial replication occurred prior to macrophage death. One focus 
in future study will be the mechanism underlying these two phenotypes.  
 
 RpsL induced cell death only happens in macrophages. Such specificity 
suggests that RpsL do not directly damage lysosomal membrane but instead that 
the components that govern the responses to RpsL may not be present or 
present at a lower abundance in other cell types. Such scenario is not without 
precedent: for instance, Pyrin, the NLR sensor for pathogen-mediated 
modifications on small GTPase RhoA, could be detected only in primary 
macrophages, but not in immortalized macrophages, dendritic cells, and dendritic 
cell line [132]. It is likely that RpsL engages this putative receptor to activate or to 
initiate the production of molecules capable of causing LMP. Alternatively, 
immortalized cell lines may have a stronger pro-survival signaling profile than 
primary macrophages, which is critical for their survival in culture. These 
signaling cascades could potentially antagonize the pathways activated by RpsL, 





That RpsL-induced macrophage death occurs independent of several 
inflammatory caspases is consistent with the observation that we did not detect 
significant induction of inflammatory cytokines in macrophages upon RpsL 
delivery. The lysosomal cell death process is involved in the activation of the 
NLRP3 inflammasome induced by cholesterol crystals [244], as well as the 
induction of the inflammatory, caspase-1/11 independent cell death in response 
to cytosolic flagellin [216]. Whether RpsL-induced cell death is accompanied by 
any inflammation awaits further investigation. Clearly, identification of the 
putative receptor for RpsL will greatly facilitate the research to elucidate the 
















Fig. 4-23 A schematic presentation of the model of host perception of RpsL 
In this model, bacterial ribosomal protein RpsL is leaked into the cytosol 
presumbly due to the promiscuous nature of the Dot/Icm secretion system. After 
accesses to host cytosol, RpsL engages host immune systems and triggers 
permeabilization of the lysosomal membrane, allowing the release of various 
hydrolases including cathepsin B into the cytosol. Cathepsin B then processes 
BID into tBID, allowing it to insert into the outer membrane of mitochondria, 
inducing the cytochrome c and intiating the classic apoptotic cascade. These 













 We favor a model in which RpsL reaches the host cytosol via the Dot/Icm 
of L. pneumophila. Upon accessing the cytosol, RpsL is recognized by a putative 
receptor, which initiates the signaling cascade that leads to the permeabilization 
of the lysosomal membrane. Compromised lysosomal membranes allows for the 
release of lysosomal hydrolases into the cytosol. One of these hydrolases, 
cathepsin B, activates the cellular apoptosis pathway by processing the BH3-only 
protein BID. Processed BID (tBID) then inserts into the mitochondria membrane 
and liberates the cytochrome c into the cytosol, which subsequently activates 





CHAPTER V: MATERIALS AND METHODS 
Bacterial strains, cell culture and media 
The L. pneumophila strains used are derivatives of the strain Lp02 (thyA 
Δ(hsdR-lvh) rpsL), and were grown on charcoal-yeast extract (CYE) solid 
medium or ACES-yeast extract (AYE) [10]; Lp03 contains the dotA mutation [10]. 
The growth media were supplemented with thymidine at 100 mg/ml when 
appropriate. For infection experiments, the L.pneumophila strains used in all 
assays were grown to post-exponential phase (OD600<3.4–3.7) unless stated 
otherwise. Antibiotics were used at the following concentrations with E. coli 
strains:  ampicillin 100 mg/ml and chloramphenicol, 30 mg/ml.  For L. 
pneumophila strains, chloramphenicol was used at 5 mg/ml. U937 cells were 
cultured in RPMI medium supplemented with 10% FBS prior to being induced by 
phorbol myristate acetate (PMA) (0.1 mg/ml). For assays in 96-well microtiter 
plates, differentiated U937 cells were plated in 96-well having optically clear 
bottoms in a density of 1x105/well. 
Non-polar deletions of each or the combination of lpg0716, lpg0898, 
lpg1625, lpg2716, and lpg2831 were constructed as described elsewhere [29]. In 
each case, primers were designed such that the open reading frame was 
replaced by a polypeptide consisting of 32 amino acids: the first and last 15 
residues of the protein separated by two residues encoded by the restriction 
enzyme used for plasmid construction. The sequences of the primers used were 
listed in Appendix Table 1.   
293T cells and mouse embryonic fibroblasts (MEFs) were cultured in 
DMEM medium supplemented with 10% FBS; U937 cells were maintained in 





 phorbol myristate acetate (PMA) (0.1 μg/ml) [5]. Bone marrow-derived 
macrophages were prepared according to an established protocol [245].  All cell 
lines were maintained at 37 °C within a humidified atmosphere and with 5% CO2. 
Dendritic cells derived from A/J mouse bone marrow were cultured as 
previously described [246]. Maturing, nonadherent DCs were plated onto poly-
lysine treated coverslips seeded in 24-well plates) at a concentration of 1x105 
cells per well. 12 hr later, DCs were challenged with properly grown L. 
pneumophila strains at an MOI of 25. The plates were centrifuged at 150xg for 10 
minutes. After two hours, extracellular bacterial growth was stopped by addition 
of 50 μg/ml gentamicin for 1 hour. DCs were then washed 3 times with PBS to 
remove residual antibiotic and cultured in fresh medium for the indicated length 
of time. At indicated time point, DCs were lysed in 0.02% saponin, and dilutions 
of lysate were plated on CYE agar to determine bacterial count.  
For single cell analysis, DCs were infected by indicated strains of L. 
pneumophila for 8 hours. Infected samples were incubated with FITC-conjugated 
anti-CD11b antibody (Miltenyi Biotec, Auburn, CA) for 10 minutes in 4 °C to 
identify DCs. Infected samples were then fixed with 4% paraformaldehyde for 20 
minutes at room temperature, washed 3 times with RPMI-1640 and 
permeabilized in RPMI-1640 containing 0.5% saponin for 15 min. L. pneumophila 
were stained as described elsewhere [29]. Apoptotic DCs were identified using In 
Situ Cell Death Detection Kit (Roche) per manufacturer’s instruction. 
Allele exchange of the rpsL gene was performed using the standard 
method [62].   
Briefly, the open reading frame of rpsL (lpg0324) together with 300bp 
flanking sequence was amplified from genomic DNA of wild type or rpsLK88R 
mutant strain of LPE509. The DNA digested with appropriate restriction enzymes 
was ligated to the pir protein-dependent plasmid pSR47s [Rankin, 2002 #16], to 






5'CTGGTCGACGTACTTCCACACTTGGGCGA-3'. Plasmids were introduced 
into appropriate L. pneumophila strains by electroporation, and transformants 
were streaked onto CYE plate supplemented with 5% sucrose and the desired 
strains were screened by the gain or loss of resistance to streptomycin followed 
by DNA sequencing of the locus.  
A/J and C56BL/6 mice were purchased from the Jackson laboratory (Bar 
Harbor, Maine). Caspase 1/11-/- and Caspase 1/7/11-/- [247] and the 
corresponding C56BL/6 control mice were generously supplied by Dr. R. E. 
Vance (UC Berkeley). The cathepsin B and cathepsin H knock mice (cstB-/-, 
cstH-/-) were generous supplied by Dr. Joyce Jones (NYU School of Medicine). 
Bone marrow-derived macrophages were prepared from 6-10-week old female 
mice with L-supernatant as described previously [245]. Macrophages were 
seeded in 24-well plate the day before infection. Cell density of 4x105/well was 
used for intracellular bacterial growth and LDH release assay, whereas 
2x105/well was used for immunofluorescence staining and other single cell-based 
assays.  L. pneumophila used for infection was grown in AYE broth to post 
exponential phase based on both optical value (OD600=3.4-4.0) and bacterial 
motility. 
Antibody and Western blotting 
  The antibody against b-lactamase was purchased from Abcam 
(Cambridge, MA). The antibody specific for the isocitrate dehydrogenase (ICDH) 
of L. pneumophila was described elsewhere [20]. To detect the expression of the 
fusion proteins in L. pneumophila,  strains harboring  the plasmids were grown in 
CYE medium  supplemented  with  thymidine  (200 mg/ml),  chloramphenicol 5 
mg/ml and IPTG (0.5 mM) to post exponential phase (OD600 = 3.4–3.7). Cells 
equal to 1 OD unit were withdrawn and dissolved in 200 ml of SDS loading buffer. 
After boiling for 5 min, cleared supernatant was resolved by SDS-PAGE. To 





cell lysis buffer or RIPA buffer in the presence of protease inhibitor cocktail 
(CalBiochem). The lysate were then cleared at top speed for 10 mins at 4°C. 
100μg total protein was then mixed with SDS loading buffer and boiled for 10 
minutes. SDS-PAGE separated proteins were transferred to nitrocellulose 
membranes and were incubated with appropriately diluted primary antibodies in 
PBS before incubating with IRDye-conjugated secondary antibodies. The signals 
were detected by a Li-COR’s Odyssey system (LI-COR Biosciences, Lincoln, 
NE). The antibody for detecting cleaved caspase-3 was from Cell Signaling 
(#9664) and was used at 1:1000.  The SOD2 antibody from Abcam was used at 
1:2000. The Cyto c antibody from Santa Cruz Biotechnology (#sc-13560) was 
used at 1:3000. The VipD antibody [30] was a kind gift from Dr. Ralph Isberg 
(Tufts Medical School). The antibody against GFP described earlier [38] was 
used at 1:20,000. The His-tag antibody from Sigma (#H1029) was used at 
1:40,000; the SdhA [52] was used as 1:5,000 and the flagellin antibody [148] was 
used at 1:5,000. Anti-cleaved PARP was purchased from Abcam (ab2317). Anti-
mouse-BID was purchased from R&D System (MAB860).  
For immunostaining, mouse macrophages were infected with L. 
pneumophila at an MOI of 2. Samples were collected 1 hour after infection for 
LAMP-1 staining, 2 hours and 6 hours after infection for Rab1 staining.  After 
fixation, samples were first stained for bacteria using anti-L.pneumophila 
antibodies [38] at a dilution of 1:10,000. Extracellular and intracellular bacteria 
were distinguished using secondary antibodies conjugated to distinct fluorescent 
dyes. Cyto c oxidase (COX4I1) was detected with an antibody from Cell 
Signaling at a 1:500 ratio for immunostaining. LAMP-1 was labeled with antibody 
clone IDB4 (Development Studies Hybridoma Bank, Iowa City, IA) at a dilution of 
1:10. Rab1 was labeled with antibody (Santa Cruz Biotechnology, sc-599) at a 
1:200 dilution. Processed coverslips were mounted on glass slides with an anti-
fade reagent (Vector laboratories, CA). For infection center, mouse macrophages 
were infected at an MOI of 1; extracellular bacteria were removed by washing the 





After fixation, extracellular and intracellular Legionella were stained with an anti-
Legionella antibody followed with secondary antibody conjugated with fluorescein 
isothiocyanate (FITC) and Texas red, respectively. Samples were examined by 
visual inspection with an Olympus IX-81 fluorescent microscope.  Infection 
centers were classified into 3 categories as small (1-3 bacteria), medium (4-9 
bacteria) and large (?10 bacteria). Average distribution of the infection centers 
was determined from triplicate infections of each bacterial strain.  
Construction of β-lactamase fusion library 
To accommodate the fusion of genes to the b-lactamase gene as 
BamHI/SalI DNA fragments in the first open reading frame, we inserted a DNA 
fragment obtained from annealing oligos  
5`-CGGATCCCTGCAGGCGGCCGCGTCGACT-3` and  
5`-CATGGCCTAGGGACGTCCGCCGGCGCAGCTGAGATC-3` into KpnI 
and XbaI digested pDXC61 [34] to give pDXC61M. To make the fusion library, 
open reading frames larger than 300 base pairs that code for hypothetical 
proteins were retrieved from the genome of L. pneumophila strain Philadelphia 1. 
19-base primers were designed to amplify the entire gene by PCR with the Pfu 
UltraII high fidelity DNA polymerase (Agilent, Santa Clara, CA). In each case, 
DNA sequences recognized by the restriction enzymes BamHI and SalI were 
added to the 5` and 3`  primers, respectively (Table S1). For genes whose 
sequences contain the BamHI or SalI recognition site, sequences for BglII or 
XhoI were added. For a number of genes that harbor one or more of these sites, 
other restriction enzymes were used (Table S1). After digestion with the 
appropriate restriction enzymes the PCR products were inserted into similarly 
digested pDXC61M. Plasmids containing correct inserts were introduced into L. 
pneumophila strains by electroporation. To make β-lactamase fusions with 
specific regions of genes, the target regions were amplified by PCR with the 






Screen for fusions that transfer the β-lactamase into mammalian cells 
To test Dot/Icm-dependent transfer of the fusion proteins into host cells, L. 
pneumophila strains expressed the fusions grown to post exponential phase in 
the presence of 0.5 mM IPTG were used to infect monolayers of U937 cells 
seeded in 96-well plates at an MOI of 20. One hour after infection, the CCF4-AM 
substrates (Invitrogen, Carlsbad, CA) were mixed with medium in the wells. After 
further incubation for 2 hours at 25°C, infected cells were visually inspected 
under a Nikon IX-80 fluorescence microscope equipped with a b-lactamase FL-
Cube (U-N41031, Chroma Technology Corp, Bellows Falls, VT). Images of 
infected cells were obtained by a DP-72 color fluorescence camera (Olympus). 
The percentage of infected cells was determined by counting the number of cells 
emitting blue fluorescence in specified areas of the wells. Experiments were 
performed in triplicate and in each sample and at least 300 cells were counted. 
Mutagenesis 
The serine residue (S73) critical for the putative phospholipase of VipD is 
mutated to alanine using primers vipDS73AF and vipDS73AR (Table S2) with the 
Pfu UltraII (Agilent Technologies) DNA polymerase. Mutants of Lpg0898 no 
longer toxic to yeast were isolated by mutagenizing pGBKT7m-0898 with 
hydroxylamine using an established protocol [248]. Treated DNA was introduced 
into yeast strain W303, colonies appeared on selective medium were screened 
for the presence of full-length Lpg0898 by immunoblot with a Gal4 specific 
antibody (sc-577, Santa Cruz Biotechnology).  All mutations were determined by 
double strand DNA sequencing.  
Library construction and screen for caspase-3 activators 
A library for expression of GFP fusions of experimentally confirmed 
Dot/Icm substrates in mammalian cells was constructed by inserting individual 
genes [158] into vector pEGFP-C1 (Clontech).  These genes were listed in Table 





harboring the GFP fusion using Lipofactamine-2000 (Invitrogen) per 
manufacturer’s instructions.  Twenty-four hours after transfection, cells were 
lysed and the cellular caspase-3 activity was measured using the Caspase-Glo 
3/7 Assay Systems (Promega, Madison, WI) according to protocols supplied by 
the manufacturer. Alternatively, transfected cells were lysed with the RIPA buffer 
(1% NP-40, 0.1% SDS, 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.5% sodium 
deoxycholate, 1 mM EDTA) supplemented with a protease inhibitor cocktail 
(Millipore, PA) 24 hr after transfection. The presence of activated caspase-3 (p17 
and p19 fragments) was detected by immunoblot.  
Measurement of mitochondrial transmembrane potential 
Mitochondrial transmembrane potential (Δψm) is measured by 
determining the mitochondrial-to-cytoplasmic fluorescence ratio (Fm/Fc) using 
tetramethylrhodamine methyl ester perchlorate (TMRM) with established 
methods [249]. Briefly, Hela-60 cells were exposed to 20 nM of TMRM in 
DMEM+10% FBS medium for 20 minutes in a CO2 incubator of 37 °C to allow 
dye equilibration. The medium is then replaced with 5 nM of TMRM in DMEM+10% 
FBS medium for imaging. After loading with the mitochondrial dye, coverslips 
were mounted on a Teflon holder and the images were acquired using a Nikon 
Eclipse Ti microscope (60x oil Plan Apo objective). TMRM images were 
thresheld to isolate the mitochondrial florescence (Fm), and the florescence 
intensity of areas of one square micrometer was measured using the software 
ImageJ (NIH). Cytoplasmic florescence (Fc) is determined in hand-drawn regions 
in close proximity to the mitochondria.  Δψm is then determined as the ratio of 
Fm/Fc using the following formula: [(Fm-(2/3) Fc)/(1/3) Fc].  At least 300 
mitochondria in each sample were analyzed and the statistical analysis was 








In vivo cytochrome c release assay 
  293T cells transfected to express individual GFP fusion of testing proteins 
were harvested and washed twice with PBS. 1X107 Cells were then 
permeabilized for 5 min on ice with a mitochondrial buffer (20 mM HEPES, pH 
7.4, 250 mM sucrose, 100 mM KCl, 5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, and 
100 μg/μl digitonin) at a concentration of about 3.5 x 107 cells/ml [250].  The 
cytosolic fraction was separated from mitochondrial fraction by centrifugation at 
600xg for 10 min at 4 °C.  50 μg of soluble cytosolic proteins (supernatant) and 
mitochondrial proteins (pellet) were then resolved on 15% SDS-PAGE gel.  The 
presence of cytochrome c (Cyto c) in these samples was detected by immunoblot.  
In vitro cytochrome c release assay 
We isolated mitochondria from HEK293T cells using a Mitochondria 
Isolation Kit (Sigma) per manufacturer recommendations.  100 μg purified 
mitochondria were then incubated with VipD or its mutant proteins in a 
mitochondrial storage buffer (Sigma) at 30 °C for 2 hr. The samples were then 
cleared at 13,000xg for 10 min at 4 °C. The resulting supernatant and pellet were 
then resolved on 15% SDS-PAGE gels and Cyto c was detected by immunoblot. 
The matrix protein SOD2 was probed to monitor the integrity of mitochondrial 
inner membrane.  
Lipid extraction 
Lipids from 200 μg purified mitochondria that had been incubated with 
purified His6-VipD or His6-VipDS73A were extracted using the Folch method [180]. 
Briefly, chloroform, methanol, and water with a volume ration of 8:4:3 were mixed 
in a separation funnel, allowed to stand to obtain a biphasic system. The upper 
phase was used as the pure-solvent-upper-phase. The mitochondria samples 
were placed into a glass homogenizer with 5 drops of ice-cold chloroform-
methanol extraction solvent (2:1) and manually homogenized with a pestle. The 





complete homogenization.  Homogenates were filtered through a lipid-free paper 
and mixed with 0.2 volumes of H2O, and the mix is allowed to separate into 2 
phases.  After removing the upper phase, the lower phase was rinsed 3 times 
with the pure-solvent-upper-phase.  The lower organic phase was collected, 
dried under a stream of nitrogen, and stored at -80°C. 
Liquid chromatography mass spectrometry 
Lipid extracts from samples treated by VipD or its S73A mutant were 
profiled using the LTQ Orbitrap instrument to determine their lipid contents.  The 
analysis was performed using a Dionex 3000 Ultimate LC system (Dionex, 
Sunnyvale, CA) interfaced to an externally calibrated LTQ Orbitrap hybrid mass 
spectrometer with an electrospray ion source (Thermo Scientific, San Jose, CA).  
A 1-μL aliquot of lipid extract dissolved in 50 μL of methanol was injected onto a 
Kinetex™ C18 column (100 mm × 2.1 mm, 2.6 μm particle size) equipped with 
an inline filter from Phenomenex (Phenomenex, Torrance, CA).  Mobile phase A 
was 10 mM ammonium acetate in water:methanol (10%:90%, v:v), and mobile 
phase B was 10 mM ammonium acetate in isopropanol:methanol (50%:50%, v:v).  
The column was maintained at 25 ºC and the gradient conditions were a linear 
ramp of 30% B to 100% B in 15 minutes using a flow rate of 250 μL/min.  
The mass spectrometer was operated in an automated data dependent 
mode alternating between an FT-MS scan in the Orbitrap and a collision-induced 
dissociation (CID) scan in the linear ion trap.  The scan in the Orbitrap was from 
m/z 300 to m/z 2000 at 15000 resolving power.  The precursor ions were isolated 
in the linear trap using the data-dependent acquisition mode with a 2 m/z 
isolation width to select automatically and sequentially the three most intense 
ions from each survey scan.  The isolated ions were collisionally activated in the 
linear trap at 35 % normalized collision energy. The cycle was continuously 
repeated throughout the entire separation with the dynamic exclusion set to 45 





Orbitrap offered high mass accuracy of the selected precursor ions.  The analysis 
was performed twice, once in positive ion mode and again in negative ion mode.   
Lipid preparation  
Five μl of lysophosphoethanolamine (Avanti Lipids, Alabaster, AL) and 7.5 
mg linolenic acid (Sigma, St. Louis, MI) were dissolved in 2-ml of chloroform: 
methanol 3:1 solvent, which are then dried to a thin film under a gentle nitrogen 
stream for at least 2 hours to remove residual organic solvent. The resulting thin 
film of lipids were then dispersed in 5-ml of L buffer (50 mM Tris·Cl 7.5, 150 mM 
NaCl) at 37 °C using a tip-sonicator with 20% vibration until optical clarity is 
achieved.  
Phospholipase activity assay and thin-layered chromatography   
Phosphatidylcholine (PC) and phosphatidylserine (PS) were purchased 
from NOF America Corp and phosphatidylethanolamine (PE) were obtained from 
Sigma. Lipids were dissolved in 100% chloroform to a final concentration of 100 
mg/ml. To prepare PC or PE only liposomes, 40 ?g of each lipid was dried in a 
Speed-Vac and rehydrated with enzyme buffer (20 mM Tris·Cl pH 7.4, 150 mM 
NaCl, and 4 mM CaCl2) at RT for 30 min followed by two 30s incubation in bath 
sonicator (Branson 220). For PC:PS or PE:PS, liposomes were made in a ratio of 
3:1 containing a total lipids of 40 ?g.  
For testing the phospholipase activity of His6-VipD, each reaction was 
prepared by mixing PC, PC:PS, PE, or PE:PS liposomes with 20 ?g of enzyme 
and incubated for 3 hr at 30°C. The reaction was quenched with the addition of 4 
volumes of chloroform/methanol (2:1 by volume). Total lipids were extracted from 
the lower organic phase and subjected to Speed-Vac drying. The dried pellet was 
resuspended in 10 ?l of methanol/isopropanol/acetic acid (5/5/2) and spotted 
onto a TLC Silica gel 60 F254 (EMD) that was pretreated by soaking in 
methanol/water (3:2) containing 1% potassium oxalate and then 1 h drying in a 





propanol/2 M acetic acid (65%:35%) and the final products were visualized using 
iodine vapor (Alfa Aesar). Phospholipase A2 from bovine pancreas (Sigma) was 
used as a positive control in the experiment. 
Elimination of potential co-factors associated with mitochondria by 
proteinase K  
We treated mitochondria (100 μg/sample) purified from HEK293T cells 
with proteinase K at a concentration of 1μg/ml or buffer at 25°C for 30 minutes. 
Proteinase K was then removed by washing three times with the storage buffer 
(Sigma) containing 2 mM PMSF. Mitochondria were then incubated with VipD or 
its mutant proteins in mitochondrial storage buffer (Sigma) at 30 °C for 2 hr. The 
release of cytochrome c from mitochondria was detected as described above.  
TUNEL staining  
  2x105 mouse macrophages were infected with an MOI of 1, and incubated 
for 14 hours after infection. Samples were fixed and stained with intracellular and 
extracellular bacteria as described above, and then stained with TUNEL using 
the In Situ Cell Death Detection Kit (Roche Diagnostics, Indianapolis, IN). Fifty 
microliter TUNEL reaction mixture was added to each coverslip and incubated at 
room temperature for 30 min. After three times washes with PBS, coverslips 
were mounted with anti-fade reagent.  
Propidium iodide and Hoechst 33342 staining  
  2x105 mouse macrophages were infected with an MOI of 1, and incubated 
for 2 hr after infection. After centrifugation at 200g for 5 min, the culture medium 
was removed, and 0.5 ml of the dye solution containing 500 nM propidium iodide 
and 1:10,000 Hoechst was then added into each well. The plate was incubated in 
the dark for 30 min before image acquisition using an Olympus IX-81 






LDH release assay and glycine protection 
  LDH release during infection was determined using the CytoTox 96 Assay 
(Promega, WI). Macrophages were infected at an MOI of 1 on 24-well plates, and 
incubated in 37?C for 2 or 4 hr. After centrifugation at 200g for 5 min, 50-μl 
supernatant of each well was transferred to a new 96-well enzymatic assay plate. 
Fifty microliter reconstituted Substrate Mix was then added to each well of the 
plate, and incubated in dark at room temperature for 30 min. The enzymatic 
reaction was stopped by adding 50-μl stop solution to each well. The absorbance 
490 was measured using a Biotek microplate reader. Total LDH release was 
determined by complete lysis of the cells using a lysis solution provided by the Kit, 
and spontaneous LDH release was determined by using the supernatant of cells 
without infection. For glycine protection, glycine was added to tissue culture 
medium at a final concentration of 20 mM 1hr prior to infection and was kept in 
infection samples throughout the entire experimental duration.  The percentage 
of LDH release was calculated with the follow formula: LDH release 
(%)=(Experimental LDH release-Spontaneous LDH release)/(Total LDH release-
Spontaneous LDH release)*100. 
Intracellular protein delivery  
  Recombinant proteins were purified as previously described [Yang, 2013 
#2612]. Briefly, recombinant proteins bound to Ni-NTA columns were subjected 
to extensive organic solvent wash (50x bed volume with wash buffer containing 
60% isopropanol) to remove the majority of endotoxin contaminants. If necessary, 
BMDMs were treated with lysosome acidification inhibitor bafilomycin A1 (20 nM), 
cathepsin B inhibitor CA-074ME (25 μM), cathepsin D inhibitor pepstatin A (25 
μM) or DMSO (vehicle) for 1 hour before protein transfection. The purified 
proteins were then introduced into macrophages using Lipofectamine 2000 as 
follows: For transfection of 2x105 macrophages, 12.5-μg recombinant protein 
suspended in 50-μl RPMI-1640 and 2-μl Lipofectamine 2000 suspended in 50-μl 





mixture was then directly applied to the macrophage cultures.  
Acridine orange staining  
  BMDMs plated on glass coverslips at a density of 2x105/well were either 
transfected with appropriate proteins or infected with different L. pneumophila 
strains at an MOI of 1.  For infection, the samples were washed 3 times with 
warm PBS to synchronize the infection 2 hrs after adding the bacteria. The 
transfected/infected samples were incubated for 8 hrs.  After centrifugation at 
200g for 5 min, the culture medium was removed, and 0.5 ml of the dye solution 
containing acridine orange (5 μg/ml) was added into each well. The plate was 
incubated at 37°C for 15 min before imaging using a fluorescent microscope 
(Olympus IX-81).  
Cytosolic cathepsin B activity  
4x105 A/J BMDMs were plated in 24-well plates. RpsL proteins were 
delivered into the cells as described above. 6 hours post protein transfection, 
cytosolic cathepsin B activity was determined as previously described [Newman, 
2009 #2798]. Briefly, macrophages were wash with phenol red and HEPES free 
DMEM (Invitrogen, OR). 100μg/ml saponin was added to each well and samples 
are incubated for 10 mins on ice. Cell lystae was cleared at 2,000 rpm for 10 min 
at 4°C in flat-bottom 96-well plates. 10μl of the cell lysate was then added to 90 
μl of the cathepsin B substrate buffer (100 μM zRR-AMC, 50 mM sodium acetate 
[pH 6.0], 4 mM EDTA, 10 mM dithiothreitol, 1 mM Pefablock). The generation of 
free AMC was determined by recording fluorescence (excitation, 355 nm; 
emission, 460 nm) at 30° in a TECAN multiplate reader. Cathepsin B activity was 
determined by measuring the increase in AMC fluorescence. 
Caspase-3 activity assay 
4x105 A/J BMDMs were plated in 24-well plates. RpsL proteins were 





macrophages were lysed according to manufacturer’s instruction (Caspase-3 
Fluorometric Assay Kit, R&D). Cleared lysate was then incubated with DEVD-
AFC in 37° for 2 hours. And the generation of free AFC from DEVD-AFC 
cleavage was determined by recording fluorescence (excitation, 355 nm; 
emission, 460 nm) at 30° in a TECAN multiplate reader. Caspase-3 activity was 
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Table 1. Candidate genes and the corresponding primers used in the 
screening for Dot/Icm substrates of L. pneumophila  
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2. Characteristics of Dot/Icm substrates identified in this study 
 







1 Lpg0021 480 5% N/A 
2 Lpg0046 399 5% N/A 
3 Lpg0130 2496 80% N/A 
4 Lpg0172 726 10% N/A 
5 Lpg0181 912 50% N/A 
6 Lpg0260 399 5-10% N/A 
7 Lpg0364 306 5% N/A 
8 Lpg0375 600 5-10% N/A 
9 Lpg0405 591 5-10% N/A 
10 Lpg0716 1014 50% N/A 
11 Lpg0796 651 50% N/A 
12 Lpg0967 594 50-60% N/A 
13 Lpg1083 684 30% N/A 
14 Lpg1106 1275 50% N/A 
15 Lpg1124 591 5-10% N/A 











18 Lpg1171 420 80% N/A 
19 Lpg1449 2613 50% 
DUS-FNM phosphate-
binding super family1 
20 Lpg1453 519 5-10% N/A 
21 Lpg1484 810 20-50% N/A 
22 Lpg1578 450 5-10% N/A 
23 Lpg1639 1317 20% N/A 
24 Lpg1654 1119 40% 
Tetratricopeptide 
repeat 
25 Lpg1661 1119 5-10% Acyltransferase family 
26 Lpg1666 1404 50% N/A 
27 Lpg1667 1392 80% IgA Peptidase M64
2 
28 Lpg1670 891 5-10% N/A 
29 Lpg1684 1398 80% D123 super family
3 
30 Lpg1685 870 40% N/A 
31 Lpg1692 1311 80% N/A 





33 Lpg1776 648 5-10% N/A 
34 Lpg1803 936 20% Rho_GEF
4 
35 Lpg1888 1332 5% PLDc Super family
5 
36 Lpg1907 1806 90% Lipase Family 
37 Lpg1924 2793 80% N/A 
38 Lpg1959 1995 70% N/A 
39 Lpg1986 2853 90% TraI_TIGR Domain6 
40 Lpg2050 1059 10-20% 
PKC_like family, CRIK 
subfamily7 
41 Lpg2148 1281 90% N/A 
42 Lpg2149 360 20-30% N/A 
43 Lpg2223 1224 80% N/A 
44 Lpg2239 3858 80% N/A 
45 Lpg2271 651 80% N/A 
46 Lpg2359 444 5-10% N/A 
47 Lpg2370 939 20% HipA Super family
8 
48 Lpg2372 1269 5% N/A 
49 Lpg2382 1455 15% N/A 
50 Lpg2434 492 5% Cupin super family 





52 Lpg2461 639 5-10% N/A 
53 Lpg2505 888 20-30% N/A 
54 Lpg2508 2424 10% N/A 
55 Lpg2538 1416 75% N/A 
56 Lpg2539 408 20% N/A 
57 Lpg2546 1410 10-20% N/A 
58 Lpg2555 855 30% HAD-like superfamily
9 
59 Lpg2628 753 50% N/A 
60 Lpg2637 1212 75% N/A 
61 Lpg2692 531 5-10% N/A 
62 Lpg2745 1968 60% N/A 
63 Lpg2826 1734 90% Peptidase C26 
64 Lpg2832 1641 40% N/A 
65 Lpg2844 1086 90% N/A 
66 Lpg2885 555 20% N/A 
67 Lpg2888 1914 10-20% N/A 
68 Lpg2912 1488 80% N/A 
69 Lpg2936 735 5-10% 
RNA methyltransferase 
super family 







1 DUS-FNM phosphate-binding super family: Dihydrouridine synthase-like (DUS-
like) FMN-binding domain 
2 IgA Peptidase M64: Highly selective metallo-endopeptidases that cleaves IgA 
3 D123 superfamily: This family contains a number of eukaryotic D123 proteins 
4 Rho GEF:  Rho GTPase Guanine exchange factor 
5 PLDc family: Phospholipase D family 
6 TraI TIGR Domain: Conjugative transfer relaxase protein TraI 
7 PKC like super family: Protein Kinase C superfamily 
8 HipA family: High-frequency-persistence mutants (Hip) A family 
9 HAD like superfamily: Haloacid dehalogenase-like hydrolases superfamily  
10 ZnMc superfamily: Zinc-dependent metalloprotease, astacin like subfamily or 


















Table 3.  Experimentally confirmed protein substrates of the Dot/Icm 
transporter 
 Lpg number Alias Size Reference  
1 Lpg0008 ravA 1260 [251] 
2 Lpg0012 CegC1 1575 [41] 
3 Lpg0021 N/A 480 This study 
4 Lpg0030 ravB 915 [251] 
5 Lpg0038 LegA10 1521 [35] 
6 lpg0041 N/A 2187 [41] 
7 Lpg0045 N/A 210 [252] 
8 Lpg0046 N/A 399 This study 
9 Lpg0059 Ceg2 1107 [42] 
10 Lpg0080 Ceg3 765 [42]  
11 Lpg0081 N/A 1326 [252] 
12 Lpg0090 Lem1 4125 [42]  
13 Lpg0096 Ceg4 1194 [42]  
14 Lpg0103 VipF 858 [108] 
15 Lpg0126 CegC2 3306 [41] 
16 Lpg0130 N/A 2496 This study 
17 Lpg0160 ravD 978 [251] 
18 Lpg0170 ravC 807 [251] 
19 Lpg0171 LegU1 564 [35] 





21 Lpg0181 N/A 912 This study 
22 Lpg0191 Ceg5 954 [42]  
23 Lpg0195 ravE 1005 [251] 
24 Lpg0196 ravF 1275 [251] 
25 Lpg0210 ravG 624 [251] 
26 Lpg0227 Ceg7 1104 [41] 
27 Lpg0234 SidE 4542 [29] 
28 Lpg0240 Ceg8 777 [42]  
29 Lpg0246 Ceg9 723 [253]  
30 Lpg0260 N/A 399 This study 
31 Lpg0276 LegG2 1497 [35] 
32 Lpg0284 Ceg10 1122 [254] 
33 Lpg0285 Lem2 684 [42]  
34 Lpg0294 N/A 693 [42]  
35 Lpg0364 N/A 306 This study 
36 Lpg0365 N/A 2688 [252]   
37 Lpg0375 N/A 600 This study 
38 Lpg0376 SdhA 4287 [29] 
39 Lpg0390 VipA 1056 [108] 
40 Lpg0401 Ceg11 675 [251] 
41 Lpg0402 LegA9 1701 [35] 
42 Lpg0403 LegA7 672 [255] 





44 Lpg0422 LegY 1347 [35] 
45 Lpg0436 LegA11 807 [35] 
46 Lpg0437 Ceg14 2001 [42]  
47 Lpg0439 Ceg15 1050 [251] 
48 Lpg0483 LegA12 1485 [35] 
49 Lpg0515 LegD2 930 [35] 
50 Lpg0518 N/A 846 [252]   
51 Lpg0519 Ceg17 2214 [42]  
52 Lpg0621 SidA 1422 [29] 
53 Lpg0634 N/A 1347 [252]   
54 Lpg0642 WipB 1572 [20] 
55 Lpg0695 LegA8 2847 [35] 
56 Lpg0696 Lem3 1713 [42]  
57 Lpg0716 N/A 1014 This study 
58 Lpg0733 ravH 1449 [251] 
59 Lpg0796 N/A 651 This study 
60 Lpg0898 Ceg18 729 [41] 
61 Lpg0926 ravI 1011 [251] 
62 Lpg0940 LidA 2190 [256] 
63 Lpg0944 ravJ 1176 [251] 
64 Lpg0945 LegL1 888 [35] 
65 Lpg0963 N/A 1242 [252]   





67 Lpg0968 SidK  1722 [38] 
68 Lpg0969 ravK 741 [251] 
69 Lpg1083 N/A 684 This study 
70 Lpg1101 Lem4 969 [42]  
71 Lpg1106 N/A 1275 This study 
72 Lpg1108 ravL 882 [251] 
73 Lpg1109 ravM 2061 [251] 
74 Lpg1110 Lem5 696 [42]  
75 Lpg1111 ravN 639 [251] 
76 Lpg1120 Lem6 1767 [42]  
77 Lpg1121 Ceg19 771 [42]  
78 Lpg1124 N/A 591 This study 
79 Lpg1129 ravO 1560 [251] 
80 Lpg1137 N/A 969 This study 
81 Lpg1144 CegC3 504 [41] 
82 Lpg1145 Lem7 2310 [42]  
83 Lpg1147 N/A 504 This study 
84 Lpg1148 N/A 1512 [252]   
85 Lpg1152 ravP 857 [251] 
86 Lpg1154 ravQ 1083 [251] 
87 Lpg1158 N/A 768 [252]   
88 Lpg1166 ravR 2013 [251] 





90 Lpg1183 ravS 1893 [251] 
91 Lpg1227 VpdB 1794 [30] 
92 Lpg1273 N/A 1065 [252]   
93 Lpg1290 Lem8 1587 [42]  
94 lpg1312 legC1 3405 [35] 
95 Lpg1316 ravT 1023 [251] 
96 Lpg1317 ravW 888 [251] 
97 Lpg1328 LegT 2463 [35] 
98 Lpg1355 SidG 2922 [29] 
99 Lpg1426 VpdC 884 [30] 
100 Lpg1449 N/A 2613 This study 
101 Lpg1453 N/A 519 This study 
102 lpg1483 LegK1 1587 [35] 
103 Lpg1484 N/A 810 This study 
104 Lpg1488 LegC5 2595 [35] 
105 Lpg1489 ravX 1032 [251] 
106 Lpg1491 Lem9 1242 [42]  
107 Lpg1496 Lem10 1797 [42]  
108 Lpg1551 ravY 747 [251] 
109 Lpg1578 N/A 450 This study 
110 Lpg1588 LegC6 2019 [35] 
111 Lpg1598 Lem11 1062 [42]  





113 Lpg1621 Ceg23 1317 [254] 
114 Lpg1625 Lem12 393 [42]  
115 Lpg1639 N/A 1317 This study 
116 Lpg1642 SidB 1251 [29] 
117 Lpg1654 N/A 1119 This study 
118 Lpg1660 LegL3 1479 [35] 
119 Lpg1661 N/A 1119 This study 
120 Lpg1666 N/A 1404 This study 
121 Lpg1667 N/A 1392 This study 
122 Lpg1670 N/A 891 This study 
123 Lpg1683 ravZ 1509 [251] 
124 Lpg1684 N/A 1398 This study 
125 Lpg1685 N/A 870 This study 
126 Lpg1687 mavA 1203 [251] 
127 Lpg1689 N/A 624 [252]   
128 Lpg1692 N/A 1311 This study 
129 Lpg1701 LegC3 1680 [35] 
130 Lpg1702 PpeB 1638 [162] 
131 Lpg1716 N/A 459 This study 
132 Lpg1717 N/A 1689 [252]   
133 Lpg1718 LegAS4 1635 [35] 
134 Lpg1751 N/A 1311 [252]   





136 Lpg1776 N/A 648 This study 
137 Lpg1797 rvfA 1281 [251] 
138 Lpg1798 marB 1197 [251] 
139 Lpg1803 N/A 936 This study 
140 Lpg1851 Lem14 663 [42]  
141 Lpg1884 YlfB 1215 [37] 
142 Lpg1888 N/A 1332 This study 
143 Lpg1890 LegLC8 1722 [35] 
144 Lpg1907 N/A 1806 This study 
145 Lpg1924 N/A 2793 This study 
146 Lpg1933 Lem15 615 [42]  
147 Lpg1947 Lem16 750 [42]  
148 Lpg1948 LegLC4 1005 [35] 
149 Lpg1949 Lem17 1341 [42]  
150 Lpg1950 RalF 1122 [28] 
151 Lpg1953 LegC4 2283 [35] 
152 Lpg1958 LegL5 1629 [35] 
153 Lpg1959 N/A 1995 This study 
154 Lpg1960 LirA 771 [36] 
155 Lpg1962 LirB 564 [36] 
156 Lpg1963 LirC 2100 [36] 
157 Lpg1964 LirD 1311 [36] 





159 Lpg1966 LirF 1566 [36] 
160 Lpg1969 PieE 1908 [162] 
161 Lpg1972 PieF 375 [162] 
162 Lpg1976 LegG1 858 [35] 
163 Lpg1978 SetA 1932 [253]  
164 Lpg1986 N/A 2853 This study 
165 Lpg2050 N/A 1059 This study 
166 lpg2131 LegA6 540 [35] 
167 Lpg2137 LegK2 1614 [35] 
168 Lpg2144 LegAU13 516 [35] 
169 Lpg2147 mavC 1449 [251] 
170 Lpg2148 N/A 1281 This study 
171 Lpg2149 N/A 360 This study 
172 Lpg2153 SdeC 4599 [29] 
173 Lpg2155 SidJ 2619 [257] 
174 lpg2156 SdeB 5178 [36] 
175 Lpg2157 SdeA 4518 [29] 
176 Lpg2166 Lem19 1260 [42]  
177 Lpg2176 LegS2 1824 [35] 
178 Lpg2199 mavD 633 [251] 
179 Lpg2200 CegC4 534 [41] 
180 Lpg2215 LegA2 1593 [35] 





182 Lpg2223 N/A 1224 This study 
183 Lpg2224 PpgA 1779 [162] 
184 Lpg2239 N/A 3858 This study 
185 Lpg2248 Lem21 2235 [42]  
186 Lpg2271 N/A 651 This study 
187 Lpg2298 YlfA 1275 [37] 
188 Lpg2300 LegA3 1401 [35] 
189 Lpg2311 Ceg28 3504 [251] 
190 Lpg2322 LegA5 1923 [35] 
191 Lpg2327 N/A 891 [252]   
192 Lpg2328 Lem22 384 [42]  
193 Lpg2344 mavE 627 [251] 
194 Lpg2351 mavF 921 [251] 
195 Lpg2359 N/A 444 This study 
196 Lpg2370 N/A 939 This study 
197 Lpg2372 N/A 1269 This study 
198 Lpg2382 N/A 1455 This study 
199 Lpg2391 sdbC 1305 [251] 
200 Lpg2392 LegL6 885 [35] 
201 Lpg2400 LegL7 1065 [35] 
202 Lpg2406 Lem23 1098 [42]  
203 Lpg2407 N/A 306 [252]   





205 Lpg2410 VpdA 1998 [30] 
206 Lpg2411 Lem24 828 [42]  
207 Lpg2416 LegA1 1107 [35] 
208 Lpg2420 N/A 552 [251] 
209 Lpg2422 Lem25 2622 [42]  
210 Lpg2424 mavG 1347 [251] 
211 Lpg2425 mavH 807 [251] 
212 Lpg2433 Ceg30 1761 [42]  
213 Lpg2434 N/A 492 This study 
214 Lpg2443 N/A 558 This study 
215 Lpg2444 mavI 615 [251] 
216 Lpg2452 LegA14 2766 [35] 
217 Lpg2456 LegA15 1413 [35] 
218 Lpg2461 N/A 639 This study 
219 Lpg2464 SidM 1944 [258] 
220 Lpg2465 SidD 1521 [29] 
221 Lpg2490 LepB 3882 [32] 
222 Lpg2498 mavJ 933 [251] 
223 Lpg2504 SidI 2899 [39] 
224 Lpg2505 N/A 888 This study 
225 Lpg2508 SdjA 2421 [257] 
226 Lpg2509 SdeD 1195 [29] 





228 Lpg2511 SidC 2751 [29] 
229 Lpg2523 Lem26 2340 [42]  
230 Lpg2525 mavK 1355 [251] 
231 Lpg2526 mavL 1368 [251] 
232 Lpg2527 N/A 1677 [252]   
233 Lpg2529 Lem27 1719 [42]  
234 Lpg2538 N/A 1416 This study 
235 Lpg2539 N/A 408 This study 
236 Lpg2541 N/A 834 [259] 
237 Lpg2546 N/A 1410 This study 
238 Lpg2552 N/A 1668 [251] 
239 Lpg2555 N/A 855 This study 
240 Lpg2556 LegK3 1386 [35] 
241 Lpg2577 mavM 759 [251] 
242 Lpg2584 SidF 2736 [29] 
243 lpg2588 LegS1 1255 [35] 
244 Lpg2591 Ceg33 495 [41] 
245 Lpg2603 Lem28 1305 [42]  
246 Lpg2628 N/A 753 This study 
247 Lpg2637 N/A 1212 This study 
248 Lpg2638 mavV 1383 [251] 
249 Lpg2692 N/A 531 This study 





251 Lpg2718 WipA 1560 [20] 
252 Lpg2720 LegN 1029 [35] 
253 Lpg2744 N/A 1170 [252]   
254 Lpg2745 N/A 1968 This study 
255 Lpg2793 LepA 3453 [32] 
256 Lpg2804 Lem29 1407 [42]  
257 Lpg2815 mavN 2052 [251] 
258 Lpg2826 Ceg34 1734 [42]  
259 Lpg2828 N/A 1257 This study 
260 Lpg2829 SidH 6675 [29] 
261 Lpg2830 LegU2 738 [35] 
262 Lpg2831 VipD 1863 [108] 
263 Lpg2832 N/A 1641 This study 
264 Lpg2844 N/A 1086 This study 
265 Lpg2862 LegC8 1911 [35] 
266 Lpg2874 N/A 885 [251] 
267 Lpg2879 mavO 1752 [251] 
268 Lpg2884 mavP 738 [251] 
269 Lpg2885 N/A 555 This study 
270 Lpg2888 N/A 1914 This study 
271 Lpg2912 N/A 1488 This study 
272 Lpg2936 N/A 735 This study 





274 Lpg2999 LegP 798 [35] 
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